1) Total spend on agency staff split by each of the following staffing groups:
2) Total spend on internal bank staff (split by the following categories)
3) Total number of staff employed on the bank, and of which, the number that also hold substantive contracts with the trust.
4) Does the trust outsource bank staff to NHSP? If so, how much was spent on outsourced bank staff?
5) Does the trust use rostering software, if so which provider (Allocate, SMART, DRS, SMI etc.)?
6) Does the trust directly engage locum staff? If so, how much of the trust’s medical locum spend was put through direct engagement in the last financial year?

Download response Agency Staff 170815

Please can you provide the following information for financial years FY2016/17, FY2017/18, FY2018/19, FY2019/20, FY2020/21, current financial year to date (FY2021/22 YTD):
1) Please provide the top 5 ON framework 3rd Party providers for nursing staff, by name, used by your trust for each of the listed financial years
2) Please provide the total annual expenditure for each of the top 5 ON framework 3rd Party providers, for nursing staff, used by your trust for each of the listed financial years
3) Please provide the top 5 OFF framework 3rd Party providers for nursing staff, by name, used by your trust for each of the listed financial years
4) Please provide the total annual expenditure for each of the top 5 OFF framework 3rd Party providers, for nursing staff, used by your trust for each of the listed financial years

3rd Party Temporary Staffing Providers. 110222.docx

1. The amount spent on employing agency/temporary/locum doctors in A&E departments in each month in 2016.
2. The number of FTE roles covered by agency/temporary/locum doctors in each month in 2016
3. The total number of FTE doctors working in the A&E department in each month in 2016.

Download response A&E agency staff 2016. 290317

1. The amount spent on employing agency, temporary and/or locum doctors in A&E departments in each month in 2019 and 2020.
2. The number of FTE roles in A&E departments covered by agency, temporary and/or locum doctors in each month in 2019 and 2020.
3. The total number of FTE doctors (including agency, temporary and/or locum and permanent staff) working in A&E departments in each month in 2019 and 2020.

Download response A&E agency staff and cost. 141021.docx

1. The amount spent on employing agency, temporary and/or locum doctors in A&E departments in each month in 2017 and 2018
2. The number of FTE roles in A&E departments covered by agency, temporary and/or locum doctors in each month in 2017 and 2018
3. The total number of FTE doctors (including agency, temporary and/or locum and permanent staff) working in A&E departments in each month in 2017 and 2018

Download response A&E staffing. 080519

You asked:
1) The total amount you spend on Agency Locum Doctors for 2017-2018: – £
2) For the above information to be broken down by grade and specialty (example provided below)
Specialty FY1/2 ST1/2 ST3-6 Staff Grade Consultant
A&E
Medicine
Anaesthetics
Medicine
Surgery
Paeds
Pathology
O & G
Ophthalmology
3) Your Bank spend on Doctors for 2017-2018 broken down as question (2): – £
4) The total number of hours filled and unfilled each month for Agency medical locums for 2017-2018.
5) The highest bank rate paid in 2017-2018, providing confirmation of the grade and speciality.
6) Your current Bank rates for each grade and speciality, including any specialities or sub specialities which have an escalated Bank rate.
7) The Trusts average rates for Agency medical locums from September, October, November and December collectively broken down by grade and specialty (example provided below).
Specialty FY1/2 ST1/2 ST3-6 Staff Grade Consultant
A&E
Medicine
Anaesthetics
Medicine
Surgery
Paeds
Pathology
O & G
Ophthalmology
(8) The spend for medical locums through off-framework agencies for 2017-2018 and confirmation of the off-framework agencies used.
(9) Please confirm any contracts you have in place for medical locums and please confirm the list of suppliers used for medical locums.

Download response Agency and Bank Doctors. 051218

Would you be able to provide me with the highest and lowest rates that have been paid for the below specialities please.
Could you please cover from January 2020 to present
General Nurse Band 5
ITU Nurse Band 6
Theatre Nurse Band 6
ODP Band 6
Advanced Scrub Practitioner
Radiographer Band 8
Pharmacist Band 8

Download response Agency and bank pay rates. 130421

Sourced Staffing Arrangements
1a. Do you have a master vendor or neutral vendor arrangement in place for sourcing agency staff? If so, please state which arrangement is in place
1b. Please state the name of the appointed supplier for the above arrangement
1c. Please state the start date of the contract with this supplier
1d. Please state the end date of the contract with this supplier
1e. Annual cost of your supplier in 18/19?

Agency Spend and Supply
2a. Please state the organisations total expenditure on agency (non-contract) staff for the financial year 18/19 (April 2018 – March 2019). Split by the following staffing groups
2b. Please state the name of the framework(s) you source your agency staff under, for each of the following staffing groups

Direct Engagement
3a. Does the organisation use a third party to provide a Direct Engagement/Outsourced Employment Solution? (This is where the NHS organisation sources agency staff via a recruitment agency but hold a direct contract between the organisation and the worker – there is often VAT savings associated to this employment model)
3b. Please state the name of the Direct Engagement/Outsourced Employment supplier (e.g. 247Time/Allocate, PlusUs, Retinue, Liaison etc.)
3c. Please state all staffing groups that are managed via your direct engagement provider; for example; Medical, Admin, Scientific staff
3d. Please state the start date of the contract with the DE supplier
3e. Please state the end date of the contract with the DE supplier
3f. What was the annual cost to the organisation for the provision of the direct engagement service in 18/19?
3g. Did the organisation procure these services via a framework? If so, please provide the full name of the framework

Internal Bank Spend
4. Please state the organisations total expenditure on internal bank staff for the financial year 18/19 (April 2018 – March 2019). Split by the following staffing groups

Medical Bank Supplier
5a. Please state the name of the technology provider used to manage the supply of your medical bank staff, inclusive of any outsourced or managed arrangements (i.e. NHSP, Patchwork, Allocate, Liaison, PlusUs, Locum’s Nest etc., please state if in-house)
5b. Please state the start date of the contract with your medical bank provider
5c. Please state the end date of the contract with your medical bank provider
5d. What was the annual cost to the organisations for the provision of bank provider services/software in 18/19
5e. Did the organisation procure these services via a framework? If so, please provide the full name of the framework

Download response Agency and bank staff. 021019

1. The total amount spent on agency temporary staff for the year 2021/22 (April ’21 to March ‘22) and between 31/10/2021 to 31/10/2022 for the following categories:
• Doctors
• Nurses
• AHP (all categories)
• Health Care Assistants
2. Bank Spend – Total amount spent on bank staff for the year 2021/22 (April ’21 to March ‘22) and between 31/10/2021 and 31/10/2022 year split into the Trusts’ staff groups (E.g. Medical, Nursing, Admin, AHP etc.) and speciality/grade (E.g. Consultants, GP, ICU Nurse, Acute Nurse, Occupational therapists, Pharmacists, Health Care Assistants, etc.) depending on how this is reported within the Trust.
3. Confirmation on whether the trust bank is currently operated by the trust themselves or by a private provider. If the latter please confirm the name of the provider.
The names and contact information of the individual divisional directors of Surgery covering the following treatment areas:
• General Surgery
• Urology
• Trauma and Orthopaedic
• Ear, Nose and Throat
• Ophthalmology
• Oral Surgery
• Neurosurgical Service
• Cardiothoracic
• Cardiology Service
• Dermatology Service
• Respiratory Medicine Service
• Gynaecology Service
• Rheumatology Service

Agency and Bank staff.100223.docx

1. Please quantify Agency recruitment splits (total spending and total WTE numbers) for medical, nursing and other employees (Forecasts 2019/20 and 2018/2019, and actuals 2018/19, 2017/2018, and 2016/2017)
2. Please quantify Bank recruitment splits (total spending and total WTE numbers) for medical, nursing and other employees (Forecasts 2019/20 and 2018/2019, and actuals 2018/19, 2017/2018, and 2016/2017)

Download response Agency and Bank Staff. 120320

Q1: Please can you confirm what percentage of your wage bill is spent on
(a) Agency staff?
(b) Bank staff?
Q2: What does the answer to Q1 (a) equate to in Pounds Sterling (£)?
Q3: What percentage of all your medical and clinical patient facing shifts are filled with staff that are paid above the ‘break glass’ ceiling rate (above the agency rules pay cap)?

Agency and Bank Staff costs.290623.docx

1)The total amount spent by the Trust on bank staff in 2021/22
2) The total amount spent by the Trust on agency staff in 2021/22
3) The total amount spent by the Trust on bank nurses in 2021/22
4) The total amount spent by the Trust on agency nurses in 2021/22
5) The largest amount spent by the Trust on a single agency nurse shift in 2021/22

Agency and Bank staff spend.181022.docx

1. Please provide agency spend for the staff group for 2019-20
2. Please provide bank spend for the staff group for 2019-20
3. Please confirm which model you have in place for managing the staff group: Email to preferred supplier List, a Master Vendor, a Neutral Vendor, or a Software cascade to a preferred supplier list
4. If you have a master vendor or neutral vendor in place, please confirm who this contract is with and the date on which this contract expires
5. Please confirm what percentage of bookings over the last 6 months have been within the NHSI/E agency caps (an approximation based on NHSI data submissions is fine)
6. Please confirm which provider manages your direct engagement process, the fee for the service and the date on which this contract expires (no this is not relevant for Nursing)
7. Please confirm what percentage of bookings are processed with a VAT savings by your direct engagement provider
8. Is your bank managed by an external bank provider (e.g. NHS Professionals, Bank Partners) or in-house? Please confirm who is the external bank provider and when the contract expires if relevant
9. Is your bank managed via software? If so, please confirm which software.
Is the Trust likely to undertake any procurement activity over the next 18 months related to provision or bank or agency services or software for the relevant staff group.

Download response Agency and Bank staffing. 240620

1. Please provide agency spend for the staff group for 2019-20
2. Please provide bank spend for the staff group for 2019-20
3. Please confirm which model you have in place for managing the staff group: Email to preferred supplier List, a Master Vendor, a Neutral Vendor, or a Software cascade to a preferred supplier list
4. If you have a master vendor or neutral vendor in place, please confirm who this contract is with and the date on which this contract expires
5. Please confirm what percentage of bookings over the last 6 months have been within the NHSI/E agency caps (an approximation based on NHSI data submissions is fine)
6. Please confirm which provider manages your direct engagement process, the fee for the service and the date on which this contract expires (no this is not relevant for Nursing)
7. Please confirm what percentage of bookings are processed with a VAT savings by your direct engagement provider
8. Is your bank managed by an external bank provider (e.g. NHS Professionals, Bank Partners) or in-house? Please confirm who is the external bank provider and when the contract expires if relevant
9. Is your bank managed via software? If so, please confirm which software.
Is the Trust likely to undertake any procurement activity over the next 18 months related to provision or bank or agency services or software for the relevant staff group.

Download response Agency and Bank staffing. 240620

1. Please provide agency spend for the staff group for the Financial Year 2021-22 (please specify your start and end date used) Financial Year indicating what percentage is on and off-framework (for example, “£4,650,000 – c80% framework / 20% off-framework”).
2. Please provide bank spend for the staff group for Financial Year 2021-22 (please specify your start and end date used)
3. Please confirm which model you have in place for managing agency within the staff group: Email to preferred supplier List, a Master Vendor, a Neutral Vendor, or a Software cascade to a preferred supplier list
4. Please confirm what percentage of bookings over the last 6 months have been within the NHSI agency caps (an approximation based on NHSI data submissions is fine)
5. Please confirm which provider manages your direct engagement process, the fee for the service and the date on which this contract expires (no this is not relevant for Nursing)
6. Please confirm what percentage of bookings are processed with a VAT savings by your direct engagement (DE) provider (average for last 3 months –December, January and February)
7. Is your bank managed by an external bank provider (e.g., NHS Professionals, Bank Partners) or in-house? Please confirm who is the external bank provider and when the contract expires if relevant
8. Is your bank managed via software? If so, please confirm which software.
9. Is the Trust likely to undertake any procurement activity over the next 18 months related to provision or bank or agency services or software for the relevant staff group?
10. If you have a managed service, master vendor or neutral vendor in place for Agency medics/Agency doctors please confirm who this contract is with and the date on which this contract expires
11. If you have a managed service, master vendor or neutral vendor in place for Agency Nurses please confirm who this contract is with and the date on which this contract expires

Agency and Bank staffing and spend.150822.docx

1. What is the total value of spend by your NHS Trust with on-framework and off-framework recruitment agencies by staff group (see staff groups below) on a temporary basis? Please provide this information for the following years (please fill in the tables below).
Note: Please provide total spend inclusive of salaries and agency margin / fees.
Note: If cannot provide split of spend by on- vs off- framework agencies, please provide total spend.
2. Do you use insourcing providers?
Note: Insourcing definition: Insourcing of Clinical Services – NHS SBS
3. If yes to previous question (use of insourcing providers), what is the total value of spend, listed by speciality and insourcing provider used for Apr-22 to Mar-23?
Note: If an insourcing provider covers multiple specialities, please list that provider multiple times (one row for each speciality).

Agency and insourcing spend.260723.docx

1.) A) Last financial year agency locum spend
B) Please break down into Specialty and Grade
2.) A) The retention rates for permanent and fixed term staff – Doctors and Nurses only
B) Please break down into Specialty and Grade
3.) A) Please provide the Names of agencies used to fill vacancies
B) how much each agency charges
4.) Please provide your trust wide budgeted establishment per specialty and grade for Doctors
– Name of Speciality / Division or Directorate
– Consultants, Locum Consultant Contract and Associate Specialists
– CT/ST3 – CT/ST7, Specialty Doctors, Senior Clinical Fellows, CESR Fellow or Middle Grade Level
– FY1-ST2, Trust Grade, Junior Clinical Fellow or SHO level
5.) Please what is your actual current establishment for Doctor
– Name of Speciality / Division or Directorate
– Consultants, Locum Consultant Contract and Associate Specialists
– CT/ST3 – CT/ST7, Specialty Doctors, Senior Clinical Fellows, CESR Fellow or Middle Grade Level
– FY1-ST2, Trust Grade, Junior Clinical Fellow or SHO level

Agency and Staff details.260423.docx

1. Staff Numbers (Average over the whole year or the count on Tuesday, March 31st 2015)
2. Staff Cost
3. Agency Hours
4. Agency Spend
I would greatly appreciate it if you could supply this information for the year 2014/15 (April ’14 to March ‘15).

Download response Agency costs 2014/2015 040216

How much have you spent on agency staff during days in which industrial action was taken by staff in your trust since 1st December 2022?

Agency costs during industrial action.030823.docx

All questions are shown as received by the Trust.
How much have you spent on agency staff during days in which industrial action was taken by staff in your trust since 1st December 2022?

Agency costs during industrial action.170823.docx

1. The Trust’s spend on agency workers (both on-framework and off-framework);
2. By role type;
3. With which provider/s and how much the Trust spends;
4. and when the current contract ends with your agency staffing provider.

Agency details.230623.docx

1) Since 1st April 2020, what are the top three / most expensive hourly rates (including all cost elements i.e. pay, agency fee, NI, PAYE taxes, VAT and any associated managed service / master vendor fee) paid for agency doctors working at each of the following grades?
Please respond to question one by populating the template below as per the example.
Please clarify the Specialty for which each of the rates was paid as shown.

2) Since 1st April 2020, what are the bottom three / least expensive hourly rates (including all cost elements i.e. pay, agency fee, NI, PAYE taxes, VAT and any associated managed service / master vendor fee) paid for agency doctors working at each of the following grades?
Please respond to question one by populating the template below as per the example.
Please clarify the Specialty for which each of the rates was paid as shown.

3) For each of the “job titles” (Grade / Specialty) mention in your response to questions 1 and 2, please disclose the average hourly rate paid for agency doctors of the same Grade and Specialty since 1st April 2020.
There should be a maximum of 18 unique “job titles” in the tables above; please use the template below as per the example given at the bottom.

Download response Agency doctor pay rates. 130421

• The total amount you spend on Agency Doctors & Nurses for the financial year 16/17 (April – March)

• For the above information to be broken down by Banding / Grade and also specialty

Download response Agency doctors and nurses 2016-2017. 231117

1. The trust’s completed ‘Detailed agency collection” for month 12 of 2016-17, showing the year to date figures. (Example attached)
If for any reason the trust is minded not to provide this document, please list the five specialties for which the trust had the highest agency staff costs – as a % of total pay costs for the specialty – in 2016-17 in the table below. Please also fill in the cells detailing expenditure. If the trust’s accounts have not yet been audited, please use the unaudited figures.
2. Please state the total number of shifts for which the trust breached the national pay cap for medical agency staff in 2016-17 (55% above basic rates), and break this total down for each specialty where the breach occurred (its fine to only detail the top five specialties).
3. Please state the total number of shifts for the trust breached the national pay cap for agency nursing staff in 2016-17 (55% above basic rates), and break this total down for each specialty where the breach occurred. (It’s fine to only detail the top five specialties).
4. Please state the total number of shifts which required CEO sign off, and break these down for each specialty.
5. Please state the ten shifts for agency medical staff for which the highest hourly rate was paid. Please state the rate paid and the specialty.
6. For individual medical locums who have incurred the greatest total expenditure for the trust in 2016-17, please state the total amounts paid by the trust in the year in relation to these individuals’ work. Please also state their specialty. E.g. Medical locum 1, emergency medicine, total expenditure by the trust in 2016-17; £196,000

Download response Agency expenditure 2016-2017. 050717

• The total amount you spend on Agency Locum Doctors for the financial year 15/16 (April – March)
• For the above information to be broken down by grade and specialty (example provided below)

Download response Agency Locum Doctor spend for 2015-2016 270616

You asked:
1. What percentage fill rates (doctors) were reached between January and present?
2. Does your organisation use a Direct Engagement scheme? If so, who provides it and when does their contract expire?
3. What percentage of bookings are made outside of the DE model (non-DE)?
4. Do you outsource any of the following services to external companies:
• Provision of Residential Medical Officers
• Gastroenterology/Endoscopy
• Dermatology
• Radiology
5. Do you use agencies for national and international permanent doctor and/or nursing recruitment? If so, do you employ nurses from the Philippines?

Download response Agency locum doctor supply. 151118

Please can you let us know what the Trust as a whole (including hospitals that are run by you) spent on employing agency locum Doctors and Consultants last year.

Download response Agency locum doctors and consultants spend for 2015-2016 010716

1. Over the last 5 years, broken down by year, the total number of hours of work provided to the trust by non-substantive doctors, either via a locum agency or a bank staffing system, and the total cost to the trust of those hours.
2. The above information broken down by staff sourced through agency and those sourced through your bank staffing arrangement.
3. The figures (hours and spend for each of locum and bank) provided in answer to 2. broken down first by specialty and then grade of doctor.
4. The standard hospital hourly rate of pay for each of the specialties and grades listed in answer to 3.
5. The hospital and NHS capped rates for each of the specialties and grades listed in 3. if different to the rate listed in 4.
6. For each category created in response to 3. (i.e bank haematology registrars), the percentage of hours worked at standard rate, above the standard rate, and above the capped rate if different from the standard rate.
7. What penalties, if any, are levied against the trust if it exceeds the ‘capped’ rate.
8. What penalties were levied against the trust for breaking the cap in each of the years for which data has been provided.
9. If the trust utilises a Bank Partner, what is the cost of said Partner and how does this cost manifest e.g. lump sum, fee per position filled etc.

Download response Agency, locum or bank staff. 181019

How much did the trust spend on agency locums last year? Broken down into SHO, Middle Grade and Consultants

If I could please have this information on the following specialities: A&E, Acute Medicine, General Medicine, Radiology and Paediatrics I would be appreciative.

Download response Agency locum spend. 010818

Please could you send me the agency locum spend for the trust for the last financial year. I would like the spend for doctors only.

Please include the agency spend in each specialty breaking it down into the different grades (SHO, Middle Grade, Consultant).

Please could you also provide the spend on introductory fees for doctors for each specialty based on Doctors taken onto NHS contracts.

Download response Agency locum spend 2015-2016 050816

Could you please let me know the locum agency spend from May 2016 – Present? This refers directly to the cardiology department only; the staff will be Cardiographers, Cardiac Physiologists, Echo cardiographers, please note this is not referring to locum doctors or specialists.

These staff will fall under AHP/HSS or healthcare.

Download response Agency locum spend in Cardiology. 040717

1. Last financial year agency locum and bank spend
• Please break down into Specialty and grade
2. Names of agencies used to fill vacancies
– How much does each agency charge
3. What is your trust wide budgeted establishment per specialty and grade for doctors
– Name of Speciality / Division or Directorate:
– Consultants, Locum Consultant Contract and Associate Specialists:
– CT/ST3 – CT/ST7, Specialty Doctors, Senior Clinical Fellows, CESR Fellow or Middle Grade Level:
– FY1-ST2, Trust Grade, Junior Clinical Fellow or SHO level:
4. What is your actual current establishment for doctor
• Name of Speciality / Division or Directorate:
– Consultants, Locum Consultant Contract and Associate Specialists:
– CT/ST3 – CT/ST7, Specialty Doctors, Senior Clinical Fellows, CESR Fellow or Middle Grade Level:
– FY1-ST2, Trust Grade, Junior Clinical Fellow or SHO level:

Download response Agency locums and Doctors. 301120

You asked: All questions are shown as received by the Trust.
1. How much have you spent on agency midwives each of the last five years?

2. What was the most expensive agency midwife shift over the last five years?

Agency midwives.140923.docx

1. What was the total cost for your trust, including fees and any other on-costs, for midwives supplied by an agency, broken down by the months in the table below?

2. What was the cost for your trust for the fees and any other on-costs, for midwives supplied by an agency, broken down by the months in the table below?

3. What was the total number of hours worked by midwives supplied by an agency, broken down by the months in the table below?

4. What was the total cost for your trust for midwives working overtime, broken down by the months in the table below?

5. What was the total number of hours worked by midwives working overtime, broken down by the months in the table below?

6. What was the total cost for your trust, for midwives supplied by the bank, broken down by the months in the table below?

7. What was the total number of hours worked by midwives supplied by the bank, broken down by the months in the table below?

8. Does your trust pay bank rates at the individual’s actual pay point or higher or lower than their pay point?

Download response Agency midwives and pay 2015 140316

1. What was the total cost for your trust, including fees and any other on-costs, for midwives supplied by an agency, broken down by the months in the table below?
2. What was the total number of hours worked by midwives supplied by an agency, broken down by the months in the table below?
3. What was the total cost for your trust for midwives working overtime, broken down by the months in the table below?
4. What was the total number of hours worked by midwives working overtime, broken down by the months in the table below?
5. What was the total cost for your trust, for midwives supplied by the bank, broken down by the months in the table below?
6. What was the total number of hours worked by midwives supplied by the bank, broken down by the months in the table below?

Download response Agency Midwives and pay 2016. 300117

1. On how many occasions in the 2019/20 financial year did you spend £1,500 or more to employ an agency nurse for a single shift? For each occasion, please state the amount paid, how many hours they were asked to work as well as the job title and department the nurse was deployed in.
2. On how many occasions in the 2019/20 financial year did you spend £3,000 or more to employ an agency doctor for a single shift? For each occasion, please state the amount paid, how many hours they were asked to work as well as the job title and department the nurse was deployed in.

Download response Agency nurse and locum doctor expenditure. 261020

1. Are off frame work agencies used to cover nurse shifts?
2. On a month by month basis, what was your spend on agencies supplying off frame work nurses from 1st November 2015 to date? Please break down this information by RGN, ITU, CRITICAL, ODP’S, SCRUBS, PAEDS, HDU, A&E, AMU, ADVANCED NURSE PRACTITIONER, HCA’S ETC. If this is not possible then please break down by nurse bands.
3. Which agencies supply off frame work nurses?
4. On a month by month basis, how many times was the break glass clause used from 1st November 2015 to date?
5. Please pick 10 random shifts which were filled via off frame work agencies between 1st November 2015 to date and provide the following for each of the 10 shifts picked at random (it is not essential to name the specific agencies which relate to the chosen shifts):
• Amount that was paid to the agency to fill each shift or the hourly rate paid to the agency
• Number of hours in the shift
• Date shift filled
• The type of nurse used to fill the shift e.g. RGN, ITU, HDU, CRITICAL, A&E, PAEDS etc.
• The type of shift or shift start time e.g. Long Day or Long Night or alternatively shift start time e.g. 08:00 etc.

Download response Agency nurse cover November 2015 – April 2016. 061216

• The total amount you spend on Agency Nurses for the financial year 15/16 (April – March)
• For the above information to be broken down by banding and specialty (example provided below)

Download response Agency nurse expenditure for 2015-2016 010716

Average Band 5 Agency Nurse Rates
Please respond to question one by populating the template below.
a) Average cost per hour (inclusive of base pay, agency margin, NI, PAYE etc. but excluding VAT) paid for Band 5 agency Nurses for Standard Day hours between 1st April 2020 and 31st January 2021
b) Average cost per hour (inclusive of base pay, agency margin, NI, PAYE etc. but excluding VAT) paid for Band 5 agency Nurses for Saturday & Evening hours between 1st April 2020 and 31st January 2021.
c) Average cost per hour (inclusive of base pay, agency margin, NI, PAYE etc. but excluding VAT) paid for Band 5 agency Nurses for Sunday & Bank Holiday hours between 1st April 2020 and 31st January 2021

Part 2 – High Rate Band 5 Nurse Hours
For the below questions, please answer number of shifts rather than number of hours if this figure is easier to obtain – please clarify which unit you’re referring to within your response. Please also indicate how many individual nurses make up the figure in response to each of the below.
a) For Band 5 Agency Nurses, regardless of rate type (i.e. Days, Nights, Bank Holidays etc.), how many hours since 1st April cost £50 per hour or more?
b) For Band 5 Agency Nurses, regardless of rate type (i.e. Days, Nights, Bank Holidays etc.), how many hours since 1st April cost £75 per hour or more?
c) For Band 5 Agency Nurses, regardless of rate type (i.e. Days, Nights, Bank Holidays etc.), how many hours since 1st April cost £100 per hour or more?

Download response Agency Nurse Rates and hours. 130421

Could the trust please provide information on how much has been spent on agency nurses?

1) This financial year to date
2) 2018/19 financial year
3) 2017/18 financial year

Are these amounts higher, lower or within the budgets allocated for agency staff?

Are there any measures being implemented to lower the reliance or use of agency staff?

Download response Agency nurses. 041019

Could you provide me with a breakdown of spend on agency nurses and midwives between May 2022 and May 2023 as below
1. Number of shifts invoiced by each provider trust has used for agency nursing
2. Framework spend on agency nursing and midwifery broken down to spend per Framework provider
3. Off-framework spend on agency nursing and midwifery broken down to spend per off-framework provider

Agency nurses and midwives.240523.docx

Please could you tell me what the cost was in wages to the trust for agency nursing during the months of January and February and July to December 2015? (Could the cost per month be separated, please?)

Please include the wage bill for the two sites, and, if at all possible, please can you break them down into departments and sites?

However, if this is not possible, please still provide me with the overall cost.

Please could you tell me what the cost was in wages to the trust for all agency staff during the months of January to December 2015? (Could the cost per month be separated, please?)

Please include the wage bill for the two sites, and, if at all possible, please can you break them down into departments and sites?

However, if this is not possible, please still provide me with the overall cost.

Download response Agency nursing costs – January and February and July to December 2015 080116

1) How many agency nursing shifts have your Trust used SNG or Thornbury Nursing Services for between 1st October 2020 and 30th November 2020?
2) Please provide a breakdown of the amount of shifts per ward or department where SNG or Thornbury Nursing Services were used in 1st October and 30th November 2020?
3) How many agency nursing shifts have your Trust used Nutrix nursing agency for between 1st October 2020 and 30th November 2020?
4) Please provide a breakdown of the amount of shifts per ward or department where Nutrix were used between 1st October 2020 and 30th November 2020.
5) Please name any other OFF CONTRACT SUPPLIERS who have been utilised by the Trust between 1st October 2020 and 30th November 2020 above the NHS Improvement + 50% caps and how many shifts each of these agencies have filled.

Download response Agency nursing. 130421

All questions are shown as received by the Trust.
Please can you confirm how much was spent on agency nursing between the period April 1st 2023 and 31st June 2023?

Further to this, please can you confirm how much of this total was spent with Off-framework agencies?

Agency nursing.160823.docx

Please could you answer the following questions in relation to the trusts agency nursing usage in financial year 2022-2023
1. How much in total did the trust spend on agency nursing supply?
2. How was that total split between Community/ Acute/ Mental Health Nursing (please delete as appropriate)?
3. Of the total spend, how much of it was spent with off-framework agencies?
4. Who within the trust is responsible for reporting on off-framework usage?

Agency Nursing.200723.docx

All questions are shown as received by the Trust.
Please answer all questions with the relevant data for the month of March 2023 ( 1st to the 31st March ) for your nursing – inclusive of Adult, Mental Health, Critical, Community and District where applicable for both frameworks and off frameworks Agencies.
Information requested :
1. The total number and spend of nursing shifts sent to agencies to fill ( frameworks and off frameworks ) Please provide these totals separately
2. The total number and spend of nursing shifts filled by agencies ( frameworks and off frameworks ) Please provide these totals separately
3. The total number and spend of critical banded nursing shifts sent to agencies to fill. ( frameworks and off frameworks ) Please provide these totals separately
4. The total number and spend of critical banded nursing shifts filled by agencies. ( frameworks and off frameworks ) Please provide these totals separately
5. The total number and spend of ‘breaches’ for filling a shift with agency nurses (Registered Nurses) not within the NHSI capped charge rates.
6. Please provide a list of all frameworks agencies that are currently ‘breaching’ ‘breaches’ when filling a shift with agency nurses (Registered Nurses) not within the NHSI capped charge rates.
7. Please provide a list of all frameworks agencies which supply the trust with nursing staff.
8. Please provide a list of off framework agencies which have supplied (from 1st January 2023 to 31st March 2023) into the trust with nursing staff across all sites.
9. From 1st March 2023 to 31st March 2023, please list the wards/ departments you have requested shifts for off framework agencies.

Agency Nursing.230823.docx

All questions are shown as received by the Trust.
For nursing registered and unregistered please could you share the below agency data:
1. For registered Nursing
a. How many hours were used in the last year?
b. What is your spend over the corresponding period?
2. For unregistered Nursing
a. How many hours were used in the last year?
b. What is your spend over the corresponding period?
Please could you also confirm if you have a:
3. Master vendor and their contract end date?
4. Neutral vendor and their contract end date?

Agency Nursing, Master Vendor and Neutral Vendor.160823.docx

1) How many agency nursing shifts have your Trust used SNG or Thornbury Nursing Services for between 01 December 2020 and 10 February 2021
2) Please provide a breakdown of the amount of shifts per ward or department where SNG or Thornbury Nursing Services were used between 01 December and 10 February 2021
3) How many agency nursing shifts have your Trust used Nutrix or Greenstaff for between 01 December 2020 and 10 February 2021?
4) Please provide a breakdown of the amount of shifts per ward or department where Nutrix, or Greenstaff were used between 01 December 2020 and 10 February 2021
5) Please name any other OFF CONTRACT SUPPLIERS who have been utilised by the Trust between 01 December 2020 and 10 February 2021above the NHS Improvement + 50% caps and how many shifts each of these agencies have filled.
6) If for any reason you are unable to supply data up until 10 February please provide the data until 31 January 2021

Download response Agency nursing shifts. 130421

1) How many agency nursing shifts have your Trust used SNG or Thornbury Nursing Services for between 1st December 2021 and 10th February 2022
2) Please provide a breakdown of the number of shifts per ward or department where SNG or Thornbury Nursing Services were used between 1st December 2021 and 10th February 2022
3) How many agency nursing shifts have your Trust used Nutrix, MED GEN, Greenstaff for between 1st December 2021 and 10th February 2022?
4) Please provide a breakdown of the number of shifts per ward or department where Nutrix, or Greenstaff were used between 1st December 2021 and 10th February 2022
5) Please name any other OFF CONTRACT SUPPLIERS who have been utilised by the Trust between 1st December 2021 and 10th February 2022
6) If for any reason you are unable to supply data up until 10th February please provide the data until 31st January 2022

Agency nursing shifts. 210222.docx

1) How many agency nursing shifts have your Trust used Thornbury nursing services for between 1st July 2019 and 31st July 2019?

2) How many agency nursing shifts have your Trust used Thornbury nursing services for between the dates of 1/8/2019 and 18/8/2019?

3) Please provide a breakdown of the amount of shifts per ward or department where Thornbury were used in July 2019 and 1/8/19- 18/8/19/.

4) Please provide a breakdown for July 2019 of the amount of shifts filled at your Trust by other off contract nursing providers (ie non-framework). Please break this down in the same format (i.e. by ward or department) as question 3.

Download response Agency nursing shifts. 260919

1. Which agency filled the most nursing shifts at your Trust in the last 30 days and how many hours or shifts did they fill?
2. How many of the shifts filled by agency nurses in the last 30 days were above cap?
3. Which wards or departments and sites within your Trust utilised agency nurses in the last 30 days and how many shifts were booked on each?
4. How many nursing shifts were filled by Framework agencies above the 50% NHS Improvement increased caps in the last 30 days?
5. Please list the nursing agencies utilised in the last 30 days above the 50% increased NHS Improvement capped rates by your Trust.

Download response Agency Nursing shifts. 2609192

1. How many agency nursing shifts have your Trust used Thornbury nursing services for in the last 30 days?
2. Please provide a breakdown of the amount of shifts per ward or Departments that Thornbury filled for agency nurses in the last 30 days.
3. What other nursing agencies do you use off contract/off framework?
4. How many nursing shifts did other off contract agencies fill in the last 30 days?
5. Are there any other services linked to your Trust that utilise TNS or any other off contract supplier re Prisons, or community based services? If so please provide a list of these services and the amount of nursing shifts filled in each over the last 30 days

Download response Agency nursing shifts. 2609193

1. Can you confirm names of all agencies supplying into the trust directly or via the NHS Professionals platform for nursing staff specifically for both Band 2 and Band 5 requirements, including off-framework agencies.
a. With the above information, can this be broken down by
• Volume of supply (per month for the last 12 months)
• Total trust spend per agency (per month for the last 12 months)
• By AfC banding of shift request and speciality of nurse
2. Please can you confirm how many shifts have been filled by agencies supplying Band 5 Registered Nursing staff at or below NHSI agency capped rates within the last 12 month period?
3. Please can you confirm how many shifts have been filled by agencies supplying Band 5 Registered Nursing staff above NHSI agency capped rates within the last 12 month period?
4. For the same 12 month period, can you confirm the average charge rate per hour for Band 5 Nursing agency staff across:
Week Days:
Night Shift/Saturday shifts:
Sunday shift/Bank Holiday:
5. Lastly can you confirm the highest agency nurse hourly charge rate, and their speciality?

Agency Nursing Spend.260822.docx

Questions on the trust’s ceiling for agency nurse spend, as per the rules introduced from October 1, 2015:

1) How many applications has your trust made to increase its ceiling for agency nurse spend?
2) How many of these applications were successful?
Questions on the agency pay caps – specifically regarding nurses – as per the rules introduced on November 23, 2015:
3) On how many shifts has your trust overridden the rules for hourly rate agency caps – specifically for nurses – since the rules were introduced?
4) Across how many weeks have these breaches (in question 3 above) occurred? .
5) How many band five nurses has your trust overridden the rules for?
6) How many band six nurses has your trust overridden the rules for?
7) How many band seven nurses has your trust overridden the rules for?
8) How many band eight nurses has your trust overridden the rules for?

Download response Agency nursing spending rules from October 01 2015 150216

1. Breakdown of shifts (Numbers only) filled by individual Nursing Agencies (by name of agency) in Trust operated theatre wards for ‘Surgical First Assistants’, Operating Department Practitioners’ and ‘SCRUB Nurses’ for March 1st 2021- April 30th 2021
2. Individual Charge rates for nursing agencies for theatre staff March 1st 2021- April 30th 2021
3. Number of shifts filled by individual ‘Off Framework Agencies’ March 1st 2021-April 30th 2021
4. Total Cost for each Nursing Agency used by theatre departments financial year April 2020- April 2021

Download response Agency nursing usage. 250521

1. Please provide the 10 largest individual agency payments for core hours your trust has authorised above the agency worker price caps set by NHS Improvement for each of the following medical grades for (a) 2017-18 and (b) 2018-19 (to date).
• Foundation Year 1
• Foundation Year 2
• Registrar ST1-2
• Registrar ST3
• Speciality staff/staff grade
• Associate specialist
• Consultant

Please provide the figures excluding VAT, as a rate per hour, what the cap was at that particular point in time, the month it was paid and the type of shift being filled.

2. Please provide the 10 largest individual agency payments for unsocial hours your trust has authorised above the agency worker price caps set by NHS Improvement for each of the following medical grades for (a) 2017-18 and (b) 2018-19 (to date).
• Foundation Year 1
• Foundation Year 2
• Registrar ST1-2
• Registrar ST3
• Speciality staff/staff grade
• Associate specialist
• Consultant

Download response Agency Payments. 090419

I would like you to send me the locum agency spend in the AHP/HSS division of the hospital for Pharmacists and Pharmacy Technicians. I would like to know the spend for 2018 with each agency- if this is not possible then I’d like to know overall spend for the year for both Pharmacists and Pharmacy Technicians.

Download response Agency Pharmacists and Pharmacy Technicians. 240119

1. Can you provide the total number of times you have exceeded the agency price cap limits for each year from 2016 -2020 broken down by each quarter right up to the most recent available data?
2. Can you provide the maximum amount paid on a per hour basis for an agency shift for each year from 2016 -2020 broken down by each quarter right up to the most recent available data?
3. I am aware that there are country wide NHSI caps but for some areas (such as medical), there are agreed Pan London ceiling rates which are higher than the NHSI caps. Could another column in the data be provided to show when those London caps are exceeded?

Download response Agency price caps. 100821.docx

You asked:
1. How many doctors have been booked outside of IR35 since April 2017?
2. What is your yearly trust spend on agency locum doctors via framework agencies, broken down into grade and specialty?
3. What is your yearly trust spend on agency locum doctors via OFF-framework agencies, broken down into grade and specialty?
4. What is your average total charge rate for a locum consultant doctor?
5. Who is the highest paid locum Consultant, what is the hourly rate and in what specialty do they practice?
6. Please can you outline your spend per agency, broken down by grade and specialty of doctor over the past 12 months?

Download response Agency Recruitment. 051218

1. What was the highest amount you paid (including any agency commission/charges) for a single shift filled by each of the following a. a doctor b. a GP (if employed) c. a registered nurse and d. a non-registered support worker/healthcare assistant in the period March 28th to April 19th 2015? Please include date and length of shift and grade of doctor/nurse involved, the department they were needed for (e.g. A&E) and the agency which supplied the doctor/nurse in each case.
2. What percentage of shifts covered by agency staff during this time period were paid in accordance with either an NHS wide or a local framework, and what proportion were off framework?
3. What was your total spend on temporary (locum, agency and bank) clinical staff for 2014-15? Please include doctors, nurses and healthcare assistants/support workers in your answer. What were the comparable figures for 2013-14 and 2012-13?

Download response Agency Shift Cost 050515

I am making a Freedom of Information Request to gain information on the volume of shifts that have been filled by agencies within nursing and medical locums (Doctors) at your organisation.

Further to this what is the percentage of shifts filled for Medical and for Nursing above the NHSi Cap.

Download response Agency shifts. 250817

Please can you outline your agency spend into each 52 weeks or 12 months for the year 2018 (I understand the year has not finished yet so up to OCTOBER 2018) would be sufficient.
1. How many agencies did your trust use in the year of 2018?
2. How much was spent on agency nurses in 2018?
3. On December 25th 2017, how many shifts went nursing shifts went unfilled?
4. What is the highest hourly rate paid to a locum agency in 2018 and what band was this nurse i.e. band 5 general.
5. Please list the names of agencies that we used in year 2018 and list the total amount of spend for each used.
6. What is the total number of different nurse locums did the trust use in 2018.
7. What was the highest hourly rate paid to an agency for a nurse in 2018 – Please state what agency this was and what band they were.
8. Of all agencies used, were any off framework? If so, what are the agencies called?
9. Who is the head of procurement at your Trust who approves agency use?
10. Who approves above-cap and/or off-framework usage?
11. Who are your tier 1 and tier 2 agencies?

Download response Agency spend.260219

Please can I have the following information under The Freedom of Information Act (FOIA)
Total Spend on Temporary Locums broken down into the following specialties and sites of the Trust – From April 2022 – April 2023
Medicine
Surgery
Trauma & Orthopaedics
Paediatrics
A&E
Anaesthetics
Obstetrics & Gynaecology

Agency spend.300623.docx

I would like to request the following information:

The trusts total temp agency spend for the financial year 22/23 broken down by Doctors, Nursing and AHP spend.

Agency spend for 2022-2023.210623.docx

I would like you to send me the locum agency spend for Doctors for the hospital in acute settings as well as the community for each specialism.

I would like to know the spend from January 2018 – present, also including the amount of locums that this refers to per month, broken down on a monthly basis. In the breakdown if you could please include the agencies that provide the locums also broken down numerically.

Download response Agency spend for doctors. 240119

The total amount spent on agency temporary staff between January 21 – December 21 for the following categories:
Doctors
Nurses
AHP’s

Agency Spend for Doctors, Nurses and Allied Health Professionals. 070222.docx

I would like to request the below information from the trust for year 2021/2022.
1. What was your agency spend for nursing and midwifery for the year April 2021- April 2022?
2. How much of the spend was above the NHSI rate caps April 2021- April 2022?
3. Have you used off-framework in the last 6 months?
4. If so, what was the total spend?
5. Which off-framework agencies have you used?
6. How many unfilled shifts have you had for:
a. A&E
b. ITU
c. General
d. Theatres
e. Mental Health
f. CPN
g. Midwifery
h. Paediatrics
i. Neonatal
j. HCA
7. If this cannot be provided via speciality, please could I have an over-all number?
8. How many vacancies do you have for band 5/6 nurses in the following areas?
a. A&E
b. ITU
c. General
d. Theatres
e. Mental Health
f. CPN
g. Midwifery
h. Paediatrics
i. Neonatal
j. HCA
9. How many incident/critical incidents have been declared as a result of staffing?
10. Who is the nurse bank/temporary staffing manager?
11. What are the contact details for the Nurse Bank / Temporary Staffing Manager?

Agency spend for nursing and midwifery.211122.docx

Can you please assist me with retrieving the total Agency spend for Locum Doctors only within Radiology over the following months, within your Trust or Health Board?

Download response Agency spend for Radiology locum doctors December 2015 to May 2016 060916

Can you please assist me with retrieving the total Agency spend for Medical Locum Doctors within Radiology over the following months, within your Trust or Health Board?
August 2016
September 2016
October 2016
November 2016
December 2016
January 2017

Download response Agency spend in Radiology August 2016 – January 2017. 240317

1. The total amount of agency spend on medical locums in the 2016/2017 tax year
2. The total amount of spend on agency nurses in the 2016/2017 tax year
3. The total amount of spend on agency AHPs in the 2016/2017 tax year
4. The percentage of substantive Doctor positions that are currently unfilled
5. The percentage of substantive Nurse positions that are currently unfilled
6. Do you have a managed service or master vendor arrangement, or an outsourced staff bank for any clinical staff groups and if so, who is/are the supplier(s)?
7. Do you have a Direct Engagement supplier and if so, who?

Download response Agency spend and substantive vacancies. 091117

Can you please assist me with retrieving the total Agency spend within Gastroenterology over the following months, within your Trust or Health Board?

Download response Agency spend within Gastroenterology

1. Since January 2018, have you allowed an Agency to fill a shift or booking above the April Cap (implemented in 2016) via the CPP Framework (otherwise known as the National Clinical Staffing Framework Agreement (Reference CPP2015/01))? For reference the term ‘shift’ can include any general nursing or critical nursing role.

2. If the answer is yes to the above question, please inform us of how many such shifts have been filled above cap via the CPP Framework.

3. What was the total value of charges paid under all of the call-off agreements identified in response to request 1 (above)?

4. Any information relating to the decision(s) of the Trust to enter into call-off agreements that include pay rates that exceed the maximum pay rates allowed under the Framework Agreement.

Download response Agency staff. 010818

1. In relation to the value of the contracts in your previous response of 1 August 2018, the value of which was £514,072.20, please state the total costs that the Trust paid in excess of the rates allowed under the fee caps (those fee caps being the April Caps (implemented in 2016) for the National Clinical Staffing Framework Agreement (Reference CPP20 15/011) (otherwise known as CPP Framework) (the “Framework Agreement”).
2. In relation to your answer to point 1, please state how much of this sum was attributed to shifts for Nursing & Midwifery staff.
3. In the event that the anticipated costs of providing all of the information requested under points 1 and 2 above are likely to exceed the appropriate limit specified in Regulation 3 of the Freedom of Information and Data Protection (Appropriate Limit and Fees) Regulations 2004, please provide instead the total costs that the Trust paid in excess of the rates allowed under the fee caps in June 2018.
4. In the event that you provided a substantive response to point 3, please provide us with how many such shifts have been filled above cap via the Framework Agreement in June 2018.
5. In the event that the anticipated costs of providing all of the information requested under point 3 above is likely to exceed the appropriate limit specified in Regulation 3 of the Freedom of Information and Data Protection (Appropriate Limit and Fees) Regulations 2004, please provide instead the total costs that the Trust paid in excess of the rates allowed under the fee caps for the period Monday 4 June 2018 to Sunday 10 June 2018.
6. In the event that you provided a substantive response to point 5, please provide us with how many such shifts have been filled above cap via the Framework Agreement, for the period Monday 4 June 2018 to Sunday 10 June 2018.
7. In your response of 1 August 2018, you stated that 16,754 shifts were for Medical & Dental staff. Please provide a breakdown of this figure and categorise the shifts into grades of staff.

Download response Agency staff.01118

All questions are shown as received by the Trust.
1. How much have you spent on agency staff each of the last five years?
a. What was the most expensive agency midwife shift last year?
b. How much on bank midwives each of the past five years?

Agency staff.040923.docx

Please can you provide the following information regarding use of agency staff in your NHS Trust.
Please note there are three parts to this request.
1. Please can you provide the total spend on agency staff in your NHS Trust in the financial year ending April 2022
2. Please can you provide the total spend on agency staff in your NHS Trust in the financial year ending April 2019
3. Please can you provide the total spend on agency staff in your NHS Trust in the financial year ending April 2017

Agency Staff.100822.docx

1. What was your trust spend on agency for the period 1 January 2022 to 31 December 2022 inclusive for the following staff groups: –
a. Registered nurse (RN)
b. Health care support workers/healthcare assistants/nursing associates?

2. What was your trust spend on agency for the period 1 January 2021 to 31 December 2021 inclusive for the following staff groups: –
a. Registered nurse (RN)
b. Health care support workers/healthcare assistants/nursing associates?

3. What was your trust spend on agency for the period I January 2020 to 31 December 2020 inclusive for the following staff groups: –
a. Registered nurse (RN)
b. Health care support workers/healthcare assistants/nursing associates?

Agency Staff.210323.docx

Nurses:
1. Total number of hours of agency nurses used by the Trust in the month of February 2023
2. Of the total number of agency nurse hours used, the number of hours procured ‘off-framework’
3. Of the total number of agency nurse hours used, the number of hours procured at ‘break glass’ or rates above the NHSI rate caps.
4. Of the total number of agency nurse hours used, the number of hours procured at an increased AFC banding i.e. band 5 offered band 6 as an incentive
Healthcare Assistants:
1. Total number of hours of agency healthcare assistants used by the Trust in the month of February 2023
2. Of the total number of agency healthcare assistants hours used, the number of hours procured ‘off-framework’
3. Of the total number of agency healthcare assistants hours used, the number of hours procured at ‘break glass’ or rates above the NHSI rate caps.
Pharmacy Staff:
1. Total number of hours of agency pharmacy staff used by the Trust in the month of February 2023
2. Of the total number of agency pharmacy staff hours used, the number of hours procured ‘off-framework’
3. Of the total number of agency pharmacy staff hours used, the number of hours procured at ‘break glass’ or rates above the NHSI rate caps.

Agency Staff.210823.docx

I am looking at the other positions supplied, starting with AHP and HSS staff.
Namely:
Allied Health Professionals Health Science Services
Dieticians Biomedical Scientists
Occupational Therapists Cytologists
Orthoptists Dental Service Staff (excluding dental nurses)
Physiotherapists Genetic Counsellors
Podiatrists Healthcare Scientists
Psychologists Medical Technologists
Radiographers Optometrists
Speech and Language Therapists Pathologists
Pharmacy Services Staff

Please could you provide me with the following information:
1. Names of Agencies used to provide AHP or HSS staff over the last 12 months
2. Monthly spend, on Agency Staff, per job role over the last 12 months
3. Hours, per job role, filled each month by Agency over the last 12 months
4. Number of shifts offered to Agencies for each role, monthly for the last 12 months.
5. Number of shifts filled by Agency for each role, monthly for the last 12 months.

Download response letter Agency Staff. 210917

Please could you advise the number of hours or shifts filled from 01th April 2018 – 31st March 2019 with qualified nursing staff within the Trust with agency staff?

Download response Agency staff. 260919

For Hospitals
1. Hospitals in trust
2. Names of off-framework agencies used between 2021- to date
3. Names of on-framework agencies used between 2021- to date
4. Do you have a master vendor in place?
5. If yes, please provide your account manager’s email
6. Temporary agency staff manager full name
7. Temporary agency staff manager email
8. Temporary agency staff manager telephone
9. Permanent agency staff manager full name
10. Permanent agency staff manager email
11. Permanent agency staff manager telephone
12. Off-framework agency spend between Feb 2021-date
13. Framework agency spend between Feb 2021 – date
14. Total agency shift cancelations Feb 2021-date
For Urgent Care Centres/Walk-in Clinics
1. Urgent treatment / walk-in centres
2. Names of off-framework agencies used between 2021- to date
3. Names of on-framework agencies used between 2021- to date
4. Do you have a master vendor in place?
5. If yes, please provide your account manager’s email
6. Temporary agency staff manager full name
7. Temporary agency staff manager email
8. Temporary agency staff manager telephone
9. Permanent agency staff manager full name
10. Permanent agency staff manager email
11. Permanent agency staff manager telephone
12. Off-framework agency spend between Feb 2021-date
13. Framework agency spend between Feb 2021 – date
14. Total agency shift cancelations Feb 2021-date

Agency Staff Bank.250322.docx

Under the freedom of information act 2000, I am writing to formally request the following information:
1. Staff Numbers
2. Staff Cost
3. Agency Hours
4. Agency Spend
I would greatly appreciate it if you could supply this information for the year 2013/14 (April ’13 to March ‘14).

Download response Agency Staff Cost 040815

The total amount spent on agency temporary staff for the year 2021/22 (April ’21 to March ‘22) and between 31/10/2021 to 31/10/2022 for the following categories:
• Doctors
• Nurses
• AHP (all categories)
• Health Care Assistants

Agency Staff costs.101122.docx

Please can you confirm your monthly Hospital and/or Trust spend on agency staff during the last three financial years (FYE Mar-14, Mar-15, & Mar-16). Ideally, this should be broken down into spend by Hospitals/Trusts, the agency supplying the staff and by month.

Download response letter Agency staff spend 2013-2016. 221116

1. Agency spend on Medical Locums/Doctors
2. Agency spend on AHP’s (Allied Health Professionals) and HSS (Health and Social Sciences)
3. Agency spend on Nursing
4. Agency spend on NMNC (Non-Medical, Non Clinical)
5. Do you use a Direct Engagement model to engage locum staff?
6. If so, please state the name of the company used
7. What is the expiry date for this contract?

Download response Agency Staffing. 050718

1. (a) Who is the head of procurement at your trust responsible for approving Nursing agency usage?
(b)Secondly, who is the temporary / flexible staffing lead responsible for the management of this service?
2. Please can you provide the contact information in relation to both question 1 (a) and (b)
3. Please can you outline your Off-Framework agency spend for each of the following staff groups between April 2019 – June 2019: (a) RGN’s (b) RCN’s (c) RN’s and (d) HealthCare Assistants (e) RMN (f) Specialist RN (ITU) (g) Medical Locums
4. Following the same breakdown of staff groups in Question 3, how many Off-framework shifts have been unfilled between April 2019 – June 2019
5. Since the start of January 2019 – present, please provide the current charge rates from your Off Framework, Nursing providers, providing a clear breakdown between the workers pay rate and agency commission
6. Based on the above information, who are your current Nursing Off-Framework agencies and how many shifts have been booked for each month from January 2019 – June 2019

Download response Agency Staffing. 260919

1. Please can you confirm whether the Trust is contracted to a managed service provider for the supply of agency staff under each of the following categories
a. Medical Locums
b. Nurses
c. Allied Health Professionals or Health Scientists
2. Please confirm which company provides the managed service for each staff category and the contract expiry date
a. Medical Locums
b. Nurses
c. Allied Health Professionals or Health Scientists
3. For Medical Locums and for AHPs, please confirm whether the Trust utilises a Direct Engagement solution for VAT efficiency
a. Medical Locums
b. Nurses
c. Allied Health Professionals or Health Scientists
4. Please confirm which company provides the Direct Engagement solution and the contract expiry date

Download response Agency staffing. 280621

1. What contractual relationships are in place for supplying agency Nursing and who is responsible for managing them?
2. Who is your primary point of contact for decision making regarding supply chain for Agency Nursing?
3. How many agencies are used to supply agency doctors?
4. Of these agencies, how many are off framework – please list them?
5. Over the past 6 months, how many shifts have been filled via an off framework agency?
6. Who is your highest paid agency nurse, what is their speciality and their hourly charge?
7. Please outline your spend per agency, broken down by grade and speciality of nurse over the past 6 months?
8. Do you have a Master Vendor for Agency Nurses In place? If so, who are they and when are they contracted until?
9. If you have a Master Vendor in place, how many hours of work for Nursing have been booked outside of your Master Vendor arrangement in the past 6 months?
10. If you have a Master Vendor in place, what % of bookings by your Master Vendor Provider are at the NHSI capped rates in the past 6 months?
11. What is your total (£) off framework agency spend for Agency Nursing?

Download response Agency staffing. 290621

1. Please can you confirm how and how regularly you confirm you and your suppliers are IR35 compliant?
2. Please can you confirm the percentage of agency shifts in the past financial year that were NHSI cap compliant? Please could you break this down by staff group?
a. Nursing
b. Doctors
c. AHP/HSS
d. Other clinical
3. Please can you confirm the number of permanent vacancies you have in the following staff groups?
a. Nursing
b. AHP/HSS

Download response Agency staffing and vacancies. 061119

1. How many agencies do you engage with for your recruitment of temporary nurses and health care assistants and can you please list them?
2. How many agencies do you engage with for your recruitment of permanent nurses and can you please list them?
3. What has your spend been on temporary nurses?
4. What has your spend been on permanent nurses in 2017?
5. How many temporary shifts have been released to agencies for mental health nurses?
6. How many temporary shifts have been released to agencies for general nurses?
7. How many temporary shifts have been released to agencies for theaters nurses?
8. How many temporary shifts have been released to agencies for A&E nurses?
9. How many temporary shifts have been released to agencies for Community nurses?
10. How many temporary shifts that have been released to agencies for mental health nurses go unfilled?
11. How many temporary shifts that have been released to agencies for general nurses go unfilled?
12. How many temporary shifts that have been released to agencies for theaters nurses go unfilled?
13. How many temporary shifts that have been released to agencies for A&E nurses go unfilled?
14. How many temporary shifts that have been released to agencies for Community nurses go unfilled?
15. Are all temporary shifts released to all agencies at the same time or is there a tiering system?
16. Do you have any off framework spend for temporary agency staff?

Download response Agency usage. 240418

1. For the last year (2020-2021) please supply a list of the agencies the trust uses for medical locums.
2. A breakdown of the monetary spend per agency for Medical Locums
3. Please supply the total number of days worked by locum RMO’s or junior doctors for 2020-2021 at your trust.
4. The hourly rate paid to agencies supplying casual RMO’s or junior doctors.

Download response Agency usage. 270521

1. Who is the head of procurement responsible for approving agency usage for Physiotherapy, Occupational Therapy, Pharmacy, Radiography, Speech and Language Therapy and Sterile Services?
2. Who are the managers responsible for agency usage (on and off framework) for the following departments at all hospitals associated with the Trust:
(a) Physiotherapy
(b) Occupational Therapy
(c) Pharmacy
(d) Radiography
(e) Sterile Services
(d) Speech and Language Therapy
3. Please can you provide the contact number and email addresses for the managers listed in relation to question 1 and 2?
4. Have you used off-framework agency staff between March 2021 – March 2022 in the following departments:
(a) Physiotherapy
(b) Occupational Therapy
(c) Pharmacy
(d) Radiography
(e) Sterile Services
(d) Speech and Language Therapy
5. How much was your Off-Framework agency spend for each of the following staff groups between March 2021 – March 2022?
(a) Physiotherapy
(b) Occupational Therapy
(c) Pharmacy
(d) Radiography
(e) Sterile Services
(d) Speech and Language Therapy
6. How many unfilled agency roles did you have between March 2021 – March 2022 for each of the departments outlined in question 5?

Agency usage for Physiotherapy, Occupational Therapy, Pharmacy, Radiography, Speech and Language Therapy and Sterile Services.220422.docx

1. Who is the person in charge for approving agency usage for the Decontamination department at your trust?
2. Who is responsible for agency usage (on and off framework) in the Decontamination department at all hospitals associated with the Trust?
3. If the decontamination service is not managed by the trust, please confirm which company runs your decontamination service.
4. Please can you provide the contact number and email address for the manager(s) in question 1 and 2.
5. Have you used off-framework agency staff between March 2022 – March 2023 in Decontamination and endoscopy?
6. How much was your Off-Framework agency spend for Decontamination and Endoscopy from March 2022 – March 2023?

Agency usage for the Decontamination department.200723.docx

1. Who is the head of procurement responsible for approving agency usage for the Physiotherapy department?
2. Who is responsible for agency usage (on and off framework) in the Physiotherapy department at all hospitals associated with the Trust for the following areas within Physiotherapy?
– Musculoskeletal
– Community
– Rehabilitation
– Neurology
– Paediatrics
– Trauma and Orthopaedics
– Acute Medical/Surgical/inpatient
– Respiratory
3. Please can you provide the contact number and email address for the manager(s) in question 1 and 2.
4. How much was your Off-Framework agency spend for Physiotherapy from June 2022-June2023
5. What agencies were providing the Off-Framework services.

Agency usage for the Physiotherapy department.040823.docx

1. Who is the head of procurement responsible for approving agency usage for the Sonography/Ultrasound department at your trust?
2. Who is responsible for agency usage (on and off framework) in the Sonography/Ultrasound department at all hospitals associated with the Trust? 3. Please can you provide the contact number and email address for the manager(s) in question 1 and 2. 4. Have you used off-framework agency staff between March 2022 – March 2023 in Sonography/Ultrasound?
5. How much was your Off-Framework agency spend for Sonography/Ultrasound from March 2022 – March 2023?

Agency usage for the Sonography and Ultrasound department.310323.docx

1) Which Frameworks do you use for the supply of;
a) Locum Doctors
b) Locum Nurses
2) Do you operate a master vend arrangement or preferred supplier list?
3) Please list the agencies on your preferred supplier list for a and b. Please provide the supply list in tearing order or PSL if applicable.
a) Locum Doctors
b) Locum Nurses
4) Please provide contact details for the member of staff in charge of this process.

Download response Agency use. 010818

Question 1
Please can you confirm what your total spend on Allied Health Professional (AHP) agency staff was during the financial year April 2015-January 2016?
Can you please break this financial information down by AHP specialism:
• Arts Therapists,
• Chiropodist/Podiatrist,
• Dietician,
• Occupational Therapist,
• Physiotherapist,
• Prosthetist / Orthotist,
• Imaging Professionals,
• Speech / Language Professionals.
Question 2
Please can you confirm the names of the organisation/s you procure temporary Allied Health Professionals (AHP) from and the total spend for each organisation/s. To provide additional clarity on my request, ‘temporary Allied Health Professionals’ is to mean all persons who are AHPs and are not on permanent contracts of employment with the Board, but are supplied via employment agencies.

Download response AHP agency staff spend 2015-2016 150316

For the last 12 months can you provide me details on the Trusts agreement with Altrix.

Specifically:
The monthly spend for the last 12 months.
The number of hours covered monthly for the last 12 months.
Agreed rates for shifts covered.
Clarification on workers under this models Tax/IR35 status and if they are paid in line with the NHS Frameworks expectations.

Download response Altrix and agency spend. 240919

Under the Freedom of Information Act, please can you provide me with the amount spent on employing agency/temporary/locum doctors in A&E departments, and the number of FTE roles covered by agency doctors, if possible for each month in 2014 and 2015, or for 2014 and for 2015 as whole years.

Please can you provide me with the number of FTE doctors working in the A&E department, if possible for each month in 2014 and 2015, or for 2014 and for 2015 as whole years?

If possible, please provide a breakdown between junior doctors and consultants.

Download response Amount spent on employing agency/temporary/locum doctors in A&E departments 2014 and 2015 140316

1) What is your annual spend on Agency Nurses?
2) How is this spend on agency Nurses broken down by individual supplier and what status are they? (i.e. PSL, Tier 1, Tier 2, Master Vendor, or Managed Service Provider?
3) What is the end / renewal date of the current contract you have in place for agency nursing?
4) Which framework do you currently use? (CCS, HTE, LPP, other)
5) Who is your senior procurement contact?
6) Who is your senior medical staffing/ nurse bank contact?

Download response Annual spend on agency nursing staff. 070417

1. The number of hours filled by agency for all categories of Allied Health Professionals and Health Science Services for calendar year 2016 – broken down by month, Job Title and Job Band

2. The number of hours filled by bank for all categories of Allied Health Professionals and Health Science Services for calendar year 2016 – broken down by month, Job Title and Job Band

3. The Trusts total spend on agency staff for all categories of Allied Health professionals and Health Science Services for calendar year 2016 – broken down by month, Job Title and Job Band

4. The Trusts total spend on bank staff for all categories of Allied Health professionals and Health Science Services for calendar year 2016 – broken down by month, Job Title and Job Band

5. The number of hours filled by agency for all Nursing Staff for calendar year 2016 – broken down by month, Job Title and Job Band

6. The number of hours filled by bank for all Nursing Staff for calendar year 2016 – broken down by month, Job Title and Job Band

7. The Trusts total spend on agency staff for all Nursing Staff for calendar year 2016 – broken down by month, Job Title and Job Band
8. The Trusts total spend on bank staff for all Nursing Staff for calendar year 2016 – broken down by month, Job Title and Job Band

Download response Bank and Agency spend 2016. 070417

How much did the Trust spend on a) agency midwives b) bank midwives in each calendar month in 2018 (calendar year)?

Download response Bank and Agency Midwife spend. 110319

Please disclose the information listed in the below table rows for each of the 4 staff groups in the table columns by return email within 20 days as per the Freedom of Information Act 2000.
1. Please provide agency spend for the staff group for the year 2022.
2. Please provide bank spend for the staff group for the year 2022.
3. Please confirm which model you have in place for managing the staff group: Email to preferred supplier List, a Master Vendor, a Neutral Vendor, or a Software cascade to a preferred supplier list.
4. If you have a master vendor or neutral vendor in place, please confirm who this contract is with and the date on which this contract expires.
5. Please confirm what percentage of bookings over the last 6 months have been within the NHSI/E agency caps (an approximation based on NHSI data submissions is fine).
6. Please confirm which provider manages your direct engagement process, the fee for the service and the date on which this contract expires (no this is not relevant for Nursing).
7. Please confirm what percentage of bookings are processed with a VAT savings by your direct engagement provider
8. Is your bank managed by an external bank provider (eg. NHS Professionals, Bank Partners) or in-house? Please confirm who is the external bank provider and when the contract expires if relevant.
9. Is your bank managed via software? If so, please confirm which software.
10. Please confirm what the percentage is on framework (for example, “£6,650,000 – 99% framework /20% off-framework”) for the year 2022.
11. Please confirm what percentage is off-framework (for example, “£6,650,000 – 99% framework /20% off-framework”) for the year 2022.
12. Please confirm the direct engagement- DE% uptake for the year 2022.
13. Please confirm the direct engagement- DE provider.
14. Please confirm the direct engagement- DE contract end date.

Bank and Agency spend.050423.docx

1) Please detail your Bank and Agency Spend in the format provided by the following NHSIE Staff Groups for the past financial year (April 2020 – March 2021)
2) Please detail your Bank and Agency usage in hours in the format provided by the following NHSIE Staff Groups for the past financial year (April 2020 – March 2021)

Download response Bank and agency spend and usage. 260421

Staff Bank
1. Do you use a nurse bank?
2. Is it outsourced?
a. If yes, who is the provider?
b. Is your outsourced bank used via a framework, e.g., CCS, HTE, LPP?
c. Do you use the bank for other staff groups?
d. What was the spend on your staff bank in 2015/2016?
3. Do you use Agency Nurses?
a. What was your spend on agency nurses during 2015/2016?
b. Which framework do you use for agency nursing staff? E.g.: CCS, HTE, LPP, NOECPP
4. Are you meeting the NHS Improvement price caps on?
a. Band 5 general nurses
b. Band 5 specialist nurses
c. HCAs

Download response letter Bank and Agency Staff 221116

1. The number of agency staff used in the Audiology department
2. The number of hours filled by agency staff in the Audiology department.
3. The number of hours filled by bank staff in the Audiology department.
4. The Trusts total spend on agency workers in the audiology department
5. The Trusts total spend on bank workers in the audiology department
I would like the above information for the 2019 calendar year (Jan-Dec) if possible.

Download response Bank and Agency staff in Audiology. 161120

1. Please could you confirm your current bank spend (FY 18/19), broken down by the following staff groups:
a. Nursing staff
b. Medical locums (Doctors)
c. AHP/HSS
d. Other clinical
e. Non-clinical
2. Please confirm your current bank fill rate (FY 18/19), broken down by the following staff groups:
a. Nursing staff
b. Medical locums (Doctors)
c. AHP/HSS
d. Other clinical
e. Non-clinical
3. Please could you confirm your current agency spend (FY 18/19), broken down by the following staff groups:
a. Nursing staff
b. Medical locums (Doctors)
c. AHP/HSS
d. Other clinical
e. Non-clinical
4. Please could you confirm your current agency engagement procedure (i.e. MV, PSL etc) and which agencies you are currently working with, broken down by the following staff groups:
a. Nursing staff
b. Medical locums (Doctors)
c. AHP/HSS
d. Other clinical
e. Non-clinical
5. Do you have DE supplier, if so who, broken down by staff group? When is the expiry date for this contract?
6. Do you have an MV supplier, if so who, broken down by staff group? When is the expiry date for this contract?
7. Do you have an external Bank supplier, if so who, broken down by staff group? When is the expiry date for this contract?
8. Please could you confirm what your agency spend is for permanent staff in the past 24 months, broken down by the following staff groups. How much of this is international recruitment?
a. Nursing staff
b. Medical locums (Doctors)
c. AHP/HSS
d. Other clinical
e. Non-clinical
9. How many permanent vacancies do you have as per the below table. Do you have a current supplier for these roles?

Download response Bank and Agency Staffing. 181019

1. Please confirm which model is in place for managing each staff group: preferred supplier list, master vendor or neutral vendor
Locum
Nurse
Allied Health Professionals
Non-medical/non-clinical
2. If you have a master vendor or neutral vendor in place, please confirm who this contract is with
3. Please confirm the contract end date with the provider
4. Is your bank managed by an external bank provider (e.g., NHS Professionals,
Bank Partners).
5. Please confirm who is the external bank provider and when the contract expires if relevant
6. Is your bank managed via software? If so, please confirm which software.

Bank and agency systems.080323.docx

1. The total internal bank spend broken down by Dr, Nurses and AHP for period Jan 19 – Dec 19
2. Is this contracted to a third party or ran by the Trust (e.g. NHSP, Bank Partners etc.)
a. If contracted to a third party the expiry date of the agreement

Download response Bank staff. 310320

1. Bank Spend – Total amount spent on bank staff for the year 2021/22 (April ’21 to March ‘22) and between 31/10/2021 and 31/10/2022 year split into the Trusts’ staff groups (E.g. Medical, Nursing, Admin, AHP etc.) and speciality/grade (E.g. Consultants, GP, ICU Nurse, Acute Nurse, Occupational therapists, Pharmacists, Health Care Assistants, etc.) depending on how this is reported within the Trust.
2. Confirmation on whether the trust bank is currently operated by the trust themselves or by a private provider. If the latter please confirm the name of the provider.

Bank Staff costs.101122.docx

Please complete the attached table with the relevant information regarding Bank Staff (Medical Locums) at your Trust.

Grade Core Hours Pay rate Unsocial Pay Rates
FY1
+FY2
Sp1-2
Sp3+
Dental Core Training
Specialty Doctor/staff grade
Associate Specialist
Consultant

Download response Bank Staff (Medical Locums) Maidstone Hospital 010216

Please complete the attached table with the relevant information regarding Bank Staff (Medical Locums) at your Trust.

Grade Core Hours Pay rate Unsocial Pay Rates
FY1
FY2
Sp1-2
Sp3+
Dental Core Training
Specialty Doctor/staff grade
Associate Specialist
Consultant

Download response Bank Staff (Medical Locums) Tunbridge Wells Hospital 010216

1. Do you have a Master Vendor or Neutral Vendor arrangement in place?
2. If yes, who is your current Master Vendor or Neutral Vendor Provider and which disciplines do they supply?
3. What fill rates are achieved with your Master Vendor or Neutral Vendor Provider in the various disciplines?
4. Are you charged a fee for the service and if so, what is the cost?
5. What is the expiry date for your current contract/contracts?
6. Do you use any external/3rd parties to manage your bank workforce?
7. If so, please provide the name of the provider and contract start and end dates.
8. Which bank software do you use and how long are you in contract with them?

Download response Bank Workforce & VMS Arrangements. 190421

1. Could you please provide me with a breakdown of all the healthcare staffing disciplines provided by agencies in which the trust are breaking glass / being charged escalated rates?
2. Could you please state how many agency workers, per discipline, the break glass / escalated rates applies to re question 1?
3. Could you please state how many healthcare agency workers, per discipline, the Trust are being charged the maximum capped rate as stipulated by their governed framework?

Download response Break glass and escalated agency rates. 171218

1. How many staff do you have in your clinical coding department?
2. How many vacancies do you currently have in your clinical coding department?
3. Do you have any 3rd party’s providing you with clinical coding service?
A. If yes, which external organisations (3rd parties or other NHS) provide you with clinical coding services?
B. When did you start these contracts, how long are they for and what procurement framework did you use?
4. How much did the Trust spend last year on bank staff for clinical coding?
5. How much did the Trust spend on consultancy relating to clinical coding last year?

Download response Clinical Coding staff. 060220

We would like to understand how much money MTW have spent with Cloud21 Broken Down for each financial year
16/17
17/18
18/19
19/20
20/21
21/22

Cloud21. 120422.docx

1. What was your trust spend for temporary community agency nursing in 2017?
2. How many rgn shifts are released to temporary agencies?
3. How many rgn shifts released to agency go unfilled?
4. How many hca shifts are released to temporary agencies?
5. How many hca shifts released to agency go unfilled?
6. How many agencies are on your proffered suppliers list for these requirements?

Download response Community Nursing. 010618

Please could you tell me how much money your trust spent on bank and/or agency and/or locum staff – and/or non-contractual rates to consultants or other medical staff employed by the trust – to cover junior doctors’ shifts during industrial action by the British Medical Association on:
A) March 13-15 2023
and
B) April 11-15 2023
Please provide as much detail as possible on the staff category (i.e. agency or bank), department of the hospital and the day(s) of employment.

Cost of strike cover.120523.docx

Can you please assist me with retrieving the total Agency spend for Medical Locum Doctors within Dermatology over the following months, within your Trust or Health Board?

Download response Dermatology locum doctors 060317

1. How many permanent staff are employed by the Radiography/Imaging department (Radiographers & Sonographers, not Radiologists)?
2. How many permanent vacancies are currently open/unfilled within the Radiography/Imaging department (Radiographers & Sonographers, not Radiologists)?
3. How many agency staff/locums are currently being used across the Radiography/Imaging department (Radiographers & Sonographers, not Radiologists)?
4. For agency staff/locums, what is the split in numbers between radiographers and sonographers?
5. How many bank temps are being used across the Radiography/Imaging department?
6. During the 2017-2018 financial year, how much did the Radiography/Imaging department spend on temporary agency staff?
7. During the 2018-2019 financial year, how much did the Radiography/Imaging department spend on temporary agency staff?
8. During the 2018-2019 financial year, how much did the Radiography/Imaging department spend on temporary bank staff?
9. During the 2018-2019 financial year, how much did the Radiography/Imaging department spend on permanent finders/introduction fees through recruitment agencies?
10. Does the Radiography/Imaging department have a dedicated breast screening unit?
11. Please provide me with the following contact names within the authority:
a) The name of the senior manager (Radiology Services Manager / Imaging Services Manager) with overall responsibility for the Radiography/Imaging department.
b) The name of the head of temporary staffing.

Download response Diagnostic radiology staff details. 260919

1. Does your organization use a Direct Engagement scheme?
2. If so, who provides it? And when did you start using it?
3. Did you take external legal advice before entering into it and, if so, from whom did you take external legal advice?
4. What has your total locum/temporary staffing spend since you started using the scheme? If you started using the scheme before April 2017 please also state the total locum/temporary staffing spend since April 2017.
5. How does the third party direct engagement facilitator save you money on the agency spend? Please answer in short point form
6. How much has been paid to the third party direct engagement facilitator thus far?
7. Was this payment calculated as a percentage of the savings generated by employing the services of the third party direct engagement facilitator? If so, what percentage is this?

Download response Engagement of locum staff using third parties. 181718

1. A list of all the areas across the Trust that use external temporary staff.
2. The monthly and annual cost of having these staff supplied, averages are fine if exact data is unavailable.
3. The types of staff that are supplied.
4. Whether these staff are supplied via an approved NHS Framework, if not what is the nature of the contract or agreement in place.

Download response External temporary staff. 220321

1. Does your Trust currently utilise a Direct Engagement (DE) model? – YES / NO
2. If Yes, who currently provides the service;
a. Brookson
b. Liaison/ PWC (StafFlow)
c. Liaison (TEMPre)
d. 24/7 Time
e. Other (please specify here)………………………..
3. What proportion (in percentage) of your agency workers for the following staff groups are directly engaged:
a. Medical Locums/Doctors (e.g. Acute, Emergency, General Surgery, Paediatrics, Gynaecology, Neurosurgery, Dermatology, Cardiology)
b. Allied Health Professionals/Health Science Staff (e.g. Biomedical Science, Clinical Physiology (Cardiology), Dietician, Occupational Therapy, Pharmacy, Physiotherapy, Radiography, Talking Therapy, Speech & Language Therapy, Psychology, Anatomical Pathology)
4. What percentage are you charged for the management of these services?
5. When was the DE contract awarded?
6. What is the contract duration?
7. What was the motivation with engaging with these services?

Download response Flexible staffing 071216

What framework and non-framework locum agencies you use for:
Doctors
Nursing staff
Doctors and nursing staff

I also want to know do you have a staff bank. Do you with any particular agencies as a rule and others when simply in need?

Download response Framework and non-framework locum agencies 260116

Please can you give me the contact details for the HR person that deals with Locum appointments?

Please can I have their full name, job title, email address and direct dial telephone number.

Download response Full contact details for the HR staff member responsible for locum appointments 180516

Question 1 – For the timescale from the 1st April 2023 until 30th April 2023, details of the lowest, highest and average fee paid to agencies providing HCA’s for band 5, 6 and 7.

Question 2 – For the single week of the 16th July 2023 until 22nd July 2023, details only of the average fee paid to agencies providing HCA’s for band 5, 6 and 7.

HCA agency fees.180823.docx

1. How many of the following scheduled procedures/appointments were cancelled by the Trust:
i) Elective operations
ii) Appointments made via urgent cancer referrals
iii) Mammograms
iv) Organ transplant operations
v) Optical appointments/procedures
During the following periods:
i) 2019-2020
ii) 2020-to date
NB. I do not require the reasons for the cancellations.
2. How many of the following scheduled procedures/appointments were pushed back by the Trust:
i) Elective operations
ii) Appointments made via urgent cancer referrals
iii) Mammograms
iv) Organ transplant operations
v) Optical appointments/procedures
NB. I do not require the reasons behind the delay/re-scheduling.
For the following time frames:
i) Up to one month
ii) Up to three months
iii) Up to six months
iv) Up to a year
v) Indefinitely
During the following periods:
i) 2019-2020
ii) 2020-to date

Download response Cancelled appointments and procedures. 091220

I would like to know how many cancer operations have been cancelled by your NHS Trust since March 1st 2020?

Download response Cancelled cancer operations. 220920

1. How many children’s operations have been cancelled each month since 1st July 2016? Please give additional details as to what the main reasons for the cancellations were, how many were urgent operations or elective operations, and what type of illness did they involve, e.g. cancer, breathing problems, broken limbs etc.

2. How many children’s operations have been cancelled over the last four financial years to date?

Kindly note a child is anyone up to the age of 18.

Download response Cancelled children’s operations – 01.07.16. 050517

The total number of children’s operations cancelled for non-clinical reasons, broken down by the cause of the cancellation, for example due to lack of beds, operating theatre capacity, staffing issues, and equipment failures. Please provide this information for each of the past three financial years 2017/18, 2018/19, 2019/20). In the total number of operations, broken down by cancellation reason, please include:

· Elective children’s operations cancelled at the last minute. For the purposes of this request, last minute means on the day the patient was due to arrive, after the patient has arrived in hospital or on the day of the operation or surgery.

· Cancelled urgent children’s operations.

For the purposes of this FOI, Children will be defined as under 18’s.

Download response Cancelled children’s operations. 131020

You asked: All questions are shown as received by the Trust.
1. The number of children (under 18s) who have an operation cancelled or delayed at your trust for non-clinical reasons, in each of the past five calendar years (2022, 2021, 2020, 2019, 2018).
2. For each of these years, please could you provide figures broken down by the reason behind the cancellation or delay, e.g. lack of staff, lack of bed capacity, or lack of equipment.
3. Please could you provide figures on the five longest waits for an operation currently faced by under-18s at your trust, e.g. 118 days, 116 days, 113 days. For each of these waits, please could you provide a summary of the surgical procedure in question, e.g. heart surgery.

Cancelled children’s operations.140323.docx

1) In the months of October, November and December, how many elective admissions and outpatient attendances had to be cancelled due to non-clinical reasons?
2) How many of these were able to be rescheduled within 28 days (please give actual figure)?
3) And how many were not able to be rescheduled within 28 days?

Download response Cancelled elective admissions and outpatient attendances. 150118

1. Since 1st April 2010 what has been the maximum cost to the Trust of an elective operation being cancelled last-minute for non-clinical reasons? Please give additional detail as to what the operation was and how many members of staff were supposed to be working on the operation.
2. Please provide the total number of elective operations cancelled last-minute for non-clinical reasons for each quarter going back to 2010.
3. Please provide the total quarterly cost of elective operations being cancelled last-minute for non-clinical reasons for each quarter going back to 2010.

Download response Cancelled elective operations 2010-2016. 200417

I would like to ask for each day over the past two months how many elective operations have had to be cancelled and what reasons were given?

And for each of those days, how many elective operations had been originally planned?

Download response Cancelled elective operations for December 2015 and January 2016 190416

Question 1
How many booked elective invasive procedures (this includes but is not limited to procedures being performed in operating theatres, interventional radiology or other radiology suites, cardiac catheter labs, endoscopy and any other site not mentioned involving an invasive procedure, whether under local anaesthetic, general anaesthetic, spinal or epidural anaesthetic, peripheral nerve block, or sedation) did your trust cancel in the calendar years:
a. 2017
b. 2018
c. 2019
d. 2020
e. 2021
Question 2
How many booked elective invasive procedures (this includes but is not limited to procedures being performed in operating theatres, interventional radiology or other radiology suites, cardiac catheter labs, endoscopy and any other site not mentioned involving an invasive procedure, whether under local anaesthetic, general anaesthetic, spinal or epidural anaesthetic, peripheral nerve block, or sedation) did your trust cancel at the date of this request in this calendar year?

Cancelled elective procedures.270722.docx

I would like to request the total number of operations cancelled for non-clinical reasons, broken down by the cause of the cancellation, for example due to lack of beds, operating theatre capacity, staffing issues, and equipment failures.

Please provide this information for each of the past five financial years (i.e. years running from April to March – 2013/14, 2014/15, 2015/16, 2016/17, 2017/18).

In the total number of operations, broken down by cancellation reason, please include:
1. Elective operations cancelled at the last minute. For the purposes of this request, last minute means on the day the patient was due to arrive, after the patient has arrived in hospital or on the day of the operation or surgery.
2. Cancelled urgent operations.
If the data is collected by the trust, please also provide a separate total for each year for all operations cancelled for non-clinical reasons, regardless of how soon before the scheduled operation time the cancellation occurred.

Download response Cancelled operations. 011018

a) How many elective operations were cancelled for a non-clinical reason at the Trust in 2021/22, broken down by reason for cancellation?
b) Of the total elective operations cancelled for a non-clinical reason at the Trust in 2021/22, how many were:
i. urgent surgery
ii. paediatric surgery
iii. surgical oncology

Cancelled operations.021222.docx

a) How many operations in total has your Trust cancelled from 1 March 2020 – 1 March 2021 and can you give a breakdown of reasons for the cancellations? How many were urgent operations?
b) How many operations in total has your Trust cancelled from 1 March 2019 – 28 February 2020 and can you give a breakdown of reasons for the cancellations? How many were urgent operations?
c) How many operations in total has your trust cancelled for Under 16s from 1 March 2020 – 1 March 2021 and can you give a breakdown of reasons for the cancellations? How many were urgent operations?
d) How many operations in total has your trust cancelled for Under 16s from 1 March 2019 – 28 February 2020 and can you give a breakdown of reasons for the cancellations? How many were urgent operations?

Download response Cancelled operations. 070721

1. Please can you tell me the number of last minute elective operations cancelled for non clinical reasons at your trust or board for each month of 2020 and 2021 to date.
2. Please can you tell me the number of urgent operations cancelled for non-medical reasons during each month.
If giving the full data requested would be likely to exceed the costs cap, please provide data for the most recent month and then as many months as possible working backwards until the limit is reached.
3. If possible, please let me know how many of the cancelled elective operations had still not been carried out 28 days later.
4. If possible, please let me know how many of the cancelled urgent operations had still not been carried out 28 days later.

Download response Cancelled operations. 131021.docx

1. The number of people who have had an operation cancelled or delayed at your trust for non-clinical reasons, in each of the past five calendar years (2022, 2021, 2020, 2019, 2018).
2. For each of these years, please could you provide figures broken down by the reason behind the cancellation or delay, e.g. lack of staff, lack of bed capacity, or lack of equipment.
3. Please could you provide figures on the five longest waits for an operation currently faced by under-18s at your trust, e.g. 110 days, 98 days, 200 days. For each of these waits, please could you provide a summary of the surgical procedure in question, e.g. heart surgery.

Cancelled operations.140323.docx

1. The number of elective operations scheduled. I would like this information for January 2022 to end of December 2022 broken down by week i.e. the total number of elective operations that were planned for Week 1, January 2022, Week 2 etc.
2. The number of elective operations performed. January 2022 to end of December 2022 broken down by week i.e. the total number of elective operations that were planned for Week 1, January 2022, Week 2, etc
3. The number of elective operations cancelled at the “last minute”, as defined by the NHS when providing data on cancelled elective operations. I would like this information for January 2022 to end of December 2022 broken down by week i.e. the total number of elective operations planned for Week 1, January 2022, Week 2 etc.
4. The total number of elective operations cancelled, regardless of how long cancellations were made before scheduled operation times, if this information is also collected. I would like this information for January 2022 to the end of December 2022 broken down by week i.e. the total number of elective operations planned for Week 1, January 2022, Week 2 etc.

Cancelled operations.2. 140323.docx

1. Over the past five financial years (2011-12, 2012-13, 2013-14, 2014-15, 2015-16) please state the number of last minute elective surgery cancellations there have been for non-clinical reasons for the following branches of surgery: trauma and orthopaedics, neurology, cancer, and ophthalmology. Please break down by year and surgery type.
2. Over the past five financial years (2011-12, 2012-13, 2013-14, 2014-15, 2015-16) please state how many patients were not treated within 28 days of last minute elective cancellation of an operation for the following branches of surgery: trauma and orthopaedics, neurology, cancer, and ophthalmology. Please break down by year and surgery type.

Download response Cancelled operations 2011 – 2016. 141216

1. The number of elective operations carried out by the Trust in the following financial years:
2012/13
2013/14
2014/15
2015/16
2016/17

2. The number of elective operations cancelled at the last minute* due to non-clinical reasons, in the following financial years:
2012/13
2013/14
2014/15
2015/16
2016/17
NOTE: Please use NHS England’s standard definition of last minute cancellations, “Last minute means on the day the patient was due to arrive, after the patient has arrived in hospital or on the day of the operation or surgery.” See: https://www.england.nhs.uk/statistics/statistical-work-areas/cancelled-elective-operations/

3. The number of elective operations cancelled at the last minute due to non-clinical reasons per financial year (2012/13 to 2016/17 inclusive), split into the following categories:
– Staff unavailable or sick (either anaesthetist, surgeon, theatre staff or other)
– Lack of available bed (either general or HDU, critical, or intensive care)
– Theatre list over-ran or no space on it (e.g. due to emergency case(s) coming in)
– Equipment missing / failure
– Any other reason

Download response Cancelled operations 2012-2017. 200917

1. In relation to (i) 2013/14, (ii) 2014/15 and (iii) 2015/16 financial year please provide me with the number of operations cancelled at your Trust on the day of operation or admission where the reason is recorded as there being no post-operative bed available for the patient.
2. For each year please state if possible how many of these cancellations were due to the fact that there was no critical care bed or intensive care bed available rather than the unavailability of a general ward bed?

Download response Cancelled operations 2013 to 2016 250716

How many operations have been cancelled for non-clinical reasons IN THE 3 DAYS BEFORE a patient was due to be admitted?
Out of those cancellations, how many were rescheduled within 1 month?
How many operations have been cancelled for non-clinical reasons ON THE DAY a patient was due to be admitted?
Out of those cancellations, how many were rescheduled within the statutory time limit – e.g. 28 days?
Please provide this data by month for 2014, 2015, 2016 and 2017 – up to and including April 2017.
The following should be included in the figures for ‘operations’:
All planned or elective operations and day surgery
For ‘non-clinical reasons’ please include a break-down of the following:
· Bed-ward not available
· Staff unavailable
· Emergency operations taking priority
· Maintenance needed on equipment
· Patient unavailable
· Admin error

Download response Cancelled operations 2014 – April 2017. 050517

The National Emergency Preparedness Panel warned on 22 December that non-urgent operations should be cancelled, with a further update on 2 January advising that “day case and outpatient procedures” should also be put on hold to preserve emergency care.

Could the trust please provide the following details about cancellations for non-clinical reasons, and last minute (on the scheduled day of arrival at hospital or later) non-clinical cancellations.

Download response Cancelled operations and appointments. 210218

The total number of operations cancelled for non-clinical reasons, broken down by the cause of the cancellation, for example due to lack of beds, operating theatre capacity, staffing issues, and equipment failures. Please provide this information for each of the past three financial years (2016/17, 2017/18, 2018/19). In the total number of operations, broken down by cancellation reason, please include:
• Elective operations cancelled at the last minute. For the purposes of this request, last minute means on the day the patient was due to arrive, after the patient has arrived in hospital or on the day of the operation or surgery.
• Cancelled urgent operations.

Download response Cancelled operations for non-clinical reasons. 050919

I would like to request the total number of operations cancelled for non-clinical reasons, broken down by the cause of the cancellation, for example due to lack of beds, operating theatre capacity, staffing issues, and equipment failures, in 2018/19 (financial year, April to March).

In the total number of operations, broken down by cancellation reason, please include:
• Elective operations cancelled at the last minute. For the purposes of this request, last minute means on the day the patient was due to arrive, after the patient has arrived in hospital or on the day of the operation or surgery.
• Cancelled urgent operations.
If the data is collected by the trust, please also provide a separate total for each year for all operations cancelled for non-clinical reasons, regardless of how soon before the scheduled operation time the cancellation occurred.

Download response Cancelled operations for non-clinical reasons.2 050919

How many operations have been cancelled for non-clinical reasons IN THE 3 DAY BEFORE a patient was due to be admitted?
Out of those cancellations, how many were rescheduled within 1 month?
How many operations have been cancelled for non-clinical reasons ON THE DAY a patient was due to be admitted?
Out of those cancellations, how many were rescheduled within the statutory time limit – e.g. 28 days?
Please provide this data by month for 2013, 2014, 2015 and 2016 – up to and including March 2016.
The following should be included in the figures for ‘operations’:
• All planned or elective operations and day surgery
For ‘non-clinical reasons’ please include a break-down of the following:
Bed-ward not available
Staff unavailable
Emergency operations taking priority
Maintenance needed on equipment
Patient unavailable
Admin error

Download response Cancelled operations for non-clinical reasons 2013 to March 2016. 170516

a) How many adult’s operations were cancelled at your Trust from 1 March 2020 – 31 August 2020?
b) How many adult’s operations were cancelled at your Trust from 1 March 2019 – 31 August 2019?
c) How many children’s operations were cancelled at your Trust from 1 March 2020 – 31 August 2020?
d) How many children’s operations were cancelled at your Trust from 1 March 2019 – 31 August 2019?

Download response Cancelled operations March – September 2019 and 2020. 141020

How many planned operations were cancelled in January 2018 due to winter pressures? If possible, please provide a specific reason for each case.

Download response Cancelled planned operations. 210318

I have been looking on the MTW website for your “2 week urgent referral policy”. I have not been able to locate this or a leaflet. Would you please be able to email me a copy of this?

Download response 2-week urgent referral policy. 031121.docx

Please outline details of the active surveillance protocol below (or attach the protocol document when replying to our request email):

Download response Active surveillance for prostate cancer. 260717

Please note the questionnaire refers only to Adult Haematology services.
1) Does your Trust have a Clinical Haematology service for Adults?
Yes / No (delete as appropriate)
If No, please return the questionnaire at this stage – there are no further questions that need to be answered.
2) If Yes, please complete the staffing table below:
3) If you have Haematology Clinical Nurse Specialists, please advise on how their jobs are split, for example 1.0WTE Myeloma CNS, 0.8WTE BMT CNS etc.
4) Which of the below haematological services does your Haematology service cover?
5) In the last 3 years, how many ‘New’ patients were seen by your Clinical Haematology Team?
6) If you have a BMT service, how many patients do you treat on average per year?

Adult Haematology services.190522.docx

1) In the past 3 months, how many advanced/metastatic breast cancer patients have the status of;
a) HR+ and HER2+ [Hormone receptor-positive and human epidermal growth factor 2-positive]
b) HR- and HER2+ [Hormone receptor-negative and human epidermal growth factor 2-positive]
2) In the past 3 months, how many breast cancer patients were treated with:
a. Abemaciclib (Verzenios) + aromatase inhibitor *
b. Abemaciclib (Verzenios) + Fulvestrant
c. (Faslodex) Alpelisib (Piqray) + Fulvestrant (Faslodex)
d. Atezolizumab (Tecentriq)**
e. Bevacizumab (Avastin)
f. Eribulin (Halaven)
g. Everolimus (Afinitor) + Exemestane
h. Fulvestrant (Faslodex) as a single agent
i. Gemcitabine + paclitaxel
j. Lapatinib (Tyverb)
k. Neratinib (Nerlynx)
l. Olaparib (Lynparza)
m. Palbociclib (Ibrance) + aromatase inhibitor*
n. Pertuzumab (Perjeta) + trastuzumab + docetaxel
o. Ribociclib (Kisqali) + aromatase inhibitor*
p. Ribociclib (Kisqali) + Fulvestrant (Faslodex)
q. Talazoparib (Talzenna)
r. Trastuzumab + paclitaxel Trastuzumab as a single agent
s. Trastuzumab emtansine (Kadcyla)
t. Trastuzumab Deruxtecan (Enhertu)
u. Tucatinib + Trastuzumab + Capecitabine (Tukysa)
v. Other active systemic anti-cancer therapy ** *aromatase inhibitor e.g. Anastrozole, Exemestane or Letrozole **e.g. docetaxel, vinorelbine or capecitabine as a single agent

Advanced breast cancer.041122.docx

1a. Does your trust treat advanced breast cancer?
1b. If none, where are your patients referred?
2. In the past 3 months, how many advanced breast cancer patients [Stage IV] have the status of;
HR+ and HER2+ [Hormone receptor-positive and human epidermal growth factor 2-positive]
HR+ and HER2- [Hormone receptor-positive and human epidermal growth factor 2-negative]
HR- and HER2+ [Hormone receptor-negative and human epidermal growth factor 2-positive]
HR- and HER2- [Hormone receptor-negative and human epidermal growth factor 2-negative] – Triple negative disease
Not Known
3. In the past 3 months, how many breast cancer patients were treated with:
Abemaciclib (Verzenios) + aromatase inhibitor *
Abemaciclib (Verzenios) + Fulvestrant (Faslodex)
Alpelisib (Piqray) + Fulvestrant (Faslodex)
Atezolizumab (Tecentriq)**
Bevacizumab (Avastin)
Eribulin (Halaven)
Everolimus (Afinitor) + Exemestane
Fulvestrant (Faslodex) as a single agent
Gemcitabine + paclitaxel
Lapatinib (Tyverb)
Neratinib (Nerlynx)
Olaparib (Lynparza)
Palbociclib (Ibrance) + aromatase inhibitor*
Pertuzumab (Perjeta) + trastuzumab + docetaxel
Ribociclib (Kisqali) + aromatase inhibitor*
Ribociclib (Kisqali) + Fulvestrant (Faslodex)
Talazoparib (Talzenna)
Trastuzumab + paclitaxel
Trastuzumab as a single agent
Trastuzumab emtansine (Kadcyla)
Other active systemic anti-cancer therapy **
*aromatase inhibitor e.g. Anastrozole, Exemestane or Letrozole
**e.g. docetaxel, vinorelbine or capecitabine as a single agent

Download response Advanced Breast Cancer. 221019

Q1. How many patients have been diagnosed with advanced hepatocellular carcinoma (Stage 3b and 4) in the last 6 months?
Q2. How many hepatocellular carcinoma patients (any stage) have been treated in the last 6 months with the following treatments:
a. Lenvatinib
b. Sorafenib
c. Regorafenib
d. Atezolizumab + Bevacizumab
Q3. In the last 6 months, how many patients has your trust treated (for any condition) with the following treatments:
a. Avatrombopag
b. Eltrombopag
c. Fostamatinib
d. Romiplostim
Q4. In the last 6 months, how many patients has your trust treated for Immune thrombocytopenia (ICD10 code D69.3) ONLY with the following treatments:
a. Avatrombopag
b. Mycophenolate mofetil
c. Rituximab
d. Surgery (splenectomy)
Q5. Does your trust participate in any clinical trials for the treatment of hepatocellular carcinoma? If so, can you please provide the name of each trial and the number of patients taking part.

Advanced hepatocellular carcinoma (Stage 3b and 4).230522.docx

1. Within your trust how many unique patients with Advanced Prostate Cancer have been treated in the past 12 months?

2. How many patients with Advanced Prostate Cancer have received:
Abiraterone (Zytiga)
Cabazitaxel (Jevtana)
Docetaxel (Taxotere)
Enzalutamide (Xtandi)
Radium-223 (Xofigo)
Bicalutamide (Casodex)

Download response Advanced Prostate Cancer 070317

Within your trust how many unique patients with Advanced Prostate Cancer have been treated in the past 12 months?

How many patients with Advanced Prostate Cancer have received;
Abiraterone (Zytiga)
Cabazitaxel (Jevtana)
Docetaxel (Taxotere)
Enzalutamide (Xtandi)
Radium-223 (Xofigo)
Bicalutamide (Casodex)
Advanced prostate cancer is cancer that has spread outside the prostate to other parts of the body such as the bones

Download response Advanced prostate cancer June 2016 to May 2017. 090617

Which of the radiotherapy locations in the trust deliver the advanced radiotherapy treatment SABR ()?

Download response Advanced radiotherapy treatment SABR (Stereotactic ablative radiotherapy).180920

1. Does your trust use any AI software within radiology? If so could you please specify programme and its application?
2. If you use AI software within radiology – how often do/would you update, upgrade or swap them?
3. What is the decision-making criteria of choosing which AI software to use?
4. Do you make purchasing decision on your own and if not, what are the other stakeholders involved?

Download response AI software within radiology.110821.docx

All questions are shown as received by the Trust.
I should be grateful if you could inform me of the number of ALK-positive lung cancer patients that your Trust is currently treating. Would it be possible to separate out NHS and private patients?

ALK-positive lung cancer.150923.docx

Q1. How many patients were treated (for any condition) in the latest 6-month period with the following drugs:
a. Juluca (rilpivirine/dolutegravir)
b. Dovato (lamivudine/dolutegravir)
c. Triumeq (abacavir/lamivudine/dolutegravir)
d. Tivicay (dolutegravir)
e. Isentress (raltegravir)
f. Biktarvy (TAF/emtricitabine/bictegravir)
g. Genvoya (TAF/emtricitabine/elvitegravir/cobisistat)
h. Symtuza (TAF/emtricitabine/darunavir/cobisistat)
i. Odefsey (TAF/emtricitabine/rilpivirine)
j. Descovy (TAF/emtricitabine)
k. Truvada or generic TDF/emtricitabine
Q2. How many patients received any antiretroviral (ART) therapy for HIV treatment (excluding pre-exposure prophylaxis):
a. for the latest 6-month period
b. for the 6 months from July-December 2019
Q3. How many patients were treated in the latest 6-months period with Truvada or generic TDF/emtricitabine for?
a. HIV treatment
b. Pre-exposure prophylaxis (PrEP)
Q4. How many packs of Truvada or generic TDF/emtricitabine were dispensed in latest 6-month period for?
a. HIV treatment
b. Pre-exposure prophylaxis (PrEP)

Download response Antiretroviral therapies. 140521

1. The number of Autoclaves commissioned and commissioned date.
2. The departments where Autoclaves are used.

Autoclaves.130223.docx

Firstly, in days what is the a) average and b) longest a single patient has waited to receive a First Consultant Appointment following a GP Urgent Referral (two week target) in calendar year 2017 (Year to Date), 2016, 2015, 2010 and 2009.
Secondly, in days what is the a) average and b) longest a single patient has waited for a First Treatment for Cancer following a Decision to Treat (31 days target) in calendar year 2017 (Year to Date), 2016, 2015, 2010 and 2009.
Thirdly, in days what is the a) average and b) longest a single patient has waited for a First Treatment for Cancer following a GP Urgent Referral (62 days target) in calendar year 2017 (Year to Date), 2016, 2015, 2010 and 2009.

Download response Average and longest waiting times for cancer treatment. 141217

1. How many patients have been treated by your trust (for any medical condition) in the past 6 months with Bevacizumab?
2. Please provide the number of patients treated in the past 6 months with Bevacizumab for the following conditions:
a. Colorectal cancer
b. Breast cancer
c. Renal cell carcinoma
d. Non-small cell lung cancer
e. Ovarian cancer (epithelial, fallopian tube or primary peritoneal)
f. Carcinoma of the cervix

Download response Bevacizumab. 290121

1. Does your Trust routinely provide bisphosphonates to postmenopausal women with primary breast cancer to reduce the risk of their cancer spreading to other parts of the body?
2. If your Trust does routinely provide bisphosphonates to reduce the risk of primary breast cancer spreading to other parts of the body, but is not providing them for all postmenopausal women, how is eligibility defined? For example, women at increased risk of recurrence.
3. If your Trust does routinely provide bisphosphonates for postmenopausal women to reduce the risk of primary breast cancer spreading to other parts of the body, which bisphosphonates do you prescribe? For example, zoledronic acid, ibandronic acid, sodium clodronate.
4. If your Trust does not routinely provide bisphosphonates for postmenopausal women to reduce the risk of primary breast cancer spreading to other parts of the body, what are your reasons for not doing so?

Download response Bisphosphonates. 160818

1. How do you obtain blood collection tubes for liquid biopsies on cancer patients?
2. From what suppliers do you obtain these products?
3. Were these products purchased through a tender or framework? If so, which one? Please provide details including the name, reference and where this was published.
4. Are you under contract with your current supplier(s) for the above? If so, what is the start and end date of the contract?
5. Can you provide the name and contact details for the person(s) responsible for procuring these products?
6. Can you provide contact details for the department responsible for managing this service?

Download response Blood collection tubes for liquid biopsies. 250521

Please provide details of the type (manufacturer and model), quantity, department, site where they are located and age of all Blood Gas Analysers listed on your trust’s asset register (or equivalent).

Blood Gas Analysers.111022.docx

1. Within your health trust how many metastatic breast cancer patients are currently [within the past 6 months] being treated, with any therapy, surgery or palliative care.
2. Within your health trust how many breast cancer patients are currently [within the past 6 months] being treated for bone metastases with the following treatments;
a. disodium pamidronate (Arcadia)
b. ibandronic acid or ibandronate (Bondronat)
c. sodium clodronate (Bonefos, Clasteon, Loron)
d. zoledronic acid or zoledronate (Zometa)
e. denosumab (Xgeva)
3. Within your health trust how many breast cancer patients are currently [within the past 6 months] being treated with adjuvant therapy with the following treatments;
a. disodium pamidronate (Aredia)
b. ibandronic acid or ibandronate (Bondronat)
c. sodium clodronate (Bonefos, Clasteon, Loron)
d. zoledronic acid or zoledronate (Zometa)
4. Within your health trust how many metastatic lung cancer patients are currently [within the past 6 months] being treated with any therapy, surgery or palliative care.
5. Within your health trust how many lung cancer patients are currently [within the past 6 months] being treated for bone metastases with the following treatments;
a. disodium pamidronate (Aredia)
b. ibandronic acid or ibandronate (Bondronat)
c. sodium clodronate (Bonefos, Clasteon, Loron)
d. zoledronic acid or zoledronate (Zometa)
e. denosumab (Xgeva)
6. Within your health trust how many metastatic renal cell cancer patients are currently [within the past 6 months] being treated with any therapy, surgery or palliative care.
7. Within your health trust how many renal cell carcinoma [RCC] patients are currently [within the past 6 months] being treated for bone metastases with the following treatments;
a. disodium pamidronate (Aredia)
b. ibandronic acid or ibandronate (Bondronat)
c. sodium clodronate (Bonefos, Clasteon, Loron)
d. zoledronic acid or zoledronate (Zometa)
e. denosumab (Xgeva)

Download response Bone Metastases. 240919

1. How many patients have been treated for glioblastoma brain cancer in the last 12 months, in your trust/ health board?
2. Which consultant is the nominated medical lead for the treatment or referral of glioblastoma brain cancer?
3.Does your trust/ health board treat all referred glioblastoma brain cancer cases, or are they referred to different centre’s? If so, which treatment centre(s) are they referred to?

Brain Cancer Treatment.051022.docx

Under the Freedom of Information Act, please could you provide the following information for your Trust?
1. How many benign breast lesions has your Trust diagnosed per annum in the last three years?
2. How many benign breast lesions have been removed surgically per annum within your Trust in the last three years?
a. Of this total number, how many of these are classified as B2?
b. Of this total number, how many of these are classified as B3?
3. How many benign breast lesions have not been removed per annum in the last three years?
4. How many benign breast lesions have been removed by vacuum assisted excision (VEA) per annum in the last three years?
a. Of this total number, how many of these are classified as B2 (definition below)?
b. Of this total number, how many of these are classified as B3 (definition below)?
5. Is the Trust aware of NICE guidance promoting the use of VAE for removal of benign lesions?
6. Does the Trust have a referral pathway in place for vacuum assisted percutaneous excision of benign breast lesions?

With regards to this request, please note the following:

B3 Breast Lesion – Lesion of Uncertain Malignant Potential
Findings typical of this category include:
1. Clusters of tiny calcifications – round or oval
2. Non-calcified solid nodules (no size limitation but non palpable on physical examination), round, ovoid and well-defined.
3. Selected focal asymmetrical areas of fibroglandular densities (not palpable): This might include concave-outward defined margins, interspersed with fat and without central increased fibular density on two projections.
4. Miscellaneous focal findings, such as a dilated duct or post biopsy architectural distortion without central density
5. Generalized distribution in both breasts. For example, multiple similar lesions with tiny calcifications or nodules distributed randomly

B2 Breast Lesion – Benign Lesion
A definitive benign finding indicating something abnormal on a mammogram but not something that is breast cancer or malignant in any way. Findings often include:
1. Round opacities with macrocalcifications (typical calcified fibroadenoma or cyst)
2. Round opacities corresponding to a typical cyst at ultrasonography
3. Oval opacities with a radiolucent center
4. Fatty densities or partially fatty images (lipoma, galactocele, oil cyst, hamartoma )
5. Surgical scar
6. Scattered macrocalcifications (fibroadenoma, cyst, cytosteatonecrosis, secretory ductal ectasia);
7. Vascular calcifications
8. Breast implants, silicone granuloma

Download response Breast Biopsy. 280317

Q1. How many patients have been treated for breast cancer (any stage) in the past 3 months with the following systemic anti-cancer therapies:
a. Abemaciclib + Aromatase Inhibitor (e.g. anastrazole, exemestane, letrozole)
b. Abemaciclib + Fulvestrant
c. Alpelisib + Fulvestrant
d. Anthracycline (e.g. doxorubicin or epirubicin) as a single agent
e. Atezolizumab +Nab-paclitaxel/Paclitaxel
f. Capecitabine as a single agent
g. Eribulin as a single agent or in combination
h. Everolimus + Exemestane
i. Fulvestrant as a single agent
j. Lapatinib
k. Neratinib
l. Parp Inhibitors (Olaparib/Talazoparib)
m. Palbociclib + Aromatase Inhibitor (e.g. anastrazole, exemestane, letrozole)
n. Palbociclib + Fulvestrant
o. Pembrolizumab
p. Platinum (e.g. carboplatin or cisplatin) as a single agent
q. Ribociclib + Aromatase Inhibitor (e.g. anastrazole, exemestane, letrozole)
r. Ribociclib + Fulvestrant
s. Sacituzumab Govitecan
t. Taxane (e.g. docetaxel, paclitaxel, nab-paclitaxel) as a single agent
u. Taxane and/or Anthracycline in combination
v. Trastuzumab as a single agent or in combination
w. Trastuzumab emtansine
x. Transtuzumab deruxtecan
y. Any other active systemic anti-cancer therapy
Q2. Does your trust participate in any clinical trials for the treatment of breast cancer? If so, please provide the name of each trial and the number of patients taking part.

Breast Cancer.030723.docx

Q1. How many patients have been treated for breast cancer (any stage) in the past 3 months with the following systemic anti-cancer therapies:
a. Abemaciclib + Aromatase Inhibitor (e.g. Anastrozole, exemestane, letrozole)
b. Abemaciclib + Fulvestrant
c. Alpelisib + Fulvestrant
d. Anthracycline (e.g. doxorubicin or epirubicin) as a single agent
e. Atezolizumab + Nab-paclitaxel/Paclitaxel
f. Capecitabine as a single agent
g. Eribulin as a single agent or in combination
h. Everolimus + Exemestane
i. Fulvestrant as a single agent
j. Lapatinib
k. Neratinib
l. Parp Inhibitors (Olaparib/Talazoparib)
m. Palbociclib + Aromatase Inhibitor (e.g. Anastrozole, exemestane, letrozole)
n. Palbociclib + Fulvestrant
o. Pembrolizumab
p. Platinum (e.g. carboplatin or cisplatin) as a single agent
q. Ribociclib + Aromatase Inhibitor (e.g. Anastrozole, exemestane, letrozole)
r. Ribociclib + Fulvestrant
s. Sacituzumab Govitecan
t. Taxane (e.g. docetaxel, paclitaxel, nab-paclitaxel) as a single agent
u. Taxane and/or Anthracycline in combination
v. Trastuzumab as a single agent or in combination
w. Trastuzumab emtansine
x. Transtuzumab deruxtecan
y. Any other active systemic anti-cancer therapy

Q2. Of the patients treated for breast cancer with Abemaciclib + Aromatase Inhibitor in the past the 3 months, please provide the number of patients with:
a. early/locally advanced breast cancer (Stages 1 to 3B)
b. advanced/metastatic breast cancer (Stages 3C and 4)

Breast cancer.090323.docx

1. In the past 3 months, how many Breast Cancer patients (any stage) were treated with:
a. Abemaciclib monotherapy
b. Aromatase inhibitor monotherapy (e.g. anastrazole, exemestane, letrozole)
c. Tamoxifen monotherapy
d. Abemaciclib + Tamoxifen
e. Abemaciclib + Tamoxifen + Goserelin
f. Abemaciclib + Aromatase Inhibitor (e.g. anastrazole, exemestane, letrozole) + Goserelin
g. Aromatase inhibitor + Goserelin
h. Tamoxifen+ Goserelin
2. How many patients have been treated for Triple-Negative Breast Cancer (any stage) in the past 3 months with the following systemic anti-cancer therapies:
a. Anthracycline (e.g. doxorubicin or epirubicin) as a single agent
b. Atezolizumab +Nab-paclitaxel/Paclitaxel
c. Pembrolizumab
d. Sacituzumab Govitecan
e. Parp Inhibitors (Olaparib/Talazoparib)
f. Eribulin as a single agent or in combination
g. Capecitabine as a single agent
h. Platinum (e.g. carboplatin or cisplatin) as a single agent
i. Taxane (e.g. docetaxel, paclitaxel, nab-paclitaxel) as a single agent
j. Taxane and/or Anthracycline in combination
k. Any other active systemic anti-cancer therapy

Breast cancer.090922.docx

1. Please confirm or deny if Maidstone and Tunbridge Wells NHS Trust holds information on the number of people diagnosed in Maidstone and Tunbridge Wells NHS Trust with early breast cancer in each year from 2013 to 2018.
If confirm, please release this data.
2. Please confirm or deny if Maidstone and Tunbridge Wells NHS Trust holds information on the number of people diagnosed in Maidstone and Tunbridge Wells NHS Trust with early breast cancer that were offered tumour profiling tests to guide adjuvant chemotherapy decisions, in each year from 2013 to 2018. If confirm, please release this data.
3. Please confirm or deny if Maidstone and Tunbridge Wells NHS Trust holds information on the number of people diagnosed in Maidstone and Tunbridge Wells NHS Trust with early breast cancer that were tested with tumour profiling tests to guide adjuvant chemotherapy decisions, in each year from 2013 to 2018. If confirm, please release this data.
4. Please confirm or deny if Maidstone and Tunbridge Wells NHS Trust holds information on the number of people diagnosed in Maidstone and Tunbridge Wells NHS Trust with oestrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative and lymph node (LN)-negative (including micrometastatic disease) early breast cancer in each year from 2013 to 2018. If confirm, please release this data.
5. Please confirm or deny if Maidstone and Tunbridge Wells NHS Trust holds information on the numbers of people diagnosed in Maidstone and Tunbridge Wells NHS Trust with oestrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative and lymph node (LN)-negative (including micrometastatic disease) early breast cancer that were offered tumour profiling tests to guide adjuvant chemotherapy decisions in each year from 2013 to 2018. If confirm, please release this data.
6. Please confirm or deny if Maidstone and Tunbridge Wells NHS Trust holds information on the number of people diagnosed in Maidstone and Tunbridge Wells NHS Trust with oestrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative and lymph node (LN)-negative (including micrometastatic disease) early breast cancer that were tested with tumour profiling tests to guide adjuvant chemotherapy decisions in each year from 2013 to 2018. If confirm, please release this data.

Download response Breast cancer. 181019

1. In the past 3 months, how many Breast Cancer patients (at any stage) were treated with:
a. Abemaciclib monotherapy
b. Aromatase inhibitor monotherapy (e.g. anastrazole, exemestane, letrozole)
c. Tamoxifen monotherapy
d. Abemaciclib + Tamoxifen
2. In the past 3 months, how many early/locally advanced Breast Cancer (Stages 1 to 3B) patients were treated with:
a. Abemaciclib + Aromatase inhibitor (e.g. anastrazole, exemestane, letrozole)
b. Taxane and/or Anthracycline (monotherapy or in combination)
c. Any other active systemic anti cancer therapy
3. How many patients have been treated for Triple Negative Breast Cancer (any stage) in the past 3 months with the following systemic anti cancer therapies:
a. Anthracycline (e.g. doxorubicin or epirubicin) as a single agent
b. Atezolizumab +Nab-paclitaxel/Paclitaxel
c. Pembrolizumab
d. Sacituzumab Govitecan
e. Parp Inhibitors (Olaparib/Talazoparib)
f. Eribulin as a single agent or in combination
g. Capecitabine as a single agent
h. Platinum (e.g. carboplatin or cisplatin) as a single agent
i. Taxane (e.g. docetaxel, paclitaxel, nab-paclitaxel) as a single agent
j. Taxane and/or Anthracycline in combination
k. Any other active systemic anti-cancer therapy

Breast Cancer.181122.docx

Q1. How many patients have been treated for breast cancer (any stage) in the past 3 months with the systemic anti-cancer therapies listed below?
a. Aromatase Inhibitor (e.g. anastrozole, exemestane, letrozole) as a single agent
b. Abemaciclib + Aromatase Inhibitor (e.g. anastrozole, exemestane, letrozole)
c. Abemaciclib + Fulvestrant
d. Anthracycline (e.g. doxorubicin or epirubicin) as a single agent
e. Atezolizumab +Nab-paclitaxel/Paclitaxel
f. Capecitabine as a single agent
g. Carboplatin or Cisplatin as a single agent
h. Eribulin as a single agent or in combination
i. Everolimus + Exemestane
j. Fluorouracil
k. Fulvestrant as a single agent
l. Goserelin
m. Lapatinib
n. Neratinib
o. Olaparib
p. Palbociclib + Aromatase Inhibitor (e.g. anastrazole, exemestane, letrozole)
q. Palbociclib + Fulvestrant
r. Pertuzumab + Trastuzumab + Docetaxel
s. Platinum (e.g. carboplatin or cisplatin) as a single agent
t. Ribociclib + Aromatase Inhibitor (e.g. anastrazole, exemestane, letrozole)
u. Ribociclib + Fulvestrant
v. Talazoparib
w. Tamoxifen
x. Taxane (e.g. docetaxel, paclitaxel, nab-paclitaxel) as a single agent
y. Transtuzumab as a single agent
z. Trastuzumab emtansine
aa. Transtuzumab deruxtecan
bb. Any other active systemic anti-cancer therapy

Q2. In the past 3 months, how many early/locally advanced (Stages I to IIIc) breast cancer patients were treated with an Aromatase Inhibitor (anastrozole, exemestane, Letrozole) as a single agent?

Download response Breast cancer. 251021.docx

Q1. How many patients were treated in total, regardless of diagnosis, with the following medicines in the latest three months for which you have data?
Name of medicine
1.1 Abemaciclib (Verzenios)
1.2 Alpelisib (Piqray)
1.3 Anastrozole (anastrozole or Arimidex)
1.4 Exemestane (exemestane or Aromasin)
1.5 Fulvestrant (fulvestrant or Faslodex)
1.6 Letrozole (letrozole or Femara)
1.7 Palbociclib (Ibrance)
1.8 Ribociclib (Kisqali)
Q2. How many patients received abemaciclib (Verzenios) as adjuvant treatment for early breast cancer in the latest three months for which you have data?
If you do not have data on early breast cancer, please state how many patients received abemaciclib (Verzenios) as adjuvant treatment.
Q3. How many patients received abemaciclib in combination with an aromatase inhibitor (anastrozole or exemestane or letrozole) for early breast cancer and locally advanced or metastatic breast cancer in the latest three months for which you have data?
3.1 Abemaciclib + aromatase inhibitor (anastrozole or exemestane or letrozole)
3.2 Abemaciclib + aromatase inhibitor (anastrozole or exemestane or letrozole)
Q4. How many patients received Olaparib (Lynparza) as adjuvant treatment for early breast cancer in the latest three months for which you have data?
If you do not have data on early breast cancer, please state how many patients received Olaparib (Lynparza) as adjuvant treatment.
Q5. How many patients were treated with the following medicines in combination in the latest three months for which you have data?
Name of combination
4.1 Abemaciclib (Verzenios) + Fulvestrant (fulvestrant or Faslodex)
4.2 Abemaciclib (Verzenios) + Anastrozole (anastrozole or Arimidex)
4.3 Abemaciclib (Verzenios) + Exemestane (exemestane or Aromasin)
4.4 Abemaciclib (Verzenios) + Letrozole (letrozole or Femara)
4.7 Alpelisib (Piqray) + Fulvestrant (fulvestrant or Faslodex)
4.8 Palbociclib (Ibrance) + Fulvestrant (fulvestrant or Faslodex)
4.9 Palbociclib (Ibrance) + Anastrozole (anastrozole or Arimidex)
4.10 Palbociclib (Ibrance) + Exemestane (exemestane or Aromasin)
4.11 Palbociclib (Ibrance) + Letrozole (letrozole or Femara)
4.12 Ribociclib (Kisqali) + Fulvestrant (fulvestrant or Faslodex)
4.13 Ribociclib (Kisqali) + Anastrozole (anastrozole or Arimidex)
4.14 Ribociclib (Kisqali) + Exemestane (exemestane or Aromasin)
4.15 Ribociclib (Kisqali) + Letrozole (letrozole or Femara)
Q5. How many patients were treated with Olaparib (Lynparza) as monotherapy for locally advanced or metastatic breast cancer in the latest three months for which you have data?
Q6. Which of these protocols does your Trust follow when issuing prescriptions for aromatase inhibitors (anastrozole or exemestane or letrozole) prescribed in combination with CDK4/6 inhibitors (abemaciclib or palbociclib or ribociclib)?
6.1 Aromatase inhibitors and CDK4/6 inhibitors are issued together To Take Out at the hospital
6.2 Aromatase inhibitors and CDK4/6 inhibitors are issued separately. The CDK4/6 inhibitors (abemaciclib or palbociclib or ribociclib) are issued To Take Out at the hospital. The aromatase inhibitors (anastrozole or exemestane or letrozole) are issued as an FP10 to the patient or a request is sent to the GP to issue in the community
6.3 Both protocols above

Breast Cancer.310323.docx

Can you please tell me how many women were diagnosed and received treatment between the years 2014 – 2015 and 2015 – 2016. How many women in each year were treated by breast conserving surgery (lumpectomy) and how many by mastectomy. Of the women who underwent mastectomy how many received an immediate reconstruction.

Download response Breast Cancer Services. 070417

Do you have data showing the outcome of breast cancer surgery at your trust in relation to?

1. Survival rates for patients five years after surgery?
1a. Can you tell me what the figure is?
1b. Do you have results for individual surgeons?

2. Survival rates for patients ten years after surgery?
2a. Can you tell me what the figure is?
2b. Do you have results for individual surgeons?

Do you have data showing the outcome of breast cancer surgery at your trust in relation to:

3. Local Recurrence rates for patients five years after mastectomy and breast conserving surgery.
3a. Can you tell me what the figures are.
3b. Do you have figures for individual surgeons?

Download response Breast Cancer Surgery. 051017

Q1. How many patients have been treated for breast cancer (any stage) in the past 3 months with the following systemic anti-cancer therapies:
a. Abemaciclib + Aromatase Inhibitor (e.g. Anastrozole, exemestane, letrozole)
b. Abemaciclib + Fulvestrant
c. Anthracycline (e.g. doxorubicin or epirubicin) as a single agent
d. Atezolizumab +Nab-paclitaxel/Paclitaxel
e. Capecitabine as a single agent
f. Eribulin as a single agent or in combination
g. Everolimus + Exemestane
h. Fulvestrant as a single agent
i. Lapatinib
j. Neratinib
k. Parp Inhibitors (Olaparib/Talazoparib)
l. Palbociclib + Aromatase Inhibitor (e.g. Anastrozole, exemestane, letrozole)
m. Palbociclib + Fulvestrant
n. Pembrolizumab
o. Platinum (e.g. carboplatin or cisplatin) as a single agent
p. Ribociclib + Aromatase Inhibitor (e.g. Anastrozole, exemestane, letrozole)
q. Ribociclib + Fulvestrant
r. Sacituzumab Govitecan
s. Taxane (e.g. docetaxel, paclitaxel, nab-paclitaxel) as a single agent
t. Taxane and/or Anthracycline in combination
u. Trastuzumab as a single agent or in combination
v. Trastuzumab emtansine
w. Transtuzumab deruxtecan
x. Any other active systemic anti-cancer therapy
Q2. In the past 3 months, how many early/locally advanced breast cancer (Stages 1 to 3B) patients were treated with:
a. Abemaciclib + Aromatase Inhibitor (e.g. Anastrozole, exemestane, letrozole)
b. Taxane and/or Anthracycline (monotherapy or in combination)
c. Any other active systemic anti-cancer therapy

Breast cancer treatment.110722.docx

1. Within your health trust how many patients are currently [within the past 3 months] being treated with the following for breast cancer?
Abemaciclib + aromatase inhibitor *
Abemaciclib + Fulvestrant
Alpelisib + Fulvestrant
Atezolizumab
Bevacizumab
Eribulin
Everolimus + Exemestane
Fulvestrant as a single agent
Gemcitabine + paclitaxel
Lapatinib
Neratinib
Olaparib
Palbociclib + aromatase inhibitor*
Pertuzumab + trastuzumab + docetaxel
Ribociclib + aromatase inhibitor*
Ribociclib + Fulvestrant
Talazoparib
Herceptin SC
Herceptin IV
Transtuzumab biosimilar SC
Transtuzumab biosimilar IV
Trastuzumab emtansine
Other active systemic anti-cancer therapy **
*aromatase inhibitor e.g. Anastrozole, Exemestane or Letrozole
**e.g. docetaxel, vinorelbine or capecitabine as a single agent

2. How many patients are being treated for
2a Neo-adjuvant breast cancer;
Transtuzumab total SC
Transtuzumab total IV
2.b Adjuvant breast cancer;
Transtuzumab total SC
Transtuzumab total IV

Download response Breast Cancer treatments.241219

1. In November and December 2019 how many requests/bookings for radical radiotherapy to the breast or chestwall were received by the radiotherapy department?
2. For those patients requested/booked in November and December 2019, how many commenced treatment?
3. Of those who received treatment what was the average length of time between the request/booking being made and the patient receiving treatment?
4. What is your average length of time for all radical radiotherapy requests/bookings to starting treatment?

Download response Breast radiotherapy access. 170120

Breast Screening – (Asymptomatic)
1. Does the trust have a dedicated breast screening service/unit (Asymptomatic mammograms) – This could be separate from the main x-ray department?
2. If so, what is the name of the service?
3. Is this run in a static unit or on breast screening vans (Or Both)? How many vans does the service run? How many static sites does the service run?
4. How many ladies are scanned/screened on average, per day on each van/static unit?
5. Does the service scan on a 5 day or 7 day week?
6. Who has the overall responsibility for the breast screening service?
7. Please provide an organisational chart for the team/department with overall responsibility for the breast screening service

Symptomatic Mammography & Breast Clinics
1. Which department has the responsibility for symptomatic mammograms / Symptomatic Breast Lists/Clinics? Does this come under the breast screening unit or the main radiography department of the trust?
2. How many ladies are assessed on average per day in the symptomatic breast clinic?
3. Does the service scan on a 5 day or 7 day week?
4. Who has the overall responsibility for the symptomatic breast clinics?
5. Please provide an organisational chart for the team/department with overall responsibility for the symptomatic breast clinics

Download response Breast Screening & Breast Clinics. 031219

Please can you answer the following questions regarding the Mobile C-arm medical imaging equipment used within the Trust?
Please can you provide the following information for each piece of Mobile C-arm medical imaging equipment? (Please complete the attached spreadsheet)
a. Manufacturer
b. Model
c. Type (Image Intensifier, Flat Panel Detector)
d. Generator Power
e. Location – Hospital Name
f. Location – Department
g. Method of Finance at Procurement
h. Initial cost of Equipment
i. Annual Maintenance cost
j. Acquisition Date
k. Planned Replacement Date

Download response C-Arm provision. 250220

I would like to know how many cancer operations have been cancelled by your NHS Trust since March 1st 2020?

Download response Cancelled cancer operations. 220920

1. In the years 2015 & 2016 of the patients that became resident for Cancer care/treatment with inside a hospital managed by your trust, please list the annual total for the patients as described?

2. Further to the above please also provide the annual total for those patients’ families who received a pass entitling free parking during the patients stay to reduce the financial burden on the family visiting?

Download response Cancer care or treatment 2015-2016. 020317

1. In the years 2015 & 2016 of the patients that became resident for Cancer care/treatment with inside a hospital managed by your trust, please list the annual total for the patients as described?

2. Further to the above please also provide the annual total for those patients’ families who received a pass entitling free parking during the patients stay to reduce the financial burden on the family visiting?

Download response Cancer care or treatment 2015-2016. 020317

1) How many PALS enquiries and official complaints your Trust has received from patients concerned about
a) the impact of the coronavirus pandemic and your Trust’s response on their or their family member’s access to cancer treatment
b) and access to cancer testing – including tests to find out whether their or their family member’s cancer has spread, returned or occurred for the first time
2) For the five most recent PALS enquiries/official complaints received, please provide me with
a) a summary of the complaint (e.g. a patient with stage 4 lung and breast cancer has contacted PALS to complain about their chemotherapy being postponed for a month)
b) the exact wording of the complaint, with redactions to remove potentially identifying information
c) what action the Trust took in response

Download response Cancer complaints. 021121.docx

Could you please tell me between 1st March 2020 and the date of this email (31st July 2020):
1) How many PALS enquiries and official complaints your Trust has received from patients concerned about
a) the impact of the coronavirus pandemic and your Trust’s response on their access to cancer treatment
b) and access to cancer testing – including tests to find out whether their cancer has spread, returned or occurred for the first time
NOTE: I suggest you search for these complaints by using the keywords ‘cancer treatment’, ‘chemotherapy’, ‘cancer testing’, ‘coronavirus’, ‘COVID-19’ and other relevant terms.
2) For the five most recent PALS enquiries/official complaints received, please provide me with
a) a summary of the complaint (e.g. a patient with stage 4 lung and breast cancer has contacted PALS to complain about their chemotherapy being indefinitely suspended)
b) the exact wording of the complaint, with redactions to remove potentially identifying information
c) what action the Trust took in response

Download response Cancer complaints. 170820

All questions are shown as received by the Trust.
1. The number of people at your trust currently receiving treatment for cancer?
2. The number of people at your trust currently waiting to receive treatment for cancer?
3. How long has the person who has waited the longest been waiting?
4. The number of people waiting to start cancer treatment, as measured from the date of urgent referral, who have waited longer than:
a. 62 days,
b. 3 months,
c. 4 months
d. 6 months,
e. 12 months.
5. The single longest wait to start cancer treatment, as measured from the date of the urgent referral, for each of the last three years?

Cancer – Longest Wait.310823.docx

In the years 2015, 2016 & 2017 from January 1st until the current date could you please provide me with the total number per month of cancer operations cancelled by Hospitals under the umbrella of your Acute NHS Trust?

Download response Cancer operations – Annual cancellations. 310117

1. How many patients on the cancer pathway started treatment within the 62 days and over 62 days, from urgent GP referral to starting treatment in each month of 2020 and 2021.
2. How many patients referred under the 2 weeks wait pathway were seen within 14 days in each month of 2020 and 2021.
3. How many patients started cancer treatment in each month of:
a. 2019
b. 2020
c. 2021

Download response Cancer pathway and treatment. 270821.docx

Please send me:
1. The total number of cancer patients receiving treatment within 62 days.
2. The total number of cancer patients waiting more than 104 days for treatment.

Download response Cancer patients. 240920

What percentage of cancer referrals received an appointment within 12 weeks of the original referral from a GP, for each month in 2019 and for each month in 2020.

Download response Cancer referrals.280521

1) What support do you offer for the family members of patients being treated for cancer within your NHS trust? (Support can include anything that would contribute to the emotional well-being of an individual, such as support groups, counselling or advice).
2) Does your NHS Trust provide any tailored support specifically for young people (under 25s) who have family members being treated for cancer?
3) If so, please could you provide details.
4) Are services actively offered to patients’ family members, or do they have to approach the Trust themselves to request support?

Download response Cancer Services. 110221

1. Over all how many Cancer trackers are employed by your Trust (WTE)?
2. Over all how many cancer MDT co-ordinators are employed by your Trust (WTE)?
3. Please provide the split of cancer tracker WTE by each tumour site of responsibility
a. Lung
b. Breast
c. Head & Neck
d. Lower GI
e. Upper GI
f. Gynaelogical
g. Children’s
h. Acute leukaemia
i. Haematological malignancies (excluding acute leukaemia)
j. Testicular
k. Urological
4. Please provide the split of cancer MDT co-coordinators WTE by each tumour site of responsibility
a. Lung
b. Breast
c. Head & Neck
d. Lower GI
e. Upper GI
f. Gynaelogical
g. Children’s
h. Acute leukaemia
i. Haematological malignancies (excluding acute leukaemia)
j. Testicular
k. Urological
5. What cancer PAS system is used by your organisation? I.e. Somerset, Infoflex other. If other please specify.

Cancer services.180522.docx

I wonder if you could get a complete copy including finance of the Trusts Cancer Policy.
On another issue, we are trying to get hold of copies of the two trusts Radiotherapy policy.

Download response Cancer Services and Radiotherapy policies. 090620

Please provide the following information:

-The number of patients who have received NHS-funded treatment for cancer (including surgery, radiotherapy and medicines) at your trust who have also received cancer treatment privately at your trust (including directly and through private patient units located on trust premises), providing an annual total for each of the last five financial years.

-Where cancer treatment was provided privately for patients at your trust in addition to NHS-funded cancer treatment, the total value of treatments received, providing an annual total for each of the last five financial years.

-Where cancer treatment was provided privately for patients at your trust in addition to NHS-funded cancer treatment, the five cancer treatments that were most commonly provided privately, providing an annual total for each of the last five financial years.

-Where cancer treatment was provided privately for patients at your trust in addition to NHS-funded cancer treatment, please include a breakdown of patient numbers and value of treatment by type of cancer.

-The number of patients who have received NHS-funded treatment for cancer (including surgery, radiotherapy and medicines) at your trust who have also received cancer treatment from any private provider, providing an annual total for each of the last five financial years.

Download response Cancer treatment. 040817

Please provide the following information:

-The number of patients who have received NHS-funded treatment for cancer (including surgery, radiotherapy and medicines) at your trust who have also received cancer treatment privately at your trust (including directly and through private patient units located on trust premises), providing an annual total for each of the last five financial years.

-Where cancer treatment was provided privately for patients at your trust in addition to NHS-funded cancer treatment, the total value of treatments received, providing an annual total for each of the last five financial years.

-Where cancer treatment was provided privately for patients at your trust in addition to NHS-funded cancer treatment, the five cancer treatments that were most commonly provided privately, providing an annual total for each of the last five financial years.

-Where cancer treatment was provided privately for patients at your trust in addition to NHS-funded cancer treatment, please include a breakdown of patient numbers and value of treatment by type of cancer.

-The number of patients who have received NHS-funded treatment for cancer (including surgery, radiotherapy and medicines) at your trust who have also received cancer treatment from any private provider, providing an annual total for each of the last five financial years.

Download response Cancer treatment. 081117

1 – Within your Health Trust how many patients are currently (within the past 6 months available) being treated for Non-small cell Lung Cancer (NSCLC) with the following
Paclitaxel
Gemcitabine
Osimertinib
Carboplatin and Pemetrexed
Cisplatin and Pemetrexed
Pembrolizumab monotherapy
Pembrolizumab in combination
Atezolizumab
Nivolumab
Other active systemic anti-cancer therapy
2a – Does your Health Trust participate in any ongoing clinical trails for the treatment of Metastatic Non Small Cell Lung cancer patients ?
2b – If so how many patients are currently taking part in clinical trials / what is the name(s) of the trials ?
3 – Within your Health Trust how many patients are currently (within the past 6 months available) being treated for Colorectal Cancer (CRC) with the following:
Cetuximab not in combination with FOLFIRIE or FOLOX
Cetuximab in combination with FOLFIRI
Cetuximab in combination with FOLFOX
Panitumumab not in combination with FOLFIRI or FOLFOX
Panitumumab in combination with FOLFIRI
Panitumumab in combination with FOLFOX
Nivolumab
Aflibercept
Bevacizumab
Ramucirumab
Regorafenib
Sorafenib
Other active systemic anti-cancer therapy (eg 5FU, CAPIRI, CAPOX, FOLFIRI, FOLFOX, Oxaliplatin, Irinotecan, Tegafur or Uracil + 5FU)
3a – Does your Health Trust participate in any ongoing clinical trials for the treatment of Colorectal cancer patients ?
3b – If so how many patients are currently taking part in clinical trials / what is the name(s) of the trials ?
4 – Within your Health Trust how many patients are currently (within the past 6 months available) being treated for Head and Neck Cancer (Squamous Cell Carcinoma) ?
4a – If your Trust is able to split these patients, how many are locally advanced and how many are recurrent and or metastatic Head and Neck Cancer patients ?
Locally advanced
Recurrent metastatic
Unable to split
4b – Of the Head and Neck cancer patients please split by their current drug treatment (if you are unable to split by locally advanced and recurrent please state the total)
Carboplatin (only or in combination with 5-FU)
Cisplatin (only or in combination with 5-FU)
Cetuximab with / without chemotherapy
Cetuximab with radiotherapy
Pembrolizumab monotherapy
Pembrolizumab with chemotherapy
Nivolumab
Docetaxel (only or in combination with 5-FU)
Fluorouracil (5-FU)
Radiotherapy only
Other
4c – Does your Health Trust participate in any ongoing clinical trials for the treatment of Head and Neck cancer patients ?
4d – If so how many patients are currently taking part in clinical trials / what is the name(s) of the trials ?
5 – Within your Health Trust how many patients are currently (within the past 6 months available) being treated for Urothelial Carcinoma UCC) with the following:
Cisplatin single agent
Cisplatin in combination with another agent
Carboplatin single agent
Carboplatin in combination with another agent
Nivolumab
Pembrolizumab
Atezolizumab
Other active systemic anti-cancer therapy
5a – Does your Health Trust participate in any ongoing clinical trials for the treatment of Metastatic Urothelial Carcinoma patients ?
5b – If so how many patients are currently taking part in clinical trials / what is the name(s) of the trials ?

Download response Cancer treatment. 181019

1 – Within your Health Trust how many patients are currently (within the past 6 months available) being treated for Non-small cell Lung Cancer (NSCLC) with the following
Paclitaxel
Gemcitabine
Osimertinib
Carboplatin and Pemetrexed
Cisplatin and Pemetrexed
Pembrolizumab monotherapy
Pembrolizumab in combination
Atezolizumab
Nivolumab
Other active systemic anti-cancer therapy
2a – Does your Health Trust participate in any ongoing clinical trails for the treatment of Metastatic Non Small Cell Lung cancer patients ?
2b – If so how many patients are currently taking part in clinical trials / what is the name(s) of the trials ?
3 – Within your Health Trust how many patients are currently (within the past 6 months available) being treated for Colorectal Cancer (CRC) with the following:
Cetuximab not in combination with FOLFIRIE or FOLOX
Cetuximab in combination with FOLFIRI
Cetuximab in combination with FOLFOX
Panitumumab not in combination with FOLFIRI or FOLFOX
Panitumumab in combination with FOLFIRI
Panitumumab in combination with FOLFOX
Nivolumab
Aflibercept
Bevacizumab
Ramucirumab
Regorafenib
Sorafenib
Other active systemic anti-cancer therapy (e.g. 5FU, CAPIRI, CAPOX, FOLFIRI, FOLFOX, Oxaliplatin, Irinotecan, Tegafur or Uracil + 5FU)
3a – Does your Health Trust participate in any ongoing clinical trials for the treatment of Colorectal cancer patients ?
3b – If so how many patients are currently taking part in clinical trials / what is the name(s) of the trials ?
4 – Within your Health Trust how many patients are currently (within the past 6 months available) being treated for Head and Neck Cancer (Squamous Cell Carcinoma) ?
4a – If your Trust is able to split these patients, how many are locally advanced and how many are recurrent and or metastatic Head and Neck Cancer patients ?
Locally advanced
Recurrent metastatic
Unable to split
4b – Of the Head and Neck cancer patients please split by their current drug treatment (if you are unable to split by locally advanced and recurrent please state the total)
Carboplatin (only or in combination with 5-FU)
Cisplatin (only or in combination with 5-FU)
Cetuximab with / without chemotherapy
Cetuximab with radiotherapy
Pembrolizumab monotherapy
Pembrolizumab with chemotherapy
Nivolumab
Docetaxel (only or in combination with 5-FU)
Fluorouracil (5-FU)
Radiotherapy only
Other
4c – Does your Health Trust participate in any ongoing clinical trials for the treatment of Head and Neck cancer patients ?
4d – If so how many patients are currently taking part in clinical trials / what is the name(s) of the trials ?
5 – Within your Health Trust how many patients are currently (within the past 6 months available) being treated for Urothelial Carcinoma UCC) with the following:
Cisplatin single agent
Cisplatin in combination with another agent
Carboplatin single agent
Carboplatin in combination with another agent
Nivolumab
Pembrolizumab
Atezolizumab
Other active systemic anti-cancer therapy
5a – Does your Health Trust participate in any ongoing clinical trials for the treatment of Metastatic Urothelial Carcinoma patients ?
5b – If so how many patients are currently taking part in clinical trials / what is the name(s) of the trials ?

Download response Cancer treatment. 181019

How many patients were treated for cancer by your trust each year since 2010?

How many of these patients in each year were ‘self-funders’ or paid the trust for their treatment, either personally or through an insurer and other third party?

What was the total amount of money raised in this way for each year?

How many patients for each year were ordinary NHS patients, ie patients whose care was free at the point of delivery?

How many designated cancer wards does your trust have for each year since 2010?

How many wards, if any, were for ‘self-funders’ and how many were for ordinary NHS patients for each year since 2010?

Download response Cancer treatment 2010 – 2016. 250917

You asked:
1. In the past 3 months, how many mNSCLC patients were treated with?
Afatinib
Atezolizumab
Becacizumab
Ceritinib
Crizotinib
Erlotinib
Gefitinib
Nitendaninb
Nivolumab
Pembrolizumab
Pemetrexed
Ramucirumab
Metastatic hepatocellular carcinoma
2. In the past three months, how many patients were treated with?
Bevacizumab
Cisplatin
Doxorubicin
Everolimus
Lapatinib
Levantinib
Regorafenib
Sorafenib
Sunitinib
TACE
Other active systemic anti-cancer therapy
Metastatic Thyroid Cancer
3. In the past three months, how many patients were treated with?
Axitinib
Cabozantinib
Levantinib
Pazopanib
Sorafenib
Sunitinib
Vandetanib
Others

Download response Cancer treatment. 291118

1a – How many melanoma patients undergoing treatment are BRAF+?
1b – In the past 3 months, how many melanoma patients were treated with the following:
Bevacizumab
Cobimetinib
Dabrafenib
Dabrafenib AND trametinib
Dacarbazine
Encorafenib AND binimetinib
Ipilimumab
Ipilimumab AND Nivolumab
Nivolumab
Pembrolizumab
Trametinib
Vemurafenib
Vemurafenib AND Cobimetinib
Other active systemic anti-cancer therapy
Palliative care
1c – In the past 3 months how many patients were seen who had stage III resectable melanoma
1d – Of all stage III patients seen, how many received a complete resection?
2 – In the past 3 months, how many Squamous Cell Non-small cell lung cancer (SqNSCLC) patients were treated with:
Afatinib
Atezolizumab monotherapy
Bevacizumab
Docetaxel monotherapy
Durvalumab
Erlotinib
Gemcitabine
Necitumumab
Nivolumab
Paclitaxel
Pembrolizumab monotherapy
Pembrolizumab chemo in combination
Pemetrexed
Ramucirumab
Vinorelbine and cisplatin / carboplatin
Other active systemic anti-cancer therapy [please state]
Palliative care only
3 – In the past 3 months, how many Non Squamous Cell Non-small cell lung cancer (Non SqNSCLC) patients were treated with:
Afatinib
Alectinib
Atezolizumab mono
Atezolizumab + bevacizumab + carboplatin + paclitaxel
Bevacizumab
Brigatinib
Ceritinib
Crizotinib
Dacomitinib
Docetaxel monotherapy
Erlotinib
Gefitinib
Nintedanib with docetaxel
Nivolumab
Osimertinib
Paclitaxel
Pembrolizumab monotherapy
Pembrolizumab chemo in combination
Pemetrexed with carboplatin
Pemetrexed with cisplatin
Ramucirumab
Other active systemic anti-cancer therapy [please state]
Palliative care only

Download response Cancer Treatments. 040320

1. Within your health trust, how many patients have been treated in the past 3 months for head and neck cancer (squamous cell carcinoma) with the following agents?
a. Carboplatin (monotherapy or in combination with 5-FU)
b. Cisplatin (monotherapy or in combination with 5-FU)
c. Cetuximab with/without chemotherapy
d. Cetuximab with radiotherapy
e. Pembrolizumab monotherapy
f. Pembrolizumab with chemotherapy
g. Nivolumab
h. Docetaxel (monotherapy or in combination with 5-FU)
i. Fluorouracil (5FU)
j. Radiotherapy only
k. Other
2. For the patients treated in the past 3 months for head and neck cancer (squamous cell carcinoma) with the therapies listed in the first question, please provide:
a. Total number of head and neck cancer patients
b. Number of locally advanced head and neck cancer patients
c. Number of recurrent and/or metastatic head and neck cancer patients
3. Within your health trust, how many patients have been treated in the past 3 months with the following agents for colorectal cancer [CRC]?
a. Aflibercept
b. Bevacizumab
c. Capecitabine
d. CAPIRI
e. CAPOX (XELOX)
f. Cetuximab in combination with FOLFIRI
g. Cetuximab in combination with FOLFOX
h. Cetuximab not in combination with FOLFIRI or FOLFOX
i. Irinotecan only
j. FOLFIRI
k. FOLFOX
l. Fluorouracil (5FU) only
m. Oxaliplatin only
n. Panitumumab in combination with FOLFIRI
o. Panitumumab in combination with FOLFOX
p. Panitumumab not in combination with FOLFIRI or FOLFOX
q. Pembrolizumab
r. Nivolumab
s. Raltitrexed
t. Ramucirumab
u. Regorafenib
v. Sorafenib
w. Other SACT

Download response Cancer treatments. 051121.docx

1. Does your trust treat adult multiple myeloma [MM] ? – if you refer your multiple myeloma patients to another centre, please state which.
2. If yes, then how many multiple myeloma patients, have been treated in the past 6 months with the following;
· Bortezomib [Velcade]
· Carfilzomib [Kyprolis]
· Ixazomib [Ninlaro]
· Lenalidomide [Revlimid]
· Daratumumab [Darzalex]
· Melphalan, prednisolone and thalidomide (known as MPT)
· Cyclophosphamide, thalidomide and dexamethasone (known as CTD)
· Pomalidomide [Imnovid]
3. Over the past 6 months [latest possible], how many chronic lymphocytic leukaemia (CLL) patients have you treated?
If possible, how many CLL patients treated were new to therapy in the past 3 months?
4. How many chronic lymphocytic leukaemia patients, have been treated in the past 6 months with the following;
· Fludarabine (Fludara), cyclophosphamide (Cytoxan), and rituximab (known as FCR)
· Bendamustine and rituximab (known as BR)
· Ibrutinib [Imbruvica]
· Chlorambucil
· Venetoclax
· Obinutuzumab
· Idelalisib
· Fludarabine and rituximab (known as FR)
· High-dose prednisone and rituximab
· Pentostatin (Nipent), cyclophosphamide, and rituximab (known as PCR)
· Alemtuzumab (Campath) with rituximab

Download response Cancer treatments. 210920

1. Within your health trust how many patients have been treated in the past 6 months for head and neck cancer (Squamous cell carcinoma)?
2. Of these patients how many are locally advanced and how many are recurrent and/or metastatic head and neck cancer patients?
Locally advanced
Recurrent metastatic
Unknown
3. Within your health trust how many patients have been treated in the past 6 months for head and neck cancer (Squamous cell carcinoma) with the following agents?
Carboplatin (only or in combination with 5-FU)
Cisplatin (only or in combination with 5-FU)
Cetuximab with/without chemotherapy
Cetuximab with radiotherapy
Pembrolizumab monotherapy
Pembrolizumab with chemotherapy
Nivolumab
Docetaxel (only or in combination with 5-FU)
Fluorouracil (5FU)
Radiotherapy only
Other
Does your health trust participate in any ongoing clinical trials for the treatment of head and neck cancer patients, if so how many patients are currently taking part in clinical trials / what is the name/s of the trials?
4. Within your health trust how many patients have been treated in the past 6 months with the following agent for colorectal cancer [CRC];
Aflibercept
Bevacizumab
Capecitabine
CAPIRI
CAPOX
Cetuximab not in combination with FOLFIRI or FOLFOX
Cetuximab in combination with FOLFIRI
Cetuximab in combination with FOLFOX
Irinotecan
FOLFIRI
FOLFOX
Oxaliplatin
Panitumumab not in combination with FOLFIRI or FOLFOX
Panitumumab in combination with FOLFIRI
Panitumumab in combination with FOLFOX
Nivolumab
Raltitrexed
Ramucirumab
Regorafenib
Sorafenib
5FU only
Tegafur Uracil + 5FU
Trifluridine–tipiracil
XELOX
Other
5. Within your health trust how many patients have been treated in the past 6 months with the following agent for Renal Cell Carcinoma :
Sunitinib
Avelumab + Axitinib
Axinitib
Cabozantinib
Everolimus
Lenvantinib + Everolimus
Nivolumab
Nivolumab + Ipilimumab
Pazopanib
Pembrolizumab + Axitinib
Sunitinib
Temsirolimus
Tivozanib
6. Does your health trust participate in any ongoing clinical trials for the treatment of renal cell cancer patients, if so how many patients are currently taking part in clinical trials / what is the name/s of the trials?

Download response Cancer treatments. 220120

1 – Within your Health Trust how many patients are currently (within the past 3 months) being treated with the following treatments for Kidney Carcinoma (Renal Cell – RCC);
If you do not treat, where do you refer these patients?
2 – Within your Health Trust how many patients are currently (within the past 3 months) being treated with the following treatments for Melanoma?
If you do not treat, where do you refer these patients?
2a – In the past 3 months, how many Melanoma patients were BRAF+?
3 – Within your Health Trust how many patients are currently (within the past 3 months) being treated with the following treatments for Liver Cancer (Hepatic Cell – HCC);
If you do not treat, where do you refer these patients?
4 – Within your Health Trust how many patients are currently (within the past 3 months) being treated with the following treatments for Thyroid Cancer;
If you do not treat, where do you refer these patients?

Download response Cancer treatments. 241019

1. In the past 3 months, how many metastatic melanoma patients were treated by your Trust?
a. Dabrafenib
b. Dabrafenib + Trametinib
c. Densoumab
d. Encorafenib + Binimetinib
e. Ipilimumab
f. Ipilimumab + Nivolumab
g. Nivolumab
h. Pembrolizumab
i. Trametinib
j. Vemurafenib
k. Vemurafenib + Cobimetinib
l. Other active systemic anti-cancer therapy
Palliative care only
2. Within your health trust how many patients are currently [within the past 3 months] being treated for metastatic Non-small-cell lung cancer (NSCLC) with the following:
a. Afatinib
b. Atezolizumab monotherapy or combination
c. Brigatinib
d. Ceretinib
e. Crizotinib
f. Docetaxel monotherapy or combination
g. Erlotinib
h. Gefitinib
i. Gemcitabine
j. Nitendanib + docetaxel
k. Nivolumab
l. Osimertinib
m. Paclitaxel
n. Pembrolizumab monotherapy
o. Pembrolizumab chemo in combination
p. Pembrolizumab monotherapy
q. Pemetrexed monotherapy or combination
r. Ramucirumab
s. Vinorelbine monotherapy or combination
t. Other active systemic anti-cancer therapy
u. Palliative care only
3. Out of the metastatic NSCLC patients currently [within the past 3 months] being treated, are you able to provide the number of patients being treated for Squamous Cell Non-small-cell lung cancer (SqNSCLC ) with the following products?
a. Afatinib
b. Atezolizumab monotherapy or combination
c. Brigatinib
d. Ceretinib
e. Crizotinib
f. Docetaxel monotherapy or combination
g. Erlotinib
h. Gefitinib
i. Gemcitabine
j. Nitendanib + docetaxel
k. Nivolumab
l. Osimertinib
m. Paclitaxel
n. Pembrolizumab monotherapy
o. Pembrolizumab chemo in combination
p. Pembrolizumab monotherapy
q. Pemetrexed monotherapy or combination
r. Ramucirumab
s. Vinorelbine mono or combination
t. Other active systemic anti-cancer therapy
u. Palliative care only

Download response Cancer treatments. 260620

All questions are shown as received by the Trust.
I writing to request, under the Freedom of Information Act, the number of cancer treatments started at each cancer stage in each of the last five years in your trust.

Cancer treatments.270923.docx

1. Within your health trust how many patients have been treated in the past 6 months for head and neck cancer (Squamous cell carcinoma)?
2. Of these patients how many are locally advanced, recurrent, metastatic and unresectable head and neck cancer patients?
a. Locally advanced
b. Recurrent
c. Metastatic
d. Unresectable
e. Unknown
3. Within your health trust how many patients have been treated in the past 6 months for head and neck cancer (Squamous cell carcinoma) with the following agents?
a. Carboplatin (only or in combination with 5-FU)
b. Cisplatin (only or in combination with 5-FU)
c. Cetuximab with/without chemotherapy
d. Cetuximab with radiotherapy
e. Pembrolizumab monotherapy
f. Pembrolizumab with chemotherapy
g. Nivolumab
h. Docetaxel (only or in combination with 5-FU)
i. Fluorouracil (5FU)
j. Radiotherapy only
k. Other
3b. Does your health trust participate in any ongoing clinical trials for the treatment of head and neck cancer patients, if so how many patients are currently taking part in clinical trials / what is the name/s of the trials?
4. Within your health trust how many patients have been treated in the past 6 months with the following agent for colorectal cancer [CRC];
a. Aflibercept
b. Bevacizumab
c. Capecitabine
d. CAPIRI
e. CAPOX
f. Cetuximab not in combination with FOLFIRI or FOLFOX
g. Cetuximab in combination with FOLFIRI
h. Cetuximab in combination with FOLFOX
i. Irinotecan
j. FOLFIRI
k. FOLFOX
l. Oxaliplatin
m. Panitumumab not in combination with FOLFIRI or FOLFOX
n. Panitumumab in combination with FOLFIRI
o. Panitumumab in combination with FOLFOX
p. Nivolumab
q. Raltitrexed
r. Ramucirumab
s. Regorafenib
t. Sorafenib
u. 5FU only
v. Tegafur Uracil + 5FU
w. Trifluridine–tipiracil
x. XELOX
y. Other
5. Within your health trust how many patients have been treated in the past 6 months with the following agent for Renal Cell Carcinoma:
a. Sunitinib
b. Avelumab + Axitinib
c. Axinitib
d. Cabozantinib
e. Everolimus
f. Lenvantinib + Everolimus
g. Nivolumab
h. Nivolumab + Ipilimumab
i. Pazopanib
j. Pembrolizumab + Axitinib
k. Sunitinib
l. Temsirolimus
m. Tivozanib
5b. Does your health trust participate in any ongoing clinical trials for the treatment of renal cell cancer patients, if so how many patients are currently taking part in clinical trials / what is the name/s of the trials?

Download response Cancer treatments. 291020

Please can you let me know what your success rate in meeting the cancer two week wait referral is? What % of patients referred are actually seen within the two weeks?

Cancer two week wait referral.110822.docx

1. How many individuals diagnosed in the last 5 years with prostate cancer?
2. How many deaths attributable to prostate cancer in the last 5 years?
3. How many individuals diagnosed in the last 5 years with breast cancer?
4. How many deaths attributable to breast cancer in the last 5 years?
5. How many individuals diagnosed with brain cancer in the last 5 years?
6. Of those diagnosed with brain cancer how many with GBM4?
7. How many deaths attributable to brain cancer in the last 5 years?
8. Of those deaths how many due to GBM4?
9. How many children diagnosed with brain cancer in the last 5 years?
10. How many child deaths attributable to brain cancer in the last 5 years?
Download response Cancers. 050718

1. The number of patients with NON SMALL CELL LUNG CARCINOMA (Stage IIIB/Stage IV) treated in the last 6 months with the following:
Afatinib (Giotrif)
Ceritinib (Zykadia)
Crizotinib (Xalkori)
Erlotinib (Tarceva)
Gefitinib (Iressa)
Pemetrexed (Alimta)
Nivolumab (Opdivo)
Nintedanib (Vargatef)

2. The number of patients with METASTATIC MELANOMA Stage IV (advanced or metastatic), treated in the last 6 months with the following:
Ipilimumab (Yervoy)
Nivolumab (Opdivo)
Ipilimumab AND Nivolumab
Pembrolizumab (Keytruda)
Vemurafenib (Zelboraf)
Vemurafenib AND Cobimetinib
Dabrafenib (Taflinar)
Trametinib (Mekinist)
Dabrafenib AND trametinib
Dacarbazine (DTIC)
For the period 1/1/2016-30/06/2016

Download response Carcinoma and melanoma 230916

Q1. Does your trust provide SACT (systemic anti-cancer therapy) treatments for the following conditions?
a. Cervical cancer
b. Endometrial cancer
In case you do not provide SACT treatments for either of the above conditions, which other trust do you refer patients to for these treatments?
Q2. How many patients were treated for cervical cancer in the past 6 months with the following treatments:
a. Paclitaxel in combination with Platinum and/or Bevacizumab
b. Pembrolizumab in combination with Platinum and/or Bevacizumab
c. Platinum standalone or in combination with Bevacizumab
d. Toptecan in combination with Platinum and/or Bevacizumab
e. Any other SACT
Q3. How many patients were treated for endometrial cancer in the past 6 months with the following treatments:
a. Dostarlimab
b. Hormone therapy (Progesterone or Letrozole)
c. Pembrolizumab in combination with Lenvatinib
d. Platinum-based chemotherapy (monotherapy or combination with taxanes, anthracyclines, cyclophosphamide)
e. Any other SACT
Q4. How many endometrial cancer patients received the following therapies as 1st Line treatment in the past 6 months:
a. Hormone therapy (Progesterone or Letrozole)
b. Platinum-based chemotherapy (monotherapy or combination with taxanes, anthracyclines, cyclophosphamide)
c. Any other SACT
Q5. Does your trust participate in any clinical trials for the treatment of cervical cancer? If so, can you please provide the name of each trial and the number of patients taking part.
Q6. Does your trust participate in any clinical trials for the treatment of endometrial cancer? If so, can you please provide the name of each trial and the number of patients taking part.

Cervical cancer and Endometrial cancer.171022.docx

We are seeking information for both general advice relevant to all chemotherapies and anything specific to carboplatin.
As part of this guidance and information we are seeking data including but not limited to:
1. The % and number of patients having the kidney function tests before chemo has begun and after it has begun, with associated outcomes, including mortality rates, split by chemo cycle stage undertaken.
2. The % and number of patients whose GFR tests taken prior to chemo starting, have indicated their kidneys were not functioning sufficiently to enable progression of chemotherapy.
3. It would then be helpful to understand which of those patients guided chemo cannot be progressed, did not progress and those that did (going against doctors wishes if that is possible to do?) and their outcomes.
It needs to reflect a time pre covid that is representative of more ‘normal’ time in treatment of cancers patients and also post pandemic peak when hospitals have been ramping up recovery.
We’d therefore be looking at two periods of data 1) 12 rolling months, February 2018 to Feb 2019 and then 5 months May 2021 to September 2021.
In addition to our questions below we’d like:
4. The specific data on number of patients during those periods who did not have a kidney function test prior to the first chemo cycle e.g total patients given chemo and not given chemo and the numbers of those that had gfr test before and those that did not.
5. For those patients that did not, also confirm of any subsequent kidney failure experienced and at what stage of chemo it was experienced.
6. To make a fair comparison, we’d welcome data of those who experienced kidney failure from chemo and at what stage chemo this happened – who undertook a gfr test prior and whose kidneys were deemed fit enough to withstand chemo treatment.

Chemotherapies and anything specific to carboplatin. 170322.docx

1. In your organisation, how many patients diagnosed with Chronic Myeloid Leukaemia (CML) have been treated in calendar year 2015?

2. Of these patients, how many are currently being treated with each of the following tyrosine kinase inhibitors (TKIs)?
· Dasatinib (Sprycel)
· Imatinib (Glivec)
· Nilotinib (Tasigna)
· Ponatinib (Iclusig)
· Bosutinib (Bosulif)

3. If possible, of these patients on a TKI, how many have had treatment with a previous TKI?

4. In your organisation, how many patients diagnosed with Philadelphia positive (Ph+) Acute Lymphoblastic Leukaemia (ALL) have been treated in calendar year 2015?

5. Of these patients how many are currently being treated with each of the following TKIs?
· Dasatinib (Sprycel)
· Imatinib (Glivec)
· Nilotinib (Tasigna)
· Ponatinib (Iclusig)
· Bosutinib (Bosulif)
· Other (i.e. not on a TKI)

Download response Chronic Myeloid Leukaemia (CML) 2015 190416

A list of the current medical imaging equipment held by the Trust across all hospital sites, providing the following information:
Q1: What is your overall spend on medical imaging products and services for the current year?
Q2: How much do you spend on each modality requested below for the current year:
a) Computed Tomography (CT)
b) Magnetic Resonance Imaging (MRI)
c) Ultrasound
d) Fluoroscopy
e) Mammography
f) Nuclear
g) Mobile X-ray
h) Static X-ray
Q3: A list of the current equipment held by the Trust across all hospital sites for each of the following:
a) Supplier
b) Product
c) Contract start date
d) Contract expiry date
e) Number of devices
f) Age of product
Example Response: 3 x Siemens Acuson SC2000, Initial cost £ 29,000, Contract start date 10/02/2022 Contract end date 10/02/2026, 6 years old
Q4: Annual cost of maintenance of equipment
Q5: What percentage of your imaging equipment has an element of Artificial Intelligence?

Clinical Imaging Equipment. 150322.docx

1. Do you insource clinical services and if so, which ones?
2. Do you have any current contracts in place with a company for these insourced services, and if so which services?
3. How much have you spent on insourcing clinical services per annum for the past 3 years?
4. Do you outsource clinical services and if so, which ones?
5. Do you have any current contracts in place with a company for these outsourced services, and if so which services?
6. How much have you spent on outsourcing clinical services per annum for the past 3 years?

Download response Clinical Insourcing and Outsourcing. 111121.docx

1. The total number of colonoscopies undertaken in Maidstone and Tunbridge Wells NHS Trust for the period
i) April 2019-March 2020
ii) April 2020-March 2021.
2. The total number of people diagnosed with colorectal cancer (or other clearly defined indications) within Maidstone and Tunbridge Wells NHS Trust for the period
i) April 2019-March 2020
ii) April 2020-March 2021.
3. The average adenoma detection rate (ADR) and post-colonoscopy colorectal cancer rate (PCCRC) for Maidstone and Tunbridge Wells NHS Trust for the period
i) April 2019-March 2020
ii) April 2020-March 2021
4. The total number of cancers detected, against cancer stage (e.g. 1,2,3 or 4), against colonoscopies performed in the prior three years within Maidstone and Tunbridge Wells NHS Trust in the period
i) April 2019-March 2020
ii) April 2020-March 2021

Colonoscopies and colorectal cancer. 160322.docx

Name of organisation (NHS Trust):
Please list the acute hospital site/s within the Trust:
PLEASE ANSWER THE FOLLOWING QUESTIONS FOR EACH ACUTE HOSPITAL SITE LISTED ABOVE
HOSPITAL AND SERVICES
1. The hospital would be described as a:
District general
Teaching hospital
2. Total number of inpatient beds at this hospital:
3. Does the hospital provide colorectal cancer services
4. Is the hospital a specialist colorectal cancer care centre
5. How many dietitians are employed in the hospital (please answer in FTE units):
6. How many dietitians are commissioned to provide dietetic services in each cancer type (please answer in FTE units. Where no time is commissioned, please enter 0):
7. a. Is there any band 5, general dietetic cover for colorectal cancer care
b. If yes, how many dietitians are commissioned (please answer in FTE units):
8. If there is dietetic time commissioned for colorectal cancer care at the hospital, does this include outpatient or community follow up after discharge?
9. If dietetic time is commissioned for colorectal cancer care, where does the funding come from?

Download response Colorectal Cancer. 280520

1. Within your health trust how many patients have been treated in the past 6 months for head and neck cancer (Squamous cell carcinoma)?
2. Of these patients how many are locally advanced, recurrent, metastatic and unresectable head and neck cancer patients?
Locally advanced
Recurrent
Metastatic
Unresectable
Unknown
3. Within your health trust how many patients have been treated in the past 6 months for head and neck cancer (Squamous cell carcinoma) with the following agents?
Carboplatin (only or in combination with 5-FU)
Cisplatin (only or in combination with 5-FU)
Cetuximab with/without chemotherapy
Cetuximab with radiotherapy
Pembrolizumab monotherapy
Pembrolizumab with chemotherapy
Nivolumab
Docetaxel (only or in combination with 5-FU)
Fluorouracil (5FU)
Radiotherapy only
Other
4. Does your health trust participate in any ongoing clinical trials for the treatment of head and neck cancer patients, if so how many patients are currently taking part in clinical trials / what is the name/s of the trials?
5. Within your health trust how many patients have been treated in the past 6 months with the following agent for colorectal cancer [CRC];
Aflibercept
Bevacizumab
Capecitabine
CAPIRI
CAPOX
Cetuximab not in combination with FOLFIRI or FOLFOX
Cetuximab in combination with FOLFIRI
Cetuximab in combination with FOLFOX
Irinotecan
FOLFIRI
FOLFOX
Oxaliplatin
Panitumumab not in combination with FOLFIRI or FOLFOX
Panitumumab in combination with FOLFIRI
Panitumumab in combination with FOLFOX
Nivolumab
Raltitrexed
Ramucirumab
Regorafenib
Sorafenib
5FU only
Tegafur Uracil + 5FU
Trifluridine–tipiracil
XELOX
Other
6. Within your health trust how many patients have been treated in the past 6 months with the following agent for Renal Cell Carcinoma :
Sunitinib
Avelumab + Axitinib
Axinitib
Cabozantinib
Everolimus
Lenvantinib + Everolimus
Nivolumab
Nivolumab + Ipilimumab
Pazopanib
Pembrolizumab + Axitinib
Sunitinib
Temsirolimus
Tivozanib
7. Does your health trust participate in any ongoing clinical trials for the treatment of renal cell cancer patients, if so how many patients are currently taking part in clinical trials / what is the name/s of the trials?

Download response Colorectal cancer [CRC]. 091220

Q1. Within your health trust, how many patients have been treated in the past 3 months with the following agents for colorectal cancer [CRC]?
a. Aflibercept
b. Bevacizumab
c. Capecitabine
d. CAPIRI
e. CAPOX (XELOX)
f. Cetuximab in combination with FOLFIRI
g. Cetuximab in combination with FOLFOX
h. Cetuximab not in combination with FOLFIRI or FOLFOX
i. Irinotecan only
j. FOLFIRI
k. FOLFOX
l. Fluorouracil (5FU) only
m. Oxaliplatin only
n. Panitumumab in combination with FOLFIRI
o. Panitumumab in combination with FOLFOX
p. Panitumumab not in combination with FOLFIRI or FOLFOX
q. Pembrolizumab
r. Nivolumab
s. Raltitrexed
t. Ramucirumab
u. Regorafenib
v. Sorafenib
w. Other SACT
Q2. In the last 3 months, how many patients has your trust treated (for any condition) with the following treatments
a. Avatrombopag
b. Eltrombopag
c. Fostamatinib
d. Romiplostim
Q3. In the last 3 months, how many patients has your trust treated for Immune thrombocytopenia (ICD10 code D69.3)?
Q4. In the last 3 months, how many patients has your trust treated for Immune thrombocytopenia (ICD10 code D69.3) ONLY with the following treatments:
a. Avatrombopag
b. Mycophenolate mofetil
c. Rituximab
d. Surgery (splenectomy)

Colorectal cancer [CRC].160922.docx

I was wondering if you’d be able to share with me a copy of the letter and information leaflet that you send out to patients who receive a colposcopy appointment.

Download response Colposcopy appointments. 140421

Please could you provide me with a copy of the business case for the Trust’s Community Diagnostic Centre project, including the capital budget for the entire project.

Community Diagnostic Centre.080922.docx

I am writing to obtain information, under the Freedom of Information Act, about your Trust’s funding of Complementary and Alternative Medicine (CAM) services they provided.
To outline my query as clearly as possible, I am requesting:
1. How much the Trust has spent on CAM services for the following financial years:
a. 2019-20
b. 2020-21
c. 2021-22
This includes salaries for those employed to carry out these services, costs of medicine, equipment and any additional costs involved.
2. A list of all services provided under CAM.

Complementary and Alternative Medicine (CAM) services.101022.docx

1. What percentage of consultations were carried out in April 2021 via:
a. Phone
b. Video
c. Face-to-face
2. Did you carry out any patient satisfaction survey on each of the channels in April 2021:
a. Phone
b. Video
c. Face-to-Face
3. Did you introduce digital services (either as new services or expanding into new departments) as a response to the pandemic?
Yes (highlight below):
a. Telephone consultations
b. Video consultations
c. Online appointment booking/management
d. E-prescription services
4. Who are your suppliers for:
a. Telephone consultations
b. Video consultations
c. Online appointment booking/management
d. E-prescription services
5. What are the most common barriers to technology use within your trust?
a. The service requires face-to-face interactions
b. The staff member is unable to use the technology
c. The patient is unable to use the technology
d. Lack of funding
e. Other (please explain)
6. Are you collecting patient feedback following interactions with the digital services you offer?
a. Yes – feedback obtained for all services
b. Feedback obtained for some services:
c. Telephone consultations
d. Video consultations
e. Online appointment booking/management
f. E-prescription services
g. No – we are not collecting this feedback
h. If no – do you plan to introduce this feedback data collection in the next six months? yes/no
i. If yes, how do you collect feedback?
7. Did you stop your FFT during the pandemic when the requirement to submit data was paused?
a. If yes, why?
b. If no, why?
8. Will you be deploying PIFU?
9. Will you be collecting feedback on PIFU?
10. Who is your FFT supplier?
11. If the FFT contract is outsourced, when was the contract initiated?
12. When does the FFT contract with your current supplier end?
13. What is the expected value of this contract (£)?

Download response Consultations. 240521

1) How many Coronary CT angiography scans were performed in the trust in the financial year 2011-12?
2) How many Coronary CT angiography scans were performed in the trust in the financial year 2012-13?
3) How many Coronary CT angiography scans were performed in the trust in the financial year 2013-14?
4) How many Coronary CT angiography scans were performed in the trust in the financial year 2014-15?
5) How many Coronary CT angiography scans were performed in the trust in the financial year 2015-16?

Download response Coronary CT angiography scans. 270918

1) How many of each of the following machines do you have in use:
i) CT
ii) MRI
iii) X-ray
2) How many of each of the following machines are you using that are older than ten years old:
i) CT
ii) MRI
iii) X-ray
3) How old is your oldest in-use machine for each of:
i) CT
ii) MRI
iii) X-ray
4) How many of each of the following machines have you purchased in the past year:
i) CT
ii) MRI
iii) X-ray
5) How much did you spend repairing CT, MRI and X-ray machines in each of the past three years?

CT and MRI machines.311022.docx

1) The number of CT scanners in your Trust, where relevant please provide a number for each hospital.
2) The number of MRI scanners in your Trust, where relevant please provide a number for each hospital.
3) The number of ultrasound scanners in your Trust, where relevant please provide a number for each hospital.
4) The number of x-ray machines in your Trust, where relevant please provide a number for each hospital.
5) For each of the items 1-4, please also provide the number of machines that are more than 10 years old and if available the year that the machine was purchased.

Download response CT, MRI and Ultrasound Scanners and X-Ray machines. 170921.docx

We are looking to produce a map of the CTCL (cutaneous T cell lymphoma) treatment centres in the UK.
To help with this, please could you provide the following:
1. Which centre/s in your NHS Trust offer treatment for CTCL, if any
2. The type of CTCL treatment these centres offer (TSEB or ECP)
3. A contact phone number for referrals for each centre

CTCL (cutaneous T cell lymphoma) treatment centres. 110322.docx

1. How many patients with cutaneous squamous cell carcinoma have you treated?
2. How many adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma have you treated?
3. Of these how many are not candidates for curative surgery or curative radiation?
4. In the past 3 months, how many adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma who are not candidates for curative surgery or curative radiation have you treated with the following;
Libtayo (cemiplimab)
Non curative surgery only
Non curative surgery + chemotherapy*
Non curative surgery + radiotherapy
Non curative surgery + chemotherapy* + radiotherapy
Chemotherapy* only
Chemotherapy* + radiotherapy
Non curative radiotherapy only
No treatment
Palliative Care / Best Supportive care
Other [please state]
*chemotherapy such as cisplatin, doxorubicin, 5-fluorouracil (5-FU), capecitabine, topotecan, or etoposide
5. Does your trust treat adult multiple myeloma [MM]? – if you refer your multiple myeloma patients to another centre, please state which.
6. If yes, then how many multiple myeloma patients, have been treated in the past 6 months with the following;
Bortezomib [Velcade]
Carfilzomib [Kyprolis]
Ixazomib [Ninlaro]
Lenalidomide [Revlimid]
Daratumumab [Darzalex]
Melphalan, prednisolone and thalidomide (known as MPT)
Cyclophosphamide, thalidomide and dexamethasone (known as CTD)
Pomalidomide [Imnovid]
7. Over the past 6 months [latest possible], how many chronic lymphocytic leukaemia (CLL) patients have you treated?
If possible how many CLL patients treated were new to therapy in the past 3 months?
8 How many chronic lymphocytic leukaemia patients, have been treated in the past 6 months with the following;
Fludarabine (Fludara), cyclophosphamide (Cytoxan), and rituximab (known as FCR)
Bendamustine and rituximab (known as BR)
Ibrutinib [Imbruvica]
Chlorambucil
Venetoclax
Obinutuzumab
Idelalisib
Fludarabine and rituximab (known as FR)
High-dose prednisone and rituximab
Pentostatin (Nipent), cyclophosphamide, and rituximab (known as PCR)
Alemtuzumab (Campath) with rituximab

Download response Cutaneous Squamous Cell Carcinoma. 270220

Question 1 – How many adult patients with Cutaneous Squamous Cell Carcinoma have you seen / treated (example Surgery, Radiotherapy, Chemotherapy or combinations of these) in the last 6 months?
Question 2 – How many adult patients with locally advanced (patients with Perineural invasion and local Lymphovascular or Bone involvement) or Metastatic Cutaneous Squamous Cell Carcinoma (patients with both local and distant Nodal involvement, as well as any other organ involvement) have you seen / treated (example Surgery, Radiotherapy, Chemotherapy or combinations of these) in the last 6 months?
Question 3 – Of these how many are not candidates for Curative surgery or Curative Radiation? *
Question 4 – In the past 6 months, how many adult patients with locally advanced or metastatic Cutaneous Squamous Cell Carcinoma have you treated with the following:
Question 5 – Are you participating in any clinical trials for Cutaneous Squamous Cell Carcinoma (CSCC)?
If yes, please state which?
*Example of factors to consider when deciding if locally advanced patients are suitable candidates for surgery: Disease recurrence after two or more surgical procedures and the treating clinicians expected that curative resection would be unlikely
CSCC in a anatomically challenging location where surgery would result in substantial complications or deformity or dysfunction significant local invasion that precludes complete resection
* Example of factors to consider when deciding if locally advanced patients are suitable candidates for radiation:
CSCC in a anatomically challenging location where radiation would be associated with unacceptable toxicity risk in context of the patients overall condition
Clinical judgement that tumour might not respond to RT
Factors / conditions contradicting for RT
Prior treatment with RT for CSCC, and further RT would exceed the threshold of acceptable cumulative does
** Chemotherapy such as Cisplatin, Doxorubicin, 5-Fluorouracil (5-FU), Capecitabine, Topotecan, Methotrexate or Etoposide

Download response Cutaneous Squamous Cell Carcinoma. 271119

1. The number of da Vinci surgical robots in use throughout your trust and the number of each model (e.g. Si, X, Xi, SP)
2. The number of yearly procedures carried out using da Vinci systems with a breakdown by procedure type for the last 5 years
3. A breakdown of the cost per procedure using da Vinci systems including instrumentation, servicing, disposable accessories, sterilisation costs, depreciation and other costs incurred
4. The upfront cost of da Vinci system instruments per surgery or on a per instrument basis
5. Historical number/rate of occurrence of incidences where cross infection has resulted from improper sterilisation and the number of associated adverse events
6. The rate of surgical site infections associated with procedures where a da Vinci system has been used.

Download response Da vinchi surgical robots. 100419

Please answer these questions relating to the usage of Dabrafenib + Trametinib in cancer treatment.
A) Over the previous 6 months, how many patients for the following diseases have been treated with a combination of Dabrafenib + Trametinib:
i) Metastatic Melanoma
ii) Adjuvant Melanoma
iii) BRAF mutated Lung Cancer

Dabrafenib + Trametinib.050722.docx

A) Over the previous 6 months, how many patients for the following diseases have been treated with a combination of Dabrafenib + Trametinib:
i) Metastatic Melanoma
ii) Adjuvant Melanoma
iii) BRAF mutated Lung Cancer

Dabrafenib + Trametinib.110423.docx

Please can you answer the following questions regarding the Dental X-Ray equipment used within the Trust?
1. Please can you provide the following information for each piece of Dental X-Ray equipment within the Trust or associated sites? (Please complete the attached spreadsheet)
a. Manufacturer
b. Model
c. Location – Hospital Name or Site Name
d. Department equipment is primarily used in
e. Method of Finance at Procurement (Trust/Lease/MES/Charity/PFI)
f. Initial cost of Equipment
g. Annual Maintenance cost
h. Acquisition Date
i. Planned Replacement Date

2. Please can you provide the following information for each Cone Beam CT Imaging equipment within the Trust or associated sites? (Please complete the attached spreadsheet)
a. Manufacturer
b. Model
c. Location – Hospital Name or Site Name
d. Department equipment is primarily used in
e. Method of Finance at Procurement (Trust/Lease/MES/Charity/PFI)
f. Initial cost of Equipment
g. Annual Maintenance cost
h. Acquisition Date
i. Planned Replacement Date

Download response Dental X-Ray equipment. 210519

Please could you provide the figures for diagnoses of cancer within your hospital from January 2010 to date.
Please could you present these figures in a yearly format.

Diagnoses of cancer. 020822.docx

1. Please tell us which Trust, Health Board or Health and Social Care Trust you are responding on behalf of?
2. What percentage of men receive mpMRI before biopsy as part of the initial diagnostic process using T2-weighted, diffusion-weighted (multi-b ADC and high/long b) and dynamic contrast enhanced (DCE) sequences?
3. What are your eligibility criteria/exclusion criteria for men to receive pre-biopsy mpMRI?
4. Are you using mpMRI before biopsy to rule some men out of biopsy as part of the initial diagnostic process?
5. What mpMRI scores and/or other clinical factors are used to rule men out of biopsy?
6. Do you intend to use mpMRI to rule men out of biopsy in the future?
7. How many men annually are referred?
8. If you are unable to provide numbers for question 6, please estimate the percentage of all men referred for b, c and d.
9. Do you carry out targeted biopsies in men with mpMRI lesions in addition to systematic biopsies?
(Please indicate with a X below)
If No, what are the reasons for not carrying this out? (e.g. expertise, equipment, don’t believe it makes a difference)
10. If you do not currently carry out targeted biopsies, but wish to in the future, what are the current barriers to doing so?
(Please indicate with a X below)
11. Please indicate the number of uroradiologists undertaking prostate MRI
12. How many scanners do you have available for mpMRI before biopsy?
Has this increased in the last 12 months?
13. What percentage of scanner time is dedicated to mpMRI before biopsy?

Download response Diagnostic data on an MRI technique for men with suspected prostate cancer.270318

Q1. Does your trust treat patients with Diffuse Large B Cell Lymphoma (DLBCL)? If not, then which trust do you refer DLBCL patients to?
Q2. In the last 6 months, how many patients have you treated for Diffuse Large B Cell Lymphoma (DLBCL)?
Q3. In the last 6 months, how many patients have you treated for Diffuse Large B Cell Lymphoma (DLBCL) with the following treatments:
a. R-CHOP (rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine and prednisolone)
b. R-mini-CHOP (rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine and prednisolone)
c. Other immuno-chemotherapy
d. Other chemotherapy
e. Stem cell transplant or bone marrow transplant (autologous or allogeneic)
f. Pola-BR (polatuzumab vedotin with rituximab and bendamustine) – any line of treatment
g. Pola-BR (polatuzumab vedotin with rituximab and bendamustine) – third-line treatment only
h. Tisagenlecleucel
i. Axicabtegene ciloleucel
j. Lisocabtagene maraleucel
Q4. In the last 6 months, how many Diffuse Large B Cell Lymphoma (DLBCL) patients have you referred to other trusts for:
a. Stem cell transplant or bone marrow transplant (autologous or allogeneic)
b. CAR-T therapy (Tisagenlecleucel, Axicabtegene ciloleucel, Lisocabtagene maraleucel)
Q5. Do you participate in any active clinical trials for Diffuse Large B-Cell Lymphoma (DLBCL)? If so, can you please provide the name of each trial along with the number of patients taking part?

Diffuse Large B Cell Lymphoma (DLBCL).270722.docx

Infrastructure:
1) Do you outsource your DXA scans? If Yes- please state the organisation providing this service and forward this FOI to your provider for completion (please continue to complete for any of the elements of the DXA pathway that are provided by your Trust/board)
2) In January 2023 how many DXA scanning machines did you have at your trust/board for clinical use?
a. n. Operational
b. n. not in use
c. n. accessible outside of Trust
3) What is the average weekly capacity for clinical scans? (N. of scans per week)
4) What was your average DNA rate over the last 3 months? (n. DNA/total n. scans booked)
5) What age range do you include in your clinical scans? Please tick all that apply
a. <20 years b. 20-40 years c. 40-60 years d. 60-75 years e. 75-80 years f. >80 years
6) What is the duration of your routine DXA appointment:
a. 15 minutes or less
b. 16-25 minutes
c. 26-30 minutes
d. >30 minutes
7) What was the average wait for clinical patients from referral to scan in January 2023?
a. <2 weeks (move to Q9) b. 2-6 weeks (move to Q9) c. 6-13 weeks d. >13 weeks
8) What are your perceived barriers to delivering DXA scans within 6 weeks from referral? Please tick all that apply
a. Scanner capacity (DXA equipment)
b. Clinical capacity (operator)
c. Other- please state
9) What was the average time from the scan to the report being available to the referrer in January 2023?
a. <3 weeks (move to Q11) b. 4-6 week c. 6-13 weeks d. >13 weeks
10) What are your perceived barriers to referrers receiving DXA scan reports within 3 weeks from scan? Please tick all that apply
a. Clerical- internal
b. Clinical- internal
c. Factors external to this service (please state)
d. Other (please state)
11) What hospital department is responsible for delivery of DXA scans:
a. Radiology
b. Medical physics
c. Nuclear medicine
d. Rheumatology
e. Other- please state
12) Which DXA examinations are included in routine protocols for the clinical service? Please tick all that apply
a. Lumbar spine
b. Proximal femur
c. Long femur (AFF assessment)
d. Total body
e. Vertebral fracture assessment (VFA)
f. Peripheral/forearm
13) What access facilities do you have available? Please tick all that apply
a. Overhead hoist
b. Portable hoist
c. Wheelchair transfers
d. Bed/trolley transfers
e. Changing room
f. Assistance for transfers
g. Other- please state
Workforce:
1)
i) What professional groups perform DXA scan measurements at your centre? (DXA operators)
a. Radiographer
b. DXA technician
c. Assistant practitioner
d. Clinical scientist
e. Nurse
f. Medical Dr- please state specialism
g. Other- please state
h. Unknown]
ii) Please indicate WTE for each group selected
2) What DXA-specific training (outside of professional training) have the DXA operators performing scans had?
a. In house
b. Manufacturers applications training
c. Recognized/accredited national training programme (please state the name of the training programme/provider)
d. Other- please state
e. Unknown
3) What professional groups report your DXA scans at your centre? ()
a. Radiographer – internal
b. Radiographer – external
c. DXA technician – internal
d. DXA technician – external
e. Assistant practitioner – internal
f. Assistant practitioner – external
g. Clinical scientist – internal
h. Clinical scientist – external
i. Nurse -internal
j. Nurse – external
k. Medical Dr – internal – please state specialism(s)
l. Medical Dr – external – please state specialism(s)
m. Other- please state
n. Reporting is outsourced
o. Unknown
4) What training (outside of professional training) have those reporting DXA scans had- specifically in DXA reporting?
a. In house
b. Manufacturers applications training
c. Recognized/accredited national training programme (please state the name of the training programme/provider)
d. Other- please state
e. Unknown
5) What professional group provides clinical leadership for your service?
a. Radiographer
b. DXA technician
c. Assistant practitioner
d. Clinical scientist
e. Nurse
f. Medical Dr- please state specialism(s)
g. Other- please state
h. Unknown
6) Please indicate how many (WTE) clinical vacancies in your DXA service do you have in January 2023? (Free text)
Quality:
1) Is your service accredited as part of a national programme?
a. ISAS
b. IOS
c. Other- please state
d. None
e. Unknown
2) What clinical audits do you routinely undertake? Please tick all that apply
a. DXA scan technique
b. Reporting (double reporting)
c. Reporting (clinical review)
d. Scanner QA review
e. Other- please state
f. Unknown
3) What IR(ME)R audits do you routinely undertake? Please tick all that apply
a. Patient pregnancy
b. DXA dose audit
c. Referrer entitlement
d. Scan justification
e. Other- please state
f. Unknown
4) What clinical protocols do you have in place? Please tick all that apply
a. Scan site
b. Scan mode
c. Reference data selection
d. Patient positioning
e. Scan analysis
f. Interpretation- T&Z-scores
g. Reporting
h. Other- please state
i. Unknown
5) Which of the following are routinely included in the DXA report issued to the PRIMARY CARE referrer? Please tick all that apply
A. Admin. details
i. Date of assessment
ii. Patient ID and demographics
iii. Reason for referral
iv. Reporter’s ID
B. BMD results for each measurement site
i. T score (after peak bone mass)
ii. Z score
iii. Rate of change for serial measurements
C. Comment on reliability of measurements
i. BMD results
ii. Documentation of excluded measurements eg. vertebrae
iii. Statistical significance of rate of change
iv. Clinical significance of rate of change
D. WHO diagnostic category (for adults after peak bone mass)
E. Results of additional investigations performed at DXA appointment
i. VFA
ii. X-ray or other imaging
iii. Laboratory tests
F. Summary of clinical risk factors for fracture
G. Summary of fracture history
H. Clinical interpretation to quantify absolute fracture risk
i. FRAX+BMD
ii. FRAX + TBS
iii. FRAX+BMD plus comment on additional adjustment
iv. Statement on level of risk based on clinical judgement (eg. low/moderate/high)
I. Management advice
i. Reference to national guideline (NICE/NOGG/ROS)
ii. Reference to local management guideline
iii. Individualised advice
J. Recommendations on:
i. Need for onward referral eg. falls assessment or additional investigation
ii. Timing of future scan
6) Which of the following are routinely included in the DXA report issued to the SECONDARY CARE referrer? Please tick all that apply
A. Admin. details
i. Date of assessment
ii. Patient ID and demographics
iii. Reason for referral
iv. Reporter’s ID
B. BMD results for each measurement site
i. T score (after peak bone mass)
ii. Z score
iii. Rate of change for serial measurements
C. Comment on reliability of measurements
i. BMD results
ii. Documentation of excluded measurements eg. vertebrae
iii. Statistical significance of rate of change
iv. Clinical significance of rate of change
D. WHO diagnostic category (for adults after peak bone mass)
E. Results of additional investigations performed at DXA appointment
i. VFA
ii. X-ray or other imaging
iii. Laboratory tests
F. Summary of clinical risk factors for fracture
G. Summary of fracture history
H. Clinical interpretation to quantify absolute fracture risk
i. FRAX+BMD
ii. FRAX + TBS
iii. FRAX+BMD plus comment on additional adjustment
iv. Statement on level of risk based on clinical judgement (eg. low/moderate/high)
I. Management advice
i. Reference to national guideline
ii. Reference to local management guideline
iii. Individualised advice
J. Recommendations on:
i. Need for onward referral eg. falls assessment or additional investigation
ii. Timing of future scan
K. The secondary care report is the same as the primary care report

DXA Facilities Audit.020323.docx

Q1. I am researching the usage of Pembrolizumab for the treatment of Melanoma. How many patients have you treated with Pembrolizumab in the three months from October to December 2022 for:
a. Melanoma – any stage
b. Melanoma – Stage IIb/IIc
c. Melanoma – Stage III
d. Melanoma – Metastatic
Q2. How many Stage IIb/IIc melanoma patients were on a “Watch and Wait” strategy in the three months from October to December 2022? These would be patients where a decision has been made to wait before commencing any treatment.

Early Melanoma.020323.docx

Information request in respect to Elastomeric Infusion Devices

Please could you kindly advise which departments and healthcare professionals within your Trust use elastomeric infusion devices?

Information request in respect of Elastomeric Infusion Devices

1. Please could you also advise if you purchase E.I.D and if so:
a. What brand(s) do you purchase?
b. What quantities do you purchase on an annual basis?
c. Who are the main clinicians responsible within your Trust for the prescribing and administration of elastomeric devices?
d. What medicines do you fill the devices with?
e. Do you fill elastomeric devices in your pharmacy aseptic unit if you have one?
2. Please could you also advise if you purchase pre-filled elastomeric devices from a commercial compounder and if so:
a. What drugs are provided pre-filled?
b. What quantities do you purchase on an annual basis?

Download response Elastomeric Infusion Devices (E.I.D) 020320

Do any hospitals in the trust perform Endomyocardial Biopsy?
– Yes
– No
a) If so how many were performed in 2014-15 financial year?
b) How many were performed for investigation of Myocarditis?
2) How many patients in 2014-15 were diagnosed with Myocarditis in the trust?
3) Does the Trust refer patients to other centres or trusts for Endomyocardial Biopsy?
4) If so which centres or trusts do you refer to?
5) Does your trust receive referrals from other centres or trusts for Endomyocardial biopsy?

Download response EMB Biopsy 060317

1. Does your trust provide SACT (systemic anti-cancer therapy) treatments for endometrial cancer? If not, which other trust do you refer endometrial cancer patients to for SACT treatments?
2. How many patients were treated for endometrial cancer in the past 6 months with the following treatments:
a. Dostarlimab
b. Hormone therapy (Progesterone or Letrozole)
c. Pembrolizumab monotherapy
d. Pembrolizumab in combination with Lenvatinib
e. Platinum-based chemotherapy (monotherapy or combination with taxanes, anthracyclines, cyclophosphamide)
f. Any other SACT
3. How many endometrial cancer patients received the following therapies as 1st Line treatment in the past 6 months:
a. Hormone therapy (Progesterone or Letrozole)
b. Platinum-based chemotherapy (monotherapy or combination with taxanes, anthracyclines, cyclophosphamide)
c. Any other SACT
4. Of the patients treated for endometrial cancer in the past 6 months with any SACT regimen, how many patients had high microsatellite instability (MSI-H) or mismatch repair deficiency (dMMR)?
5. Does your trust participate in any clinical trials for the treatment of endometrial cancer? If so, can you please provide the name of each trial and the number of patients taking part.

Endometrial Cancer.020623.docx

1. Please state what software/ systems the Trust utilises for managing medical equipment/ devices in order to be compliant with MHRA Guidance (see URL below) from the list below. If not listed, please specify:
a. EMAT
b. F2
c. RAM
d. e-Quip
e. Other – please specify
2. Please state the name and contact for the person responsible for ensuring compliance with the MHRA guidance quoted above.

Ensuring MHRA Compliance.190422.docx

Name of person completing request:
Hospital Trust/Health Board:
Telephone No:
E-mail Address:
1. Does your organisation provide a chemotherapy service – this may include inpatient, outpatient or a community service? 0 Yes 0 No
2. In the past financial year, how many doses of chemotherapy did you deliver? (April 2016 – March 2017)
3. In the past financial year, how many doses of anthracyclines did you administer? (April 2016 – March 2017)
4. In the past financial year, how many anthracycline extravasations have been reported due to chemotherapy? (April 2016 – March 2017)
5. In the past 3 financial years, how many patients have submitted a claim for medical negligence and/or damages against the Trust/Health Board due to an anthracycline extravasation injury?
6. In the past 3 financial years, how much compensation has the Trust/Health Board had to pay to those claimants who have suffered an anthracycline extravasation injury and have been successful in their medical negligence and/or damages case?
7. Does your Trust/Health Board have in place guidelines as to how to recognise and manage an extravasation injury? If not, is this available via your Cancer Alliance/Network or another source? If other, please state source ………………………………………………….
Trust/Health Board Guidelines 0 Yes 0 No If yes, when were they last updated?…………………………………………
8. Does your Trust/Health Board stock or have readily available any of the following extravasation treatments for chemotherapy?
a. Sodium Thiosulfate 0 Yes 0 No If yes, how often used in the past financial year? (April 2016 – March 2017)……………………
b. Hyaluronidase 0 Yes 0 No If yes, how often used in the past financial year? (April 2016 – March 2017)……………………
c. DMSO 0 Yes 0 No If yes, how often used in the past financial year? (April 2016 – March 2017)……………………
d. Dexrazoxane (Savene) 0 Yes 0 No If yes, how often used in the past financial year? (April 2016 – March 2017)……………………
9. In the past 3 financial years, how many annual reconstruction operations have been carried out by the Trust/Health Board due to an extravasation injury?
10. Does your Trust/Health Board’s plastics and/or nursing team have the expertise/core competency to undertake the wash-out/flush-out technique if an extravasation occurs?
0 Yes 0 No
11. If you answered yes to question 10, in the past 3 financial years, how many wash-out/flush-out procedures have been carried out by the Trust/Health Board due to an extravasation incident?

Download response Extravasation Incidents. 310118

Could you please tell me, do you have such services as ‘Flushing and locking of intravenous catheters’ in your clinic?

Flushing and locking of intravenous catheters.010722.docx

1. Fundus Camera
a. How many devices do you have and which model?
b. When were these devices installed?
c. When are these due to be replaced?
d. Is there a replacement budget allocated?
e. Do you have a service contract? When does it expire?
2. Optical Biometer
a. How many devices do you have and which model?
b. When were these devices installed?
c. When are these due to be replaced?
d. Is there a replacement budget allocated?
e. Do you have a service contract? When does it expire?
3. Capsular Tension Ring
a. Which Brand do you use?
b. How many did you use in 2019?

Download response Fundus and Optical Biometer. 220421

1 The manufacturer & model name of each gamma camera (Nuclear Medicine imaging system) installed in your Trust
2 The hospital name where each system is installed
3 The date that the current service/maintenance contract on each gamma camera started
4 The date that the current service/maintenance contract on each gamma camera expires

Gamma camera (Nuclear Medicine imaging system). 080422.docx

1. How many general anaesthetics were administered by your NHS Trust in 2018, 2017, 2016 and 2015?
2. How many patients died as a result of general anaesthesia in 2018, 2017, 2016 and 2015?
3. How many patients were given a general anaesthetic for the purpose of carrying out a diagnostic scan/test (MRI, CT etc.) in 2018, 2017, 2016 and 2015?
4. How many patients died as a result of being given a general anaesthetic for the purpose of carrying out a diagnostic scan/test (MRI, CT etc.) in 2018, 2017, 2016 and 2015?
5. How many patients were given a general anaesthetic for the purpose of carrying out an MRI scan in 2018, 2017, 2016 and 2015?
6. How many patients died as a result of being given a general anaesthetic for the purpose of carrying out an MRI scan in 2018, 2017, 2016 and 2015?
7. How many patients were given any other form of sedation for the purpose of carrying out a diagnostic scan/test (MRI, CT etc.) in 2018, 2017, 2016 and 2015?
8. How many patients were given any other form of sedation for the purpose of carrying out an MRI scan in 2018, 2017, 2016 and 2015?
9. How many diagnostic scans/tests (MRI, CT etc.) were aborted at your NHS Trust in 2018, 2017, 2016 and 2015 as a result of patients failing to attend the appointment or the process being stopped mid-way.
10. How many MRI scans were aborted at your NHS Trust in 2018, 2017, 2016 and 2015 as a result of patients failing to attend the appointment or the process being stopped mid-way.

Download response General Anaesthetics. 180319

1. Please can you tell me if the Trust sends NHS Patients to GenesisCare for Cancer treatment?
2. Does the Trust send private patients to GenesisCare for cancer treatment?
3. How many Maidstone & Tunbridge Wells NHS Trust patients were treated by GenesisCare in 2018 and 2019? Please break the numbers down into NHS and private.
4. How long is the Trusts contract with GenesisCare?

Download response Genesiscare. 270919

a. For the period 1st January 2018 to 31st December 2018 (or the most recent 12 month period available), the number of patients diagnosed with genetic haemochromatosis (GH) under your care.
b. For the period 1st January 2018 to 31st December 2018 (or the most recent 12 month period available), the average time in days from first referral from primary care to the patient’s first appointment within your trust.
c. A copy of the protocol and/or patient pathway applicable to the care of people with genetic haemochromatosis.
d. The date that your protocol/patient pathway for genetic haemochromatosis was last reviewed or revised.
e. A copy of your clinical protocol(s) for therapeutic venesection.
f. The date that your protocol(s) for therapeutic venesection were last reviewed or revised.

Download response Genetic Haemochromatosis. 190320

1 Within your organisation, which healthcare professional (role) clinically recommends the LHRH that is prescribed?
2 Which healthcare professional (role) within your organisation usually administers the first injection?
3 Where is the first injection usually given (hospital or primary care)?
4 Which healthcare professional (role) within your organisation usually administers subsequent injections?
5 Where are subsequent injections usually given (hospital or primary care)?
6 For subsequent injections, does the patient still remain under the care of the hospital (e.g. attends hospital clinics although injections are given in primary care), and if so, for how long?
7 If injections are administered in primary care, what recommendation/advice comes from the hospital?

Download response Gonadorelin (GnRH) Analogues 300316

I am researching the use of certain types of drugs used in haematology. Could you please provide the number of patients treated (for any disease in the past 3 months with:
1. Aragam
2. Berinert
3. Cinryze
4. Cutaquig
5. Cuvitru
6. Firazyr
7. Flebogamma DIF
8. Gammagard
9. Gammanorm
10. Gammaplex
11. Gamunex
12. Hizentra
13. Hyqvia
14. Intratect
15. Iqymune
16. Kiovig
17. Octagam
18. Orladeyo
19. Panzyga
20. Privigen
21. Ruconest
22. Subgam
23. Takhzyro

Haematology.281222.docx

1. Please can you tell me how many of the following two devices – MCS+ 9000 Mobile Platelet Collection System and/or MCS+ 8150 Multicomponent Collection System both from a company called Haemonetics – the trust has used over the last 10 years and how many of these devices are currently in operation.

2. Please provide a figure for each device and each year over the last 10 years. If possible, please also state how many patients have had this device used on them.

Download response Haemonetics. 311019

Please can you tell me how many deaths have been reviewed by the trust or reported to a coroner in the past 10 calendar years where the hospital used a Haemonetics plasma device (any model number) on the patient before they died.

Where the death was investigated please can you send me the report (redacted to remove personal details if necessary) and include the age, gender and diagnosis of the patient. If the death was reported to the coroner please include a copy of their report.

Download response Haemonetics plasma device. 220120

1. How many patients have been treated in the past 3 months for head and neck cancer (squamous cell carcinoma) with the following agents:
a. Carboplatin (monotherapy or in combination with 5-FU)
b. Cisplatin (monotherapy or in combination with 5-FU)
c. Cetuximab with/without chemotherapy
d. Cetuximab with radiotherapy
e. Pembrolizumab monotherapy
f. Pembrolizumab with chemotherapy
g. Nivolumab
h. Docetaxel (monotherapy or in combination with 5-FU)
i. Fluorouracil (5FU)
j. Radiotherapy only
k. Other
2. For the patients treated in the past 3 months for head and neck cancer (squamous cell carcinoma) with the therapies listed in the first question, please provide:
a. Total number of head and neck cancer patients
b. Number of locally advanced head and neck cancer patients
c. Number of unresectable recurrent and/or metastatic head and neck cancer patients
3. How many Urothelial cancer patients have been treated in the past 3 months with the following agents:
a. Avelumab
b. Atezolizumab
c. Carboplatin with Gemcitabine
d. Carboplatin single or in any other combination
e. Cisplatin with Gemcitabine
f. Cisplatin single or in any other combination
g. Nivolumab
h. Pembrolizumab
i. Any other regimen including Paclitaxel
j. Any other chemotherapy regimen
k. Other active systemic anti-cancer therapy [please state]
l. Palliative care only
4. Does your trust participate in any ongoing clinical trials for the treatment of head and neck cancer? If so, can you please provide the name of each trial along with the number of patients taking part?

Head and neck and urothelial cancer.030822.docx

Within your health trust how many patients are currently [within the past 6 months] being treated for head and neck cancer (Squamous cell carcinoma)?
April to September 2015 – 26 patients
Of these how many are treated with the following therapies;
Carboplatin
Cetuximab
Cisplatin
Docetaxel
5-Fluorouracil (5FU)
Radiotherapy Only
Please see the table below:
If your health trust has a protocol or pathway for the treatment of head and neck cancer patients [including referral pathway to other trusts], please could you provide details?
Please see the attached document.
Within your health trust how many patients are currently [within the past 6 months] being treated for Colorectal Cancer?
April to September 2015 – 136 patients
Of these how many are treated with the following therapies;
Bevacizumab
Cetuximab
Panitumumab
Aflibercept
Oxaliplatin
Irinotecan
5-Fluorouracil
Irinotecan with 5-fluorouracil (5FU) and folinic acid [FOLFIRI]
Oxaliplatin with 5-fluorouracil (5FU) and folinic acid [FOLFOX]
Capecitabine and oxalipatin (CAPOX / XELOX)
Capecitabine and irinitecan (CAPIRI)

Download response letter Head and Neck Cancer 201115

1. Within your health trust how many patients are currently [within the past 6 months] being treated for head and neck cancer (Squamous cell carcinoma)?
2. Of these patients how many are locally advanced and how many are recurrent and/or metastatic head and neck cancer patients?
A. Locally advanced
B. Recurrent and/or metastatic
Of the these patients please split by their current drug treatment;
Carboplatin (Only or in combination with 5-FU)
Cetuximab (Erbitux) and chemotherapy or radiotherapy
Cetuximab (Erbitux) Only
Cisplatin (Only or in combination with 5-FU)
Docetaxel (Taxotere), (Only or in combination with 5-FU)
Fluorouracil (5FU)
Radiotherapy Only
Other – Specify
3. Does your health trust participate in any ongoing clinical trials for the treatment of head and neck cancer patients, if so please could you provide details?
4. Within your health trust how many patients are currently [within the past 6 months] being treated for metastatic Colorectal Cancer?
Of those patients please split by their current drug treatment;

Bevacizumab
Cetuximab
Panitumumab
Aflibercept
Oxaliplatin
Irinotecan
5-Fluorouracil
Irinotecan with 5-fluorouracil (5FU) and folinic acid [FOLFIRI]
Oxaliplatin with 5-fluorouracil (5FU) and folinic acid [FOLFOX]
Capecitabine and oxalipatin (CAPOX / XELOX)
Capecitabine and irinitecan (CAPIRI)
Other – Specify

Download response Head and Neck Cancer (Squamous cell carcinoma) 270616

1. Within your health trust how many patients are currently [within the past 6 months] being treated for head and neck cancer (Squamous cell carcinoma)?
Of these patients how many are locally advanced and how many are recurrent and/or metastatic head and neck cancer patients?
A. Locally advanced
B. Recurrent and/or metastatic
Of these patients please split by their current drug treatment;
Carboplatin (Only or in combination with 5-FU)
Cetuximab (Erbitux) and chemotherapy or radiotherapy
Cetuximab (Erbitux) Only
Cisplatin (Only or in combination with 5-FU)
Docetaxel (Taxotere), (Only or in combination with 5-FU)
Fluorouracil (5FU)
Radiotherapy Only
Other – Specify
2. Within your health trust how many patients are currently [within the past 6 months] being treated for metastatic Colorectal Cancer?
Of those patients please split by their current drug treatment;
Bevacizumab
Cetuximab
Panitumumab
Aflibercept
Oxaliplatin
Irinotecan
5-Fluorouracil
Irinotecan with 5-fluorouracil (5FU) and folinic acid [FOLFIRI]
Oxaliplatin with 5-fluorouracil (5FU) and folinic acid [FOLFOX]
Capecitabine and oxalipatin (CAPOX / XELOX)
Capecitabine and irinitecan (CAPIRI)
Other – Specify

Download response Head and Neck Cancer (Squamous Cell Carcinoma). 081116

1. Within your health trust, how many patients have been treated in the past 3 months for head and neck cancer (squamous cell carcinoma)? Of these patients, how many are locally advanced, recurrent and/or metastatic?
a. Total squamous cell carcinoma
b. Locally advanced
c. Recurrent and/or metastatic
2. For the metastatic head and neck cancer patients treated in the past 3 months, could you specify (if possible) how many received first-line treatment versus second-line treatment?
3. Within your health trust, how many patients have been treated in the past 3 months for head and neck cancer (squamous cell carcinoma) with the following agents?
a. Carboplatin (monotherapy or in combination with 5-FU)
b. Cisplatin (monotherapy or in combination with 5-FU)
c. Cetuximab with/without chemotherapy
d. Cetuximab with radiotherapy
e. Pembrolizumab monotherapy
f. Pembrolizumab with chemotherapy
g. Nivolumab
h. Docetaxel (monotherapy or in combination with 5-FU)
i. Fluorouracil (5FU)
j. Radiotherapy only
k. Other
4. Within your health trust, how many patients have been treated in the past 3 months with the following agents for renal cell carcinoma:
a. Sunitinib
b. Avelumab + Axitinib
c. Axinitib
d. Cabozantinib
e. Everolimus
f. Lenvantinib + Everolimus
g. Nivolumab
h. Nivolumab + Ipilimumab
i. Pazopanib
j. Pembrolizumab + Axitinib
k. Sunitinib
l. Temsirolimus
m. Tivozanib
n. Other
5. Does your trust participate in any ongoing clinical trials for the treatment of head and neck cancer? If so, can you please provide the name of each trial along with the number of patients taking part?
6. Does your trust participate in any ongoing clinical trials for the treatment of renal cell carcinoma? If so, can you please provide the name of each trial along with the number of patients taking part?

Download response Head and neck cancer (squamous cell carcinoma). 301120

1. How many patients have been treated in the past 3 months for head and neck cancer (squamous cell carcinoma) with the following agents:
a. Carboplatin (monotherapy or in combination with 5-FU)
b. Cisplatin (monotherapy or in combination with 5-FU)
c. Cetuximab with/without chemotherapy
d. Cetuximab with radiotherapy
e. Pembrolizumab monotherapy
f. Pembrolizumab with chemotherapy
g. Nivolumab
h. Docetaxel (monotherapy or in combination with 5-FU)
i. Fluorouracil (5FU)
j. Radiotherapy only
k. Other
2. For the patients treated in the past 3 months for head and neck cancer (squamous cell carcinoma) with the therapies listed in the first question, please provide:
a. Total number of head and neck cancer patients
b. Number of locally advanced head and neck cancer patients
c. Number of recurrent and/or metastatic head and neck cancer patients
3. How many Urothelial cancer patients have been treated in the past 3 months with the following agents:
a. Atezolizumab
b. Carboplatin with Gemcitabine
c. Carboplatin single or in any other combination
d. Cisplatin with Gemcitabine
e. Cisplatin single or in any other combination
f. Nivolumab
g. Pembrolizumab
h. Any other regimen including Paclitaxel
i. Any other chemotherapy regimen
j. Other active systemic anti-cancer therapy [please state]
k. Palliative care only
4. Does your trust participate in any ongoing clinical trials for the treatment of urothelial cancer? If so, can you please provide the name of each trial along with the number of patients taking part?

Head and Neck cancer (squamous cell carcinoma) and Urothelial cancer. 140422.docx

1. How many patients have been treated in the past 3 months for head and neck cancer (squamous cell carcinoma) with the following agents:
a. Carboplatin (monotherapy or in combination with 5-FU)
b. Cisplatin (monotherapy or in combination with 5-FU)
c. Cetuximab with/without chemotherapy
d. Cetuximab with radiotherapy
e. Pembrolizumab monotherapy
f. Pembrolizumab with chemotherapy
g. Nivolumab
h. Docetaxel (monotherapy or in combination with 5-FU)
i. Fluorouracil (5FU)
j. Radiotherapy only
k. Other
2. For the patients treated in the past 3 months for head and neck cancer (squamous cell carcinoma) with the therapies listed in the first question, please provide:
a. Total number of head and neck cancer patients
b. Number of locally advanced head and neck cancer patients
c. Number of unresectable recurrent and/or metastatic head and neck cancer patients
3. How many Urothelial cancer patients have been treated in the past 3 months with the following agents:
a. Avelumab
b. Atezolizumab
c. Carboplatin with Gemcitabine
d. Carboplatin single or in any other combination
e. Cisplatin with Gemcitabine
f. Cisplatin single or in any other combination
g. Nivolumab
h. Pembrolizumab
i. Any other regimen including Paclitaxel
j. Any other chemotherapy regimen
k. Other active systemic anti-cancer therapy [please state]
l. Palliative care only
4. Does your trust participate in any ongoing clinical trials for the treatment of head and neck cancer? If so, can you please provide the name of each trial along with the number of patients taking part?
5. Does your trust participate in any ongoing clinical trials for the treatment of urothelial cancer? If so, can you please provide the name of each trial along with the number of patients taking part?

Head & neck and urothelial cancer.281122.docx

We are researching the incidence and treatment of Head & Neck Cancer (H&N), Renal Cancer (RCC) and Colorectal Cancer (CRC). Could you please answer the following questions for patients treated by your trust?
1. Within your health trust, how many patients have been treated in the past 3 months for head and neck cancer (squamous cell carcinoma) with the following agents?
a. Carboplatin (monotherapy or in combination with 5-FU)
b. Cisplatin (monotherapy or in combination with 5-FU)
c. Cetuximab with/without chemotherapy
d. Cetuximab with radiotherapy
e. Pembrolizumab monotherapy
f. Pembrolizumab with chemotherapy
g. Nivolumab
h. Docetaxel (monotherapy or in combination with 5-FU)
i. Fluorouracil (5FU)
j. Radiotherapy only
k. Other
2. Within your health trust, how many patients have been treated in the past 3 months with the following agents for renal cell carcinoma :
a. Sunitinib
b. Avelumab + Axitinib
c. Axinitib
d. Cabozantinib
e. Everolimus
f. Lenvantinib + Everolimus
g. Nivolumab
h. Nivolumab + Ipilimumab
i. Pazopanib
j. Pembrolizumab + Axitinib
k. Sunitinib
l. Temsirolimus
m. Tivozanib
n. Other
3. Within your health trust, how many patients have been treated in the past 3 months with the following agents for colorectal cancer [CRC]?
a. Aflibercept
b. Bevacizumab
c. Cetuximab monotherapy
d. Cetuximab in combination with FOLFOX or FOLFIRI
e. Panitumumab monotherapy
f. Panitumumab in combination with FOLFOX or FOLFIRI
g. Nivolumab
h. Ramucirumab
i. Regorafenib
j. Sorafenib

Download response Head & Neck Cancer (H&N), Renal Cancer (RCC) and Colorectal Cancer (CRC). 050321

1. Within your health trust how many patients are currently [within the past 6 months available] being treated for head and neck cancer (Squamous cell carcinoma)?
2. Of these patients how many are locally advanced and how many are recurrent and/or metastatic head and neck cancer patients?
a. Locally advanced
b. Recurrent metastatic
3. Of the locally advanced/ recurrent or metastatic head and neck cancer patients how many are currently [within the past 6 months available]
Carboplatin (only or in combination with 5-FU)
Cisplatin (only or in combination with 5-FU)
Cetuximab (Erbitux) with/without chemotherapy
Cetuximab (Erbitux) with radiotherapy
Docetaxel (Taxotere) -only or in combination with 5-FU
Fluorouracil (5FU)
Radiotherapy only
Other
4. Does your health trust participate in any ongoing clinical trials for the treatment of head and neck cancer patients, if so how many patients are currently taking part in clinical trials?
5. Within your health trust how many patients are currently [within the past 6 months available] being drug treated for metastatic colorectal cancer?
Of those patients please split by their drug treatment;
Cetuximab (Erbitux) with/without chemotherapy
Panitumumab (Vectibix) with/without chemotherapy
Nivolumab (Opdivo) with/without chemotherapy
Chemotherapy + other mAb
Chemotherapy alone
Other
6. Does your health trust participate in any ongoing clinical trials for the treatment of colorectal cancer patients, if so how many patients are currently taking part in clinical trials?
Download response Head and Neck Cancer (Squamous cell carcinoma). 260418

1. Could you detail the quantity of helium that has been purchased each year for the last 5 years?
2. What are the main uses for helium within the Trust?
3. Could you outline the various grades/types of helium purchased?
4. What has the cost of helium been for each of those 5 years?
5. Who are your suppliers of helium and can you provide a copy of the supply contracts?
6. Can you detail your procurement process for obtaining helium and send any tender documents relating to helium?

Helium consumption.271022.docx

In your trust, how many patients with HER2 breast cancer are currently being treated (in the past 3 months available) with the following products;

Herceptin IV (trastuzumab IV) only
Herceptin SC (trastuzumab SC) only
Perjeta (pertuzumab) combined with Herceptin/Docatexel
Kadcyla (trastuzumab emtansine)
Tyverb (lapatinib)

Download response HER2 Breast Cancer. 080517

How much money did the trust raise from car parking charges in each of the last four years (state the amount and the years for which figures are available)?
Do you charge for disabled parking? If so, how much of the total amount raised by the trust from car parking charges came from disabled parking?
Do you employ a private firm to run the car park for you? If so, how much of the money generated by parking fees is taken by the private firm?
Please provide a breakdown of your car park charges – per hour/per day/per week.
Do you provide concessions for long-term visitors? What are these?

Download response Car Parking Charges 181115

How much money was generated by your hospital trust through parking charges in the hospital car parks during 2013-14 and 2014-15?
How many parking fines were issued for parking infringements in your car parks during 2013-14 and 2014-15?
How many parking fines were written off during 2013-14 and 2014-15?

Download response Hospital Parking Charges 200515

1) How many instances of abandoned motor vehicles were recorded between 2004-15? If the data doesn’t stretch back to 2004, please use the earliest you have.

2) If a 3rd party was called to recover, what was the average cost involved?

Download response Abandoned motor vehicles 181215

1. In the years 2015 & 2016 of the patients that became resident for Cancer care/treatment with inside a hospital managed by your trust, please list the annual total for the patients as described?

2. Further to the above please also provide the annual total for those patients’ families who received a pass entitling free parking during the patients stay to reduce the financial burden on the family visiting?

Download response Cancer care or treatment 2015-2016. 020317

1. Please could you confirm when your contract for Car Park Management will expire and also when the contract will be re-tendered?

2. Do you currently manage your own car parks or use a Car Park Management company?

3. Which Portal does the trust use when they tender the Car Park Management out?

Download response Car park management 070317

1. What are the contractual performance KPI’s for this contract?
2. Suppliers who applied for inclusion on each framework/contract and were successful & not successful at the PQQ & ITT stages
3. Actual spend on this contract/framework (and any sub lots), from the start of the contract to the current date
4. Start date & duration of framework/contract?
5. Could you please provide a copy of the service/product specification given to all bidders for when this contract was last advertised?
6. Is there an extension clause in the framework(s)/contract(s) and, if so, the duration of the extension?
7. Has a decision been made yet on whether the framework(s)/contract(s) are being either extended or renewed?
8. Who is the senior officer (outside of procurement) responsible for this contract?

Car park management contract.140923.docx

1. Please state what the income was to the Trust from parking income in patient car parks in (i) the (14/15) financial year and (ii) the (15/16) financial year?
2. What is the highest hourly rate for parking charged to patients in any of your car parks?

Download response Car parking 090916

1. How much revenue did the Trust receive from car parking fees between 1st October 2015 and 1st October 2016?
2. What are the Trusts rates per hour and per day (can you indicate if this varies between hospitals in the Trust)? Is there any way to get a reduction in this rate?
3. Has the Trust increased the parking charge in the last two years and if so by how much?
4. If the Trust car parks are run by an outside firm and can you please say who that is?

Download response letter Car parking 071116

1. How much revenue did the Trust receive from car parking fees between 1st October 2015 and 1st October 2016?
2. What are the Trusts rates per hour and per day (can you indicate if this varies between hospitals in the Trust)? Is there any way to get a reduction in this rate?
3. Has the Trust increased the parking charge in the last two years and if so by how much?
4. If the Trust car parks are run by an outside firm and can you please say who that is?

Download response Car parking 071116

1. Do you currently manage your car parking in-house or do you contract to a third party?
2. If you do employ a parking operator to manage your parking services, who is your current parking provider?
3. What is the exact date your current contract/s terminate?
4. Does the Trust receive the income generated from the hospital parking and notice charges or does the income go to a third party?
5. Please confirm the revenue amount generated from the third-party provider if there is one
6. What are the key challenges that the Trust face with regards to the parking provision?
7. Can you confirm the expenditure on maintenance for the car park equipment for 2019/2020?
8. Overall what was the profit generated by the trust after the cost of maintaining and staffing the car park for 2019/2020?

Download response Car parking. 091220

1. Hourly Car Parking Charges
2. Daily Car Parking Charges
3. Weekly Car Parking Charges
4. Car Parking Charges for Blue Badge Holders
5. Car Parking Charges for Staff

Download response Car parking. 190717

1. Are your carparks managed by a private contractor? If yes, please provide the name of the contractor.
2. How many parking enforcement tickets were issued in your carparks between 1st April 2015 and 31st March 2016?
3. What is the cost of a parking enforcement fine in your carparks?
4. How many parking enforcement ticket appeals did you receive between 1st April 2015 and 31st March 2016?
5. How many parking enforcement ticket appeals were successful between 1st April 2015 and 31st March 2016?

Download response Car parking 2015-2016 221216

1. The income earned from hospital car parking charges for the financial years:
1. 2014-2015
2. 2015-2016
3. 2016-2017
2. The money spent on maintenance for car parking facilities in the financial years:
1. 2014-2015
2. 2015-2016
3. 2016-2017
3. Where the income earned from hospital car parking facilities was spent in the financial years:
1. 2014-2015
2. 2015-2016
3. 2016-2017

Download response Car parking. 210318

Subject to the Freedom of Information Act, I would like to request the following information in the relation to the Trust and associated hospitals.
1. Do you currently manage your car parking in-house or do you contract to a third party?
2. If you do employ a parking operator to manage your parking services, who is your current parking provider?
3. What is the exact date/s your current contract/s terminate?
4. What date do you expect to go to tender?

Download response Car parking. 240119

Under the Freedom of Information Act 2000, I am seeking the following pieces of information in relation to parking at the hospitals covered under your trust.
1. The parking ticket costs at the hospitals under your trust.
2. How much does your trust – or a third party contracted by the trust – charge in fines and/or penalty notices if people are deemed to have breached parking rules?
3. What is the revenue from visitors paying for parking tickets? I would like this broken down for each hospital. I would like this information annually for 2012-2013, 2013-2014, and 2014-2015.
4. What is the revenue received from the payment of fines and/or penalty notices? I would like this broken down for each hospital. I would like this information annually for 2012-2013, 2013-2014, and 2014-2015.

Car parking at the Trust sites 261015

1. Do hospitals in your area charge patients/visitors to park in their own car park?
2. If so, how much do they charge?
3. Do the hospitals operate their car park under a PFI contract?

Download response Car parking charges. 011118

How much money did the trust raise from car parking charges in each of the last four financial years (state the amount and the years for which figures are available)? Include a breakdown of staff and visitor/patient parking if possible.

How much money was raised from parking fines in each of the last four financial years (state the amount and the years for which figures are available)? Include a breakdown of staff and visitor/patient fines if possible.

Do you charge for disabled parking?

Do you employ a private firm to run the car park for you? If so, how much of the money generated by parking fees is taken by the private firm?

Download response Car parking charges 041116

1. How much money did the trust raise from car parking charges in each of the last four financial years – up to and including 2016/17 (state the amount and the years for which figures are available)? Include a breakdown of staff and visitor/patient parking if possible.

2. How much money was raised from parking fines in each of the last four financial years (state the amount and the years for which figures are available)? Include a breakdown of staff and visitor/patient fines if possible.

3. Do you charge for disabled parking?

4. Do you employ a private firm to run the car park for you? If so, how much of the money generated by parking fees is taken by the private firm?

Download response Car parking charges. 111217

1. How much money did the trust raise from car parking charges in each of the last two financial years – 2017/18 and 2018/19? Include a breakdown of staff and visitor/patient parking if possible.
2. How much money was raised from parking fines in each of the last two financial years – 2017/18 and 2018/19? Include a breakdown of staff and visitor/patient fines if possible.
3. Have you increased the cost of parking in your car parks during the last financial year – between 2017/18 and 2018/19? Please give a breakdown of how much parking has increased by.
4. Do you charge for disabled parking?
5. Is your car park managed by a private firm? If so, what proportion of revenue created by a) parking income and b) parking fines does the firm take?

Download response Car parking charges. 160519

1. How much money did the trust raise from car parking charges in each of the last two financial years – 2017/18 and 2018/19? Include a breakdown of staff and visitor/patient parking if possible.
2. How much money was raised from parking fines in each of the last two financial years – 2017/18 and 2018/19? Include a breakdown of staff and visitor/patient fines if possible.
3. Have you increased the cost of parking in your car parks during the last financial year – between 2017/18 and 2018/19? Please give a breakdown of how much parking has increased by.
4. Do you charge for disabled parking?
5. Is your car park managed by a private firm? If so, what proportion of revenue created by a) parking income and b) parking fines does the firm take?

Download response Car parking charges. 181019

1. How much money has the trust raised from car parking charges so far this year?
2. How many parking fines were issued for parking infringements in your car parks so far this year?
3. How many parking fines were written off so far this year?

Download response Car parking charges 2015/2016 to date 100516

1. Name of your organisation
2. Does your Trust use a private contractor to oversee the car park?
Yes (if yes please provide name of contractor)
No
Parking Charges
3. Parking charges made to general public (patients, visitors, etc.)
4. Parking charges made to staff
5. Agreed exemptions from charges
6. How income from charges is used
Parking Fines (fines issued from 1 January 2016 to date)
7. Number of fines issued to the general public
8. Income from those fines
9. Number of fines issued to staff
Income from those fines
10. How income from fines is used
11. Does the policy for fining staff differ from the fines policy for the general public?
Yes (if yes, please advise how the policy differs) No
12. Please provide details of any policy or agreements covering car parking charges (e.g. collective agreement with NHS Trade Unions)

Download response Car parking charges 2016. 140317

1. How much money did the trust raise from car parking charges in each of the last two financial years – 2016/17 and 2017/18? Include a breakdown of staff and visitor/patient parking if possible.

2. How much money was raised from parking fines in each of the last two financial years – 2016/17 and 2017/18? Include a breakdown of staff and visitor/patient fines if possible.

3. Have you increased the cost of parking in your car parks during the last financial year – between 2016/17 and 2017/18? Please give a breakdown of how much parking has increased by.

4. Do you charge for disabled parking?

Download response Car parking charges. 280918

1) How much revenue was made by Maidstone and Tunbridge Wells NHS Trust on all car parking charges and fines in 2015, 2016 and 2017. Please break this down by charges and fines.

2) How much profit was made by Maidstone and Tunbridge Wells NHS Trust on all car parking charges and fines in 2015, 2016 and 2017. Please break this down by charges and fines.

Download response Car parking charges and fines. 070618

Can you please confirm if you planning to extend the current contract with APCOA or extend, if so could you please confirm for how long?

Download response Car parking contract. 051021.docx

Could you please advise me if you manage the Car Parking facilities on your own or do you employ a contractor to manage the facilities for you? I.e. ANPR, POF’s and PCN’s etc.  If you use a contractor can you please advise me who they are and when their existing contract with yourselves expire?

Download response Car parking contractor 080515

1. Could you please advise me if you manage the car parking facilities on your own, or do you employ a private operator/contractor to manage the facilities for you i.e., ANPR, POFs and PCNs etc?
2. If you use a private operator/contractor, can you please advise me who they are and when their existing contract with yourselves expires?

Car parking facilities.180123.docx

1. How much money was generated by your hospital trust through parking charges in the hospital car parks during 2019-20?
2. How many parking fines were issued for parking infringements in your car parks during the year stated above?
3. How many parking fines were written off during the year stated above?

Download response Car parking income. 290620

Car Parking Management Services and Security Services Management for Maidstone & Tunbridge Wells NHS Trust:
https://procontract.due-north.com/Advert?advertId=db2f64cd-fa28-e711-80df-005056b64545

The details we require are:

1. Suppliers who applied for inclusion on each framework/contract and were successful & not successful at the PQQ & ITT stages
2. Actual spend on this contract/framework (and any sub lots), from the start of the contract to the current date
3. Start date & duration of framework
4. Is there an extension clause in the framework(s)/contract(s) and, if so, the duration of the extension?
5. Has a decision been made yet on whether the framework(s)/contract(s) are being either extended or renewed?
6. Who is the senior officer (outside of procurement) responsible for this contract?

Download response Car Parking Management Services and Security Services Management. 150421

How much revenue the hospital trust made through the charging of hospital car parking in 2016?

Download response Car parking revenue. 241017

Can you please provide a copy of your current Security Contract?

Download response Contract for MTW car parking and Security provider 060416

1. The total amount of revenue generated by in each of the last 5 years by car parking.
2. What was the cost for an hour of car parking in 2010 and 2016?

Download response Cost and revenue of car parking 2010 – 2016 060916

1. How many staff members at the trust are declared disabled?
2. How many staff members with a disability use the staff car park?
3. Do the trust charge disabled staff for parking?
4. If yes in Q3 is this charge at a discounted rate compared to a non-disabled staff member?
5. How much is staff car parking for disabled staff and non-disabled staff?

Download response Disabled parking for staff. 030719

1) How many nurses and midwives (from Band 5 upwards) waiting to take up employment with your trust are awaiting completion of Disclosure and Barring Service (DBS) checks?
2) How long is the average wait for DBS approval for new starters at your organisation?
3) How many parking spaces at your hospitals are exclusively for staff use and how much do they pay to use them?
4) What is your FTE nursing and midwifery staff establishment (from Band 5 upwards)?

Download response Disclosure and Barring checks and staff parking. 221116

1) Does your organisation already offer charging facilities (Electric Vehicle Charging Points EVCP) for electric vehicles and if so, how many charge points?
2) If there is currently no charging provision, what plans do you have to install EVCP and when?
3) Will the charge points be for fleet usage or public charging?
4) Within your organisation, which department is responsible for the selection and installation of EVCP?

Download response Electric Vehicle charging points 060916

1. Do you provide free parking for NHS staff and/or patients?
2. If not, how much do you charge staff to park?
3. how long does it take for staff to be issued a permit when joining your trust?

Free NHS Staff Parking.220722.docx

1. Please state the current fee for parking at the trust for one hour. (If there is no specific fee for one hour, please state the lowest possible time and cost)
2. Please state the fee for parking for one hour in 2018.
3. Please tell me whether the hospital provides free parking for any of the following groups a) cancer patients b) disabled patients c) other patients who are frequent visitors to the trust d) the relatives of patients who are frequent visitors.
4. Please tell me if the hospital provides reduced parking for any of the following groups a) cancer patients b) disabled patients c) patients who are frequent visitors d) the relatives of patients who are frequent visitors 5. If yes to question 4, please provide details.
6. Please state how much the trust collected in parking charges and fines in a) 2018/19 and b) 2017/18.
7. Does the trust hire any private firms to issue parking fines or clamp vehicles?
8. If yes to question 7, please provide the names of these firms

Download response Hospital parking. 190719

1. How much money was generated by your hospital trust through parking charges in the hospital car parks during 2013-14, 2014-15, 2015-16 and 2016-17?
2. How many parking fines were issued for parking infringements in your car parks during the years stated above?
3. How many parking fines were written off during the years stated above?

Download response Hospital parking 2013-2017. 060617

1. How many fines have been issued by the hospital for overstaying at Maidstone Hospital and Tunbridge Wells Hospital in Pembury?
2. Can this be broken down year by year from 2018 to 2021 (to date)
– 2018
– 2019
– 2020
– 2021
3. Can you also confirm how much the fines cost, where the money goes to and the outcome of the fines (e.g. paid for, rescinded or other action)

Download response Hospital parking overstaying fines.300621

a) The number of 6-in-1 vaccines offered to be given to babies in the financial years 2017/18, 2016/17, and 2015/16.

b)The number of 6-in-1 vaccines that were refused by parents or guardians of the baby in the financial year 2017/18, 2016/17, and 2015/16.

c) The number of children diagnosed with any of the following in 2017/18 alone, who had not received the 6-in-1 vaccine when they were a baby because their parent or guardian had refused it. If a child was diagnosed with more than one of the below, please provide that information: diphtheria, hepatitis B, Hib, polio, tetanus, or whooping cough

Download response 6-in-1 vaccine. 170718

For every month from 1 January 2019 to 31 May 2021, please answer the following questions:
1 In that month, how many children and young people (CYP) aged 18 and under did you refer to CAMH services after they arrived in your emergency department(s)?
2 In that months, of these CYP in question one, how many were referred to CAMH services for treatment of a suspected or confirmed eating disorder? If helpful, please search against the ICD Code F50.0, which may be included in the referral.
3 In that month, how many CYP were admitted to or treated by your acute hospital trust for the following:
3 a Treatment of an eating disorder, such as refeeding and medical stabilisation? If helpful, please search against the ICD Code F.50, which should cover all relevant eating disorder diagnoses.
3 b Treatment of self-inflicted injury? If helpful, please search against ICD Codes X60 to X69.
3 c Treatment of drug or other toxic substance overdose, whether accidental or intentional? If helpful, please search against ICD Codes X70 to X84.
4 In this month, how many CYP were admitted to your acute trust for compulsory treatment with use of the Mental Health Act?
5 In this month, of those CYP admitted to your acute trust for compulsory treatment with use of the Mental Health Act, how many had an eating disorder diagnosis (ICD Code in the F50 category)?

Download response Acute Trust CYP Healthcare. 050821.docx

1- Number of paediatric patient attended A/E in 2018, Tunbridge wells hospital
2- Number of patient attended paediatric OPD (outpatient department) in 2018, Tunbridge wells hospital

Download response A&E and Outpatient Paediatric attendances. 250419

1. How many babies (i.e.) below the age of 1) were diagnosed with issues of Ankylossia (tongue-tie) in each financial year since 2013/14.
2. Of the babies diagnosed with issues of Ankylossia (tongue-tie) in 2017 how many had a surgical procedure carried out by NHS surgeons to resolve these specific issues, and how long did they wait (on average, in calendar days) for the procedure following diagnosis?
3. In 2017, what was the mean age of babies with such issues when the Ankylossia (tongue-tie) procedure was performed?

Download response Ankylossia (tongue-tie). 270918

The number of children under the age of 14 your trust has treated for anorexia and bulimia from 1 January 2010 up until the date this request was received.
Please provide the information in yearly breakdowns;
Please break the numbers down by age and, if possible, by gender;
Please keep the data for anorexia and bulimia separate;

Download response Anorexia and bulimia in under 14 year olds 060916

Please send me an example of all of the following that are in use:
a) Letter/email reporting low chance combined or quadruple screen results
b) Letter/email reporting high chance combined or quadruple screen results
c) Letter/email reporting low chance NIPT results
d) Letter/email reporting high chance NIPT results
e) Letter/email reporting ‘no result’ NIPT results
f) Letter/email reporting negative QF-PCR/FISH CVS results
g) Letter/email reporting positive QF-PCR/FISH CVS results
h) Letter/email reporting negative full karyotype CVS results
i) Letter/email reporting positive full karyotype CVS results
j) Letter/email reporting negative amniocentesis result
k) Letter/email reporting positive amniocentesis result

Download response Ante natal screening or diagnostic results for Down syndrome. 100519

QUESTION 1
A. How many children are currently waiting to receive a first assessment appointment?
B. What is the average wait time for these children, starting from the point of initial referral?
C. How many of these children have been waiting longer than 13 weeks?
D. What are the longest three wait times for these children?
QUESTION 2
A. How many children are currently waiting to receive a second assessment appointment?
B. What is the average wait time for these children to receive a second appointment, since their first appointment?
C. What are the longest three wait times for these children, since their first appointment?
QUESTION 3
A. How many children are currently waiting to receive a diagnosis (ie. waiting for an assessment outcome to find out whether they do or do not have ASD)?
B. What is the average wait time, since the point of initial referral?
C. What are the longest three wait times for these children, since their initial referral?
QUESTION 4
A. In the year up to 31 March 2022, how many children with suspected autism received a first assessment appointment?
B. What was the average wait time for these children to receive a first assessment appointment, since their initial referral?
C. What were the longest three wait times for these children to receive a first diagnostic appointment, since their initial referral??
QUESTION 5
A. In the year up to 31 March 2022, how many children with suspected autism received a second assessment appointment?
B. What was the average wait time for these children to receive a second diagnostic appointment, since their first appointment?
C. What were the longest three wait times for these children to receive a second assessment appointment, since their first appointment?
QUESTION 6
A. In the year up to 31 March 2022, how many children with suspected autism received an ASD diagnosis?
B. What was the average wait time for these children to receive an ASD diagnosis, since their initial referral?
C. What were the longest three wait times for these children to receive an ASD diagnosis, since their initial referral?
QUESTION 7
A. In the year up to 31 March 2021, how many children with suspected autism received a first assessment appointment?
B. What was the average wait time for these children to receive a first assessment appointment, since their initial referral?
QUESTION 8
A. In the year up to 31 March 2021, how many children with suspected autism received a second assessment appointment?
B. What was the average wait time for these children to receive a second diagnostic appointment, since their first appointment?
QUESTION 9
A. In the year up to 31 March 2021, how many children with suspected autism received an ASD diagnosis?
B. What was the average wait time for these children to receive an ASD diagnosis, since their initial referral?
QUESTION 10
A. In the year up to 31 March 2020, how many children with suspected autism received a first assessment appointment?
B. What was the average wait time for these children to receive a first assessment appointment, since their initial referral?
QUESTION 11
A. In the year up to 31 March 2020, how many children with suspected autism received a second assessment appointment?
B. What was the average wait time for these children to receive a second diagnostic appointment, since their first appointment?
QUESTION 12
A. In the year up to 31 March 2019, how many children with suspected autism received an ASD diagnosis?
B. What was the average wait time for these children to receive an ASD diagnosis, since their initial referral?
QUESTION 13
A. In the year up to 31 March 2020, how many children with suspected autism received an ASD diagnosis?
B. What was the average wait time for these children to receive an ASD diagnosis, since their initial referral?
QUESTION 14
A. In the year up to 31 March 2019, how many children with suspected autism received a first assessment appointment?
B. What was the average wait time for these children to receive a first assessment appointment, since their initial referral?
QUESTION 15
A. In the year up to 31 March 2019, how many children with suspected autism received a second assessment appointment?
B. What was the average wait time for these children to receive a second diagnostic appointment, since their first appointment?

ASD waiting times.230522.docx

Please provide numbers spanning the last 3 years – please segment by year where possible (i.e. 2018, 2019, 2020 – to date) for the following questions:
1. How many children age 7 and under have been admitted/treated for asthmatic symptoms in your Trust in these 3 instances:
a. Have been diagnosed as displaying asthmatic symptoms
b. Have been prescribed home treatment (reliever at home)
c. Have been admitted to A&E / ER for emergency treatment
2. For what number of children aged 7 and under was their admission to A&E/ER/Emergency GP (for asthmatic symptoms) their first instance of having asthmatic symptoms diagnosed and treated (i.e. the first instance of the NHS being made aware of asthmatic symptoms)?
3. How many children age 7 or under have had to be treated due over-medication of prescribed asthma medication?
4. How many children age 7 or under have had to be treated due under-medication of prescribed asthma medication?
5. What number of children age 7 and under are referred to a paediatrician/3rd party to help manage their asthmatic symptoms?
6. Yes/No: Has your trust seen a decline in parents seeking medical help for children aged 7 and under with asthma/asthmatic symptoms since March 2020?

Download response Asthma treatment and care for Children. 240321

1. Thinking about the 2015/16 financial year, did your service experience longer waiting times for?
2. Were there any changes in policy or practice in what your audiology service provided in 2015/16?
3. If you have ticked yes to any of the above, please tell us what has changed and the reasons for the
Change
4. At what age does your service transfer deaf young people to adult services?
5. Were there any changes to how your audiology service for deaf children is commissioned in 2015/16?
6. Were there any changes in the number and skill-mix of full time equivalent (FTE) staff in your team, including administrative staff, in 2015/16?
7. If you have ticked yes to any of the above, please describe in more detail what has changed (including the number of staff reductions, if any) and the reasons for the change.
8. Was there a training programme in place for audiologists in your service in 2015/16?
9. If yes, were there any changes to the availability of training in 2015/16?
10. Looking ahead to the 2016/17 financial year, are you aware of any planned changes to any of the below?
11. Did your service provide informal family support services such as parent coffee mornings, playgroups, use of voluntary sector, etc. in 2015/16?
12. If yes, were there any reductions in informal family support services in 2015/16?
13. Is anyone from the audiology team involved in the development of Education Health and Care plans?
14. Have you faced any barriers to being involved in developing Education Health and Care plans?
15. If yes, what were the barriers?
16. Did your service provide any assistive listening devices or take any action to ensure they work effectively with the child’s personal amplification in 2015/16?
17. If you have ticked any of the above, were there any reductions in the provision of assistive learning devices or services to ensure they work effectively with the child’s personal amplification in 2015/16
18. Has your service gained accreditation with (Improving Quality in Physiological Diagnostic Services) IQIPS?
19. Has your service registered for the IQIPS process?
20. Has your service started using the Self-Assessment and Improvement Tool (SAIT)?
21. Has your service applied to UKAS to begin the accreditation peer review process?
22. Has your service booked or completed its onsite assessment with UKAS?
23. If you have not registered with the SAIT for IQIPS, what are your reasons for not doing so?
24. What are the most successful aspects of your audiology service at the moment?
25. What are main challenges or problems facing your audiology service at the moment?
26. Is there anything else you would like to tell us about the audiology service and any future plans?
* 27. Your name:
* 28. Your role:
* 29. Name of audiology service (please don’t use abbreviations):
* 30. Name of Trust that provides the paediatric audiology service (please don’t use abbreviations):
* 31. Sites where paediatric audiology is delivered by your service (please don’t use abbreviations):

Download response Audiology services for children and young people.150317

In the 2015 calendar year were there any babies born at your hospitals where the weight of the baby was 12lbs (5443g) or more? If so please state how many and what their birth-weights were.

Download response Babies born in 2015 whose birth-weight was 12lbs or 5443g or more 280416

How many babies were born with neonatal abstinence syndrome (showing signs of drug addiction because of their mother taking drugs during pregnancy) at hospitals run by your trust in the past financial year, April 2016 to April 2017? Please break the figures down by hospital.

Download response letter Babies born with neonatal abstinence syndrome 2016-2017. 150517

You asked:
For each year between 2009 and up-to the end of 2017, how many babies born under your trust were born to drug dependent mothers and once born, were transferred to a drug treatment programme to wean them off their addiction?

Download response Babies born to drug dependent mothers. 151118

1) Please state the number of babies that were injured during delivery when tools to assist in delivery were used, for example a vacuum extractor or forceps.
Please provide information for each of the following calendar years:
i) 2014
ii) 2015
iii) 2016
iv) 2017 to date
2) Of these babies injured, please provide a breakdown of injuries that they suffered. Please provide a summary of each incident, including the cause of the injury.
Please provide information for each of the following calendar years:
i) 2014
ii) 2015
iii) 2016
iv) 2017 to date
3) Please state the number of babies injured during delivery due to hospital error.
Please provide information for each of the following calendar years:
i) 2014
ii) 2015
iii) 2016
iv) 2017 to date

Download response Babies injured during assisted delivery. 280317

1. In the 2018 calendar year were there any babies born at your hospitals where the weight of the baby was 12lbs (5443g) or more? If so please state how many and what their birthweights were.
2. In the 2019 calendar year were there any babies born at your hospitals where the weight of the baby was 12lbs (5443g) or more? If so please state how many and what their birthweights were.
3. In the 2020 calendar year were there any babies born at your hospitals where the weight of the baby was 12lbs (5443g) or more? If so please state how many and what their birthweights were.

Download response Babies over 12lbs (5443g) at birth. 070421

In the 2016 calendar year were there any babies born at your hospitals where the weight of the baby was 12lbs (5443g) or more? If so please state how many and what their birthweights were.

Download response Babies weighing 12lbs (5443g) or more at birth 2016. 250417

I would like to know the following regarding live births:
1. The weights of the five heaviest babies that were born in the Trust last year – financial (2015-16) or calendar (2015) year, whichever is easiest.
2. The weights of the five lightest babies that were born in the Trust last year for pregnancies that reached around full term (i.e. that weren’t born prematurely).

Download response Baby weights 2015-2016 090916

1. Do you have any strategy or informal policy that allows adults to be treated in beds/wards that are usually used for paediatric care to help with overcrowding?
2. What is that wording of that strategy?
3. When as it first drawn up?
4. How many times since January 2016 year has this been implemented? If applicable, how many times was it implemented between Jan 2015 and Jan 2016?
5. How many individual adult patients since January 2016 have been treated on child wards/bed -with dates if possible? And the same figure Jan 2015-16.
6. Were there any occasions when adults and children were treated on the same ward?
7. How many times has the hospital been on a) black alert and b) red alert for capacity since January 2016? How many times was it put on a and b from January 2015 – 2016?

Download response Bed shortages and overcrowding. 310117

(a) Does your trust have a bereavement suite available for use by parents in the event of limited life expectancy of an anticipated birth of a child?

(b) If the answer to (a) is no, what alternative arrangements are available?

(c) If the answer to (a) is yes, would parents of a baby who turn up at hospital with a sudden infant death be allowed to use the bereavement suite?

(d) If the answer is yes to (a) where in relation to the Labour ward is the suite located?

(e) Do you have bereavement trained midwives? If yes, how many?

(f) Do you have a trained bereavement councillor at the hospital? If yes, what is the average waiting time to be able access support from that councillor?

(g) Do you provide any written information to parents following the loss of a baby? If yes, please name the third sector organisation information is provided from.

(h) Can you list the guidelines around infant death which are implemented by the hospital?

(i) Does the hospital provide support around funeral arrangements for infants or babies who have died at the hospital?

Download response Bereavement of babies 030216

For the time period 1 April 2022 to 31 December 2022, if you do not have figures available for the whole period, please provide the most up-to-date figures and state the period they cover.
LIVE BIRTHS
1. How many live births were there at your hospital Trust in the following periods?
(Please exclude home births from this number and detail them separately in brackets.)
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
STILL BIRTHS
2a. How many stillbirths were there at your hospital Trust in the same periods?
Stillbirth is defined as occurring when a baby is born dead after 24 completed weeks of pregnancy.
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
2b. Of these stillbirths (in answer 2a) how many were Intrapartum stillbirths?
Intrapartum stillbirth is defined as when a baby was thought to be alive at the start of labour but was born, beyond 37 weeks of gestation, with no signs of life.
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
2c. Of the Intrapartum stillbirths (in answer 2b) how many were referred to HSIB?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
2d. Of the Intrapartum stillbirths referred to HSIB (in answer 2c), how many did HSIB investigate?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
NEONATAL DEATHS
3a. In the same periods, how many Neonatal deaths were there at your hospital Trust?
Neonatal deaths are defined as a baby that dies within 28 days of birth of any cause or, for the purposes of this process, a baby who dies that has not left hospital since birth.
If a baby was born at your hospital Trust and was transferred to another hospital and died at another hospital Trust, please exclude them from these numbers and specify the number separately in brackets.
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
3b. Of these Neonatal deaths (in answer 3a) how many were ‘early Neonatal deaths’?
Early Neonatal deaths are defined as a baby that dies within the first week of life (0-6 days) of any cause.
If a baby was born at your hospital Trust and was transferred to another hospital and died at another hospital Trust, please exclude them from these numbers and specify the number separately in brackets.
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
4a. Of the Neonatal deaths (in answer 3a) at your hospital Trust, in how many cases was the medical cause identified?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
4b. Of the Early Neonatal deaths (in answer 3b) at your hospital Trust, in how many cases was the medical cause identified?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
5a. Of the Neonatal deaths at your hospital Trust, where the medical cause was identified (in answer 4a), how many were referred to the Coroner?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
5b. Of the Early Neonatal deaths at your hospital Trust, where the medical cause was identified (in answer 4b), how many were referred to the Coroner?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
6a. Of the Neonatal deaths at your hospital Trust, in how many cases was the medical cause not identified?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
6b. Of the Early Neonatal deaths at your hospital Trust, in how many cases was the medical cause not identified?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
7a. Of the Neonatal deaths at your hospital Trust, where the medical cause was not identified, how many were referred to the Coroner?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
7b. Of the Early Neonatal deaths at your hospital Trust, where the medical cause was not identified, how many were referred to the Coroner?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
8a. Of the Early Neonatal deaths (in answer 3b) at your hospital Trust, how many were referred to HSIB?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
8b Of the Early Neonatal deaths referred to HSIB (in answer 8a), how many did HSIB investigate?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
HYPOXIC ISCHEMIC ENCEPHALOPATHY
9a. Of the Neonatal deaths at your hospital Trust, in how many cases was the cause of death recorded as Hypoxic Ischemic Encephalopathy?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
9b. Of the Neonatal deaths at your hospital Trust, where the cause of death was recorded as Hypoxic Ischemic Encephalopathy, how many were referred to the coroner?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
9c. Of the Neonatal deaths at your hospital Trust, where the cause of death was recorded as Hypoxic Ischemic Encephalopathy (in answer 9a), how many were referred to HSIB?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
9d. Of the Neonatal deaths at your hospital Trust, where the cause of death was recorded as Hypoxic Ischemic Encephalopathy (in answer 9c), how many did HSIB investigate?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
Please provide a copy of your hospital Trust’s current policy in respect of referring Neonatal deaths to a coroner and advise the date it was last updated.
MATERNAL DEATHS
10a. How many maternal deaths were there at your hospital Trust in the same periods?
Maternal deaths are defined as the death of a woman while pregnant or within 42 days of the end of the pregnancy from any cause related to or aggravated by the pregnancy or its management, and not from accidental or incidental causes. Excludes death by suicide.
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
10b. In how many cases of maternal death was a Neonatal death also recorded?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
10c. In how many cases of maternal death where a Neonatal death also recorded, was the death an Early Neonatal death?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
11. Of the maternal deaths at your hospital Trust (in answer 10a), how many were referred to HSIB?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?

Births and deaths.100223.docx

In the 2018 calendar year were there any babies born at your hospitals where the weight of the baby was 12lbs (5443g) or more? If so please state how many and what their birthweights were.

Download response Birthweights. 250419

In the 12 months to date (23.08.18) please confirm the following:
1) Whether the Trust currently is, or has been in the past 12 months, engaged in a contract or written agreement with Bounty UK Limited. If the Trust is currently engaged in a contract please attach a copy of it, making necessary redactions in order to comply with the Act. Please provide the date that the contract began and/ or ended. Please provide an overview of the terms of payment. (i.e. per mother visited / per photo pack purchased).
2) Please confirm how much money has been paid to the Trust by Bounty UK Limited in the past 12 months and how many new mothers are recorded as having been approached by Bounty representatives (if held).
3) Please provide details of the policies the Trust has in place with regards to protecting new mothers (i.e. are representatives allowed on any ward at any time, or do they have restricted access? Are mothers given the option to opt out of being visited?)
4) Please confirm the number of complaints made to the Trust by new parents. If not time prohibitive, please provide details of the complaints.

Download response Bounty. 110219

Q1) Please provide the name of your Trust
Q2) Do you have a contract with Bounty, whose representatives hand out ‘Bounty Packs’ to new mothers on maternity wards?
Q3) If you answered YES to Question 2, how much money did your trust receive from Bounty in the financial years;
Q4) Please explain how the payment from Bounty is calculated (i.e. a pre-agreed figure, or a set payment per child born in your care).
Q5) How many babies were born in your care during the financial years?

Download response Bounty Packs. 110219

1. Please provide the number full term babies at 36 weeks or later who , because of HIE, were transferred for consideration of brain cooling to a tertiary centre for the following calendar years 2014,2015, 2016 and 2017 to date. ( if you are already one of those tertiary centres then please let me know how many babies were considered for brain cooling because of HIE.)
2. For those same babies, and years, please let me know how many were subject to a serious incident report relating to childbirth?

Download response Brain cooling in babies. 011217

Please provide the number of cases where breast milk of a new mother was given to a child who is not her own at all maternity wards in your Trust.

For clarity, I am asking you to please provide the number of instances where a child on a maternity ward was given breast milk from a person who was not their mother.

Please provide annual figures for how many times this happened at your Trust for 2017, 2018, 2019, 2020, 2021, 2022 and so far in 2023.

Please also give the number of times disciplinary action was taken on a member of staff over these instances. Please provide a breakdown of the outcome of any disciplinary action: How many were cautioned, suspended, terminated etc as a direct result of the mistake.

Breast milk.100823.docx

1) How many children received treatment from your local CAMHS in the financial years:
a. 2014/15
b. 2015/16
c. 2016/17
d. 2017/18

2) Please can you breakdown the figures given in answer to Q1a-d by (i) the type of mental health issue that was being treated, and (ii) the ethnicity of the child?

Download response CAMHS. 170818

How many referrals were made to CAMHS from any possible referrer for the last three financial years (April 1 2015 – March 31 2016, April 1 2016 – March 31 2017, April 1 2017 – March 31 2018)?
How many were accepted for each of the years above?
Of those accepted, how many had any of the below factors known or believed to be evident (if information is available), for each of the years above?
– Previous contact with CAMHS
– Recurrent threats or acts of self-harm
– High levels of risk
– Eating disorders
How many accepted were from each type of referrer (e.g. GP, A&E etc.) for each of the years above?
What was the mean and median waiting time between referral and treatment for each of the years above?
How many were declined for each of the years above?
Of those rejected, how many had any of the below factors known or believed to be evident (if information is available), for each of the years above?
– Previous contact with CAMHS
– Recurrent threats or acts of self-harm
– High levels of risk
– Eating disorders
How many rejected were from each type of referrer (e.g. GP, A&E etc.) for each of the years above?

Download response CAMHS. 270618

For each month between (and including) January 2018 and June 2021, please could you tell me the mean average number of days to elapse between a patient being assessed by your CAMHS service and that patient having their first appointment with an appropriate specialist as part of an ongoing treatment plan under CAMHS (as opposed to an appointment with a non-specialist; or supportive care while waiting for therapist availability; or an unscheduled call, letter or other contact that does not qualify as a treatment appointment)?

For each month, please could you specify which specialist or specialists were in attendance at those first treatment appointments, expressed as percentages of the total number of first treatment appointments that month (e.g., 74% of patients had their initial appointment as part of an ongoing treatment plan with a clinical psychologist, 20% with a CBT therapist etc)

Download response CAMHS treatment.160721.docx

1. How many children’s operations have been cancelled each month since 1st July 2016? Please give additional details as to what the main reasons for the cancellations were, how many were urgent operations or elective operations, and what type of illness did they involve, e.g. cancer, breathing problems, broken limbs etc.

2. How many children’s operations have been cancelled over the last four financial years to date?

Kindly note a child is anyone up to the age of 18.

Download response Cancelled children’s operations – 01.07.16. 050517

The total number of children’s operations cancelled for non-clinical reasons, broken down by the cause of the cancellation, for example due to lack of beds, operating theatre capacity, staffing issues, and equipment failures. Please provide this information for each of the past three financial years 2017/18, 2018/19, 2019/20). In the total number of operations, broken down by cancellation reason, please include:

· Elective children’s operations cancelled at the last minute. For the purposes of this request, last minute means on the day the patient was due to arrive, after the patient has arrived in hospital or on the day of the operation or surgery.

· Cancelled urgent children’s operations.

For the purposes of this FOI, Children will be defined as under 18’s.

Download response Cancelled children’s operations. 131020

1. What is the total number of children and young people diagnosed with Cerebral Palsy by your Trust/Health Board in the last five years? (N.B.: this should be recorded as a total figure rather than figures for each year individually.)
2. What is the care pathway for children and young people with cerebral palsy in your Trust/Health Board? Please provide a copy of this if possible.
3. Is there a specific timescale set out in your care pathway for referral to a child development service for diagnosis of cerebral palsy from the point when symptoms are initially identified? If so, please provide this data.
4. What is the total number of:
a. Health visitors employed by your Trust/Health Board?
b. Specialist health visitors for children with special needs employed by your Trust/Health Board?
5. What training is given to healthcare professionals, including health visitors and GP’s, to recognise the risk factors and possible symptoms for Cerebral Palsy?
6. What is the total number of specialist staff employed by your Trust/Health Board, who are trained to work with children and young people with Cerebral Palsy, from the following disciplines:
a. Paediatric speech and language therapy
b. Paediatric physiotherapy
c. Paediatric occupational therapy
7. How many children and young people with Cerebral Palsy are currently on a waiting list to access any of the above services within your Trust/Health Board?

Download response Cerebral Palsy (CP). 270618

How many people under specialist Child and Adolescent Mental Health Services were issued with the ICD-10 code F12. – ‘mental and behavioural disorders due to use of cannabinoids’, during the 2016/17, 2015/2016, 2014/2015, 2013/2014, 2012/2013, 2011/2012, 2010/ 2011, 2009/ 2010, 2008/ 2009, 2007/ 2008, 2006/ 2007 periods?

Download response Child and Adult Mental Health Services. 260218

For the purposes of this request we define children and young adults as being between the ages of 0 and 25 years.
1. The information request:
Please can you provide us with the following information?
• The (a) budget and (b) expenditure for all mental health services.
• The (a) budget and (b) expenditure for Child and Adolescent Mental Health (CAMHS) services (total spend) – if you attribute to a CAMHs Tier 1-4 please specify.
• The (a) budget and (b) expenditure for mental health urgent and emergency care (including mental health crisis care) for children and young people – if only total spend is available please approximate proportion that is spent on children and young adults.
• Any additional, discretionary monies (a) budgeted for and (b) spent on child, adolescent or young adult mental health – please specify source.
We are requesting information for the financial years: 2010/11, 2011/12, 2012/13, 2014/15, 2015/16, 2016/17.
And if available – we are also requesting the projected budget (or settlement) for the financial years covering the remainder of Future in Mind and the Five Year Forward View for Mental Health, which includes: 2017/18, 2018/19, 2019/2020, 2020/21.
2. Clarifications:
If the requested information does not relate to your activity, please answer ‘not applicable’ (N/A).
If you share a budget with another organisation, please specify:
a. The name of the other organisation(s) (for example a Clinical Commissioning Group, Local Authority or NHS Trust).
b. Whether the expenditure / budget reported is the total amount of the shared budget, or your organisation’s contribution to the shared budget.

Download response Child and Adolescent Mental Health Services (CAMHS) 270616

This request relates to drug and alcohol related admissions of children. Please include cases where the relevant diagnoses were recorded as both the primary and secondary condition.

I) Broken down by each of the following calendar years a) 2012, b) 2013, c) 2014, d) 2015 and e) 2016 so far, please state the total number of children aged under 13 admitted to hospitals in your trust due to:

1. The toxic effect of alcohol
2. Mental and behavioural disorders due to use of alcohol
3. Poisoning by drugs, medicaments and biological substances
4. Mental and behavioural disorders due to drug and psychoactive substance use
5. Poisoning by antidepressants (subset of question 3)
6. Poisoning by ecstasy (subset of question 3)

II) Broken down by each of the following calendar years a) 2012, b) 2013, c) 2014, d) 2015 and e) 2016 so far, please state the total number of children aged 13-16 admitted to hospitals in your trust due to:

1. The toxic effect of alcohol
2. Mental and behavioural disorders due to use of alcohol
3. Poisoning by drugs, medicaments and biological substances
4. Mental and behavioural disorders due to drug and psychoactive substance use
5. Poisoning by antidepressants (subset of question 3)
6. Poisoning by ecstasy (subset of question 3)

III) Broken down by each of the following calendar years a) 2012, b) 2013, c) 2014, d) 2015 and e) 2016 so far, please state the total number of children aged 16-17 admitted to hospitals in your trust due to:

1. The toxic effect of alcohol
2. Mental and behavioural disorders due to use of alcohol
3. Poisoning by drugs, medicaments and biological substances
4. Mental and behavioural disorders due to drug and psychoactive substance use
5. Poisoning by antidepressants (subset of question 3)
6. Poisoning by ecstasy (subset of question 3)

Download response Child drug and alcohol related admissions. 241016

What was the average waiting time for patients referred to the Child and Mental Health Services at your trust between May 31st 2016 and May 30th 2017?
What was the average waiting time for patients referred to the Child and Mental Health Services at at your trust between May 31st 2015 and May 30th 2016?
What was the longest waiting time for a patient referred to the Child and Mental Health Services at your trust between May 31st 2016 and May 30th 2017?
What was the longest waiting time for a patient referred to the Child and Mental Health Services at your trust between May 31st 2015 and May 30th 2016?
How often did limited capacity mean your trust had to decline access to services for patients referred to the Child and Mental Health Services between May 31st 2016 and May 30th 2017?
How often did limited capacity mean your trust had to decline access to services for patients referred to the Child and Mental Health Services between May 31st 2015 and May 30th 2016?
What’s the furthest distance a patient has had to travel from your trust to find adequate, available care from the Child and Mental Health Services between May 31st 2016 and May 30th 2017, having been turned away due to a lack of resources?
What’s the furthest distance a patient has had to travel from your trust to find adequate, available care from the Child and Mental Health Services between May 31st 2015 and May 30th 2016, having been turned away due to a lack of resources?
What age was the youngest patient dealt with by the Child and Mental Health Services at your trust between May 31st 2016 and May 30th 2017?

Download response Child and Mental Health Services. 170817

1.a. What was the average waiting time for patients referred to the Child and Mental Health Services at your trust during the financial year 2017-2018, and what was their age and gender?
1.b. What was the average waiting time for patients referred to the Child and Mental Health Services at your trust during the financial year 2016-2017, and what was their age and gender?
1.c. What was the average waiting time for patients referred to the Child and Mental Health Services at your trust during the financial year 2015-2016, and what was their age and gender?
2.a. What was the longest waiting time for a patient referred to the Child and Mental Health Services at your trust during the financial year 2017-2018, and what was their age and gender?
2.b. What was the longest waiting time for a patient referred to the Child and Mental Health Services at your trust during the financial year 2016-2017, and what was their age and gender?
2.c. What was the longest waiting time for a patient referred to the Child and Mental Health Services at your trust during the financial year 2015-2016, and what was their age and gender?
3.a. How often did limited capacity mean your trust had to decline access to services for patients referred to the Child and Mental Health Services during the financial year 2017-2018?
3.b. How often did limited capacity mean your trust had to decline access to services for patients referred to the Child and Mental Health Services during the financial year 2016-2017?
3.c. How often did limited capacity mean your trust had to decline access to services for patients referred to the Child and Mental Health Services during the financial year 2015-2016?
4.a. What’s the furthest distance a patient has had to travel from your trust to find adequate, available care from the Child and Mental Health Services during the financial year 2017-2018, having been turned away due to a lack of resources, and what was their age and gender?
4.b. What’s the furthest distance a patient has had to travel from your trust to find adequate, available care from the Child and Mental Health Services during the financial year 2016-2017, having been turned away due to a lack of resources, and what was their age and gender?
4.c. What’s the furthest distance a patient has had to travel from your trust to find adequate, available care from the Child and Mental Health Services during the financial year 2015-2016, having been turned away due to a lack of resources, and what was their age and gender?
5.a. What age was the youngest patient dealt with by the Child and Mental Health Services at your trust during the financial year 2017-2018?
5.b. What age was the youngest patient dealt with by the Child and Mental Health Services at your trust during the financial year 2016-2017?
5.c. What age was the youngest patient dealt with by the Child and Mental Health Services at your trust during the financial year 2015-2016?

Download response Child and Mental Health Services. 200418

What is the name of your acute trust?
(1) Does your trust provide a weight management service for children living with obesity?
Yes ☐ No ☐
If No, you need not answer further.
If yes, what is the name of the service and where delivered:
Who leads this service?
It is a hospital ☐ or community-based☐ clinic
(2) What if any are the criteria for eligibility to attend (for instance BMI >98th percentile)?
None ☐
Eligible if:
(3) Through what mechanism is the service funded?
CCG ☐
NHS England ☐
Research ☐
Charity ☐
Trust Self-Funding ☐
Other ☐
Please specify
(4) Who are the key personnel providing service? Please tick all who apply:
a. Paediatricians ☐
b. Dieticians ☐
c. Psychologists ☐
d. Trained volunteers ☐
e. Hospital or Community based Nursing staff ☐
f. Exercise specialists ☐
g. Social workers ☐
h. CAHMS ☐
i. Youth workers ☐
(5) How many new cases are seen each year?
(6) Over how many weeks is the clinic intervention delivered?
(7) What is the usual follow up period (entry to discharge?)
(8) What final outcomes are collected: Examples: change in BMI, BMI SDS, Self Esteem, Waist Circumference, recruitment, retention.
Please list all.

Download response Childhood obesity services. 160320

1. The number of low secure Children and Adolescent Mental Health Service (CAMHS) and medium secure CAMHS beds within your Authority or Trust and how many of those are currently available for new admissions.
2. The number of low secure CAMHS beds within your Authority or Trust and how many of those are currently available for new admissions.
3. The number of medium secure CAMHS Service beds within your Authority or Trust and how many of those are currently available for new admissions.
4. The number of welfare social care secure beds within your Authority or Trust and how many of those are currently available for new admissions.
5. The number of forensic secure beds within your Authority or Trust and how many of those are currently available for new admissions.
Further, please could you kindly provide details of:
6. The number of young people within your Authority area or Trust area who have been assessed as requiring a CAMHS Tier 4 mental health bed but have not been admitted due to a shortage in resource (we do not require personal details or reasons for the conclusion reached, just numbers).
7. The number of young people within your Authority area or Trust area who have been assessed as requiring a CAMHS low secure mental health bed but have not been admitted due to a shortage in resource.
8. The number of children accommodated within your Authority area or Trust area in unapproved, unregulated settings.

Download response Children and Adolescent Mental Health Service (CAMHS). 051021.docx

1. Number of children attending A&E per month, since Jan 2019 due to a mental health related issue.
2. The top 10 longest stays in A&E of a child who is presenting a mental health issue over the last 12 months.

Children attending A&E due to mental health. 120422.docx

You asked:
Please may you tell me the number of people, under the age of 18, who were treated by the trust for alcohol dependence and/or alcohol misuse in 2012, 2013, 2014, 2015, 2016, 2017, and 2018?

May you please tell me the youngest person you treated for this in 2016, 2017 and 2018?

Download response Children treated for alcohol dependency or misuse. 151118

1. As of March 31st, 2017, can you tell me how many children were on the waiting list to visit the Trust’s children’s dental hospital?
2. How long is the present waiting list, in terms of months/weeks to be seen?
3. How long is the wait for teeth extractions?
4. How many children are affected by the wait for teeth extractions?
5. Is there a wait for youngsters to be added to the waiting list? if, so how many children are waiting to be placed on to the waiting list?
6. How many dental nurses does the Trust employ at the children’s dental hospital?
7. How many vacancies does it have at present?
8. How many children were on the waiting list to visit the Trust’s children’s dental hospital on?
a) March 31st, 2016?
b) March 31st 2015?
c) March 31st 2014?
d) March 31st 2013?
9. How many children received treatment at the children’s dental hospital between January 1, 2016 and December 31, 2016?

Download response Children’s Dental Hospital. 250417

1. Between 1st April 2018 and 31st March 2019 how many visits to/patients were/are seen at Riverbank Children’s unit? (Volume)
2. Between 1st April 2018 and 31st March 2019 how many individual patients were/are seen at Riverbank Children’s unit? (Reach)
3. How many of these were transferred to Pembury?
4. On a typical day / on average how many patients are transferred from Riverbank to woodlands every day?
5. What are the main reasons for these transfers?
6. On a typical day/ on average many patients transfer each day due to the Riverbank closing time?
7. How often/ on average how many times a week do the staff at Riverbank have to stay past 8.00pm to accommodate patients needs/ transfer to Pembury?
8. Between 1st April 2018 and 31st March 2019 how many visits to/patients were/are seen at Woodlands and hedgehog Children’s unit? (Volume)
9. Between 1st April 2018 and 31st March 2019 how many individual patients were are seen at Woodlands and hedgehog Children’s unit? (Reach)
10. How many of these were transferred from Riverbank?

Download response Children’s Unit. 250919

We require sight of the Cooling/Therapeutic hypothermia protocol in the neonatal and/or Special Care Baby Unit at Maidstone & Tunbridge Wells NHS Trust, that was in force in November 2015. We are merely requesting this to provide us with knowledge in accordance with the act.

Download response Cooling-Therapeutic Hypothermia Protocol. 101220

1) Do you allow private stem cell companies to promote their services on your sites, e.g. leaflets?
2) Do you allow representatives from stem cell companies on any of your sites to promote or collect cord blood, e.g. in delivery suites?
3) Does the Trust allow its staff to work for stem cell companies, e.g. collecting umbilical cord blood for private companies?
4) How long (how many minutes) does the Trust consider ‘optimal’ cord clamping?
5) Please supply the following information for each of the individual calendar years: 2015, 2016, 2017, 2018 and 2019 to date:
a) The number of babies born whose umbilical cord blood was collected for banking by a private company.
b) The number of babies born whose umbilical cord blood was collected for banking by the NHS.
c) The income received from stem cell companies.

Download response Cord blood stem cells. 300819

Please provide under the FOI act, the figures for each of the last 5 years (please provide data for each calendar year data 2015-2020)
Please provide the following figures per calendar year:
1. How many live births occurred in your organisation (please break this down to premature and term babies)
2. How many of these live births had cord clamping as being recorded at being at or after one minute? (please break this down to premature and term babies)
3. Please provide the numbers where cord clamping occurred before one minute (please break this down to premature and term babies)
4. How many times this was not documented (please break this down to premature and term babies)
5. Please provide any audits in the last 5 years on cord clamping times.
6. Is it mandatory to record the cord clamping time on any of your systems?

Download response Cord clamping. 011121.docx

1. “Since 01 January 2017, please specify the number of individual cases where the Court has had to intervene in the treatment of a critically ill child, when there has been a difference of opinion between parents and doctors, over the course of treatment for that child?”

Download response Court intervention. 141119

1) Does your organisation use any guidelines when prescribing specialised infant formula for cow’s milk protein allergy (CMPA)?

2) If yes, please provide a link to, or a copy of the guidelines referenced by your organisation.

3) Please can you confirm whether we are permitted to reuse any information provided under the Open Government Licence?

Download response Cow’s milk protein Allergy (CMPA) 090916

PART 1: ABOUT PAEDIATRIC COMMUNICATION

1. Is there a psychologist dedicated to paediatric wards?
2. Who is in charge to communicate about care and hospitalization practices? (multiple answers)
3. What kind of communication material do you use inside your ward in order to support and enhance the experience of the child and his/her family in hospital, providing information on his/her clinical condition, exams and treatment?
* If you choose “Paper” or “We don’t use communication material” go to PART 3

PART 2: ABOUT THE USE OF TECHNOLOGICAL DEVICES

1. IF YOU USE TECHNOLOGICAL DEVICES, which of the following ones are used in the ward to communicate with and support THE CHILD : (multiple answers)
2. If you use technological devices, which of the following ones are used in the ward to communicate with THE PARENTS: (multiple answers)
3. If you use technological devices, which of the following ones are used in the ward to communicate with THE SIBLINGS: (multiple answers)
4. If you use technological devices, which of the following ones are used in the ward to communicate with THE CHILDREN OF HOSPITALIZED PARENTS: (multiple answers)
5. If you use technological devices to communicate with the child and his family, what do they apply to, CONSIDERING THE CLINICAL CONDITIONS? (multiple answers)
6. If you use technological devices to communicate with the child and his family, what do they apply to, CONSIDERING THE TYPE OF INTERVENTION? (multiple answers)
7. What are the goals of the technological devices you use? (multiple answers)
8. Can you mention some examples of the technological devices you use?
9. Have you published an assessment study on the efficacy of the tool?
10. If your answer was YES, could you please give us references?
* If you use technological devices DON’T answer to PART 3

PART 3: ABOUT THE EVENTUAL USE OF TECHNOLOGICAL DEVICES

1. IF YOU DON’T USE TECHNOLOGICAL DEVICES – Do you think they could be useful tools to improve the quality of communication directed to the child and his family?
2. IF YOUR ANSWER WAS YES – For which clinical conditions? (multiple answers)
3. AND – For which type of intervention? (multiple answers)
4. Which purpose should they set themselves? (up to 3 answers)
5. Why don’t you use technological devices to communicate with the children and their families? (up to 3 answers)

Download response Digital devices inside Paediatric Wards. 081121.docx

We seek information about the evaluation and care given to those with Disorders of Sex Development. In particular, we would like to know more about the number of international referral requests received by your trust from Malta.
We have put together a list of questions, which we would be grateful if you could answer in this order:
1) Since 2015, how many children receiving diagnostic tests and/or treatment for DSDs have been referred to this trust from Malta?
2) Of these children, how many are government-sponsored patients?
a. How many pay privately?
3) Of these referrals, how many have undergone genital surgeries?
4) Which specific DSDs have been referred from Malta? (e.g. Congenital Adrenal Hyperplasia, Androgen Insensitivity Syndrome, Turners Syndrome). If possible, please list them.
5) Are there specific legal or ethical guidelines tailored for Maltese patients?

Disorders of Sex Development in Children. 150222.docx

1. Who provides expert evaluation of gender assignment in newborns with Disorders of Sex Development?

2. Does the trust use a multidisciplinary team that deals with the evaluation and long-term management and needs of patients with Disorders of Sex Development?

3. If yes to question 2, can you provide contact details for the team?

4. What specialties are represented on the multidisciplinary team (e.g. paediatric subspecialists in endocrinology, surgery, and/or urology, psychology/psychiatry, gynaecology, genetics, neonatology, and, if available, social work, nursing, and medical ethics)? Please list them.

5. When dealing with Disorders of Sex Development, what guidelines, if any, do decision makers follow?

6. How many people are referred to this team per year (please give numbers for the last five years)?

Download response Disorders of Sex Development in the UK. 070818

Can I ask for the following information: for each of the last four financial years (including the current one) I request disclosure of data relating to children aged 15 and under who have been diagnosed with alcoholism or drug related conditions.
1. For each year I would like a table containing patients’ ages, from 0 to 15 years old accompanied by a figure for the number of children of that age who were diagnosed as alcoholic, alcohol poisoning, treated for alcoholism or excessive alcohol consumption (for example 2016/17: Age 15– 33 Age 14 – 3). Can you outline the figures for each?
2. For each financial year I would also like a table set out in the same way detailing the numbers of children aged 15 or below who were admitted to A&E suffering alcohol-related illness.
3. For each year I would like a table containing patients’ ages, from 0 to 15 years old accompanied by a figure for the number of children of that age who were diagnosed for drug related illnesses or over-consumption (for example 2016/17: Age 15– 33 Age 14 – 3).
4. For each financial year I would also like a table set out in the same way detailing the numbers of children aged 15 or below who were admitted to A&E suffering drug-related illness. Can you outline the figures for each?
5. For each admission in Q1 and Q3, please tell me a) the sex of the child c) a brief summary of the problem, e.g. child was drunk

Download response Drug and alcoholism in children aged under 15 2013-2017. 280417

The Royal College of Obstetricians and Gynaecologists ran an initiative called Each Baby Counts aimed at reducing the number of intrapartum stillbirths, early neo-natal deaths and babies born with severe brain injuries. Please provide the total number of notifiable cases reported to the initiative by your organisation and the time period the data relates to, e.g. 1 January 2015 – 31 December 2019.

Each Baby Counts. 140322.docx

1) How many admissions of children (under 18’s) presenting with eating disorders your trust has recorded in the past five years?
2) I would like to know how many of these children treated were male/female/transgender.
3) Please present all this information simply and clearly and break it down by year. Please provide as much detail as possible about the nature of their illness (I understand that some children may present with multiple illnesses). I would like this information broken down by type of eating disorder e.g. bulimia, anorexia etc.

Download response Eating disorders. 160119

The number of paediatric patients you have seen between January 1st 2014 and December 31st 2014 for the treatment of eating disorders
The number of paediatric patients you have seen between January 1st 2015 and December 31st 2015 for the treatment of eating disorders
The number of paediatric patients you have seen between January 1st 2016 and December 31st 2016 for the treatment of eating disorders
How many of the paediatric patients were aged 10 and under between January 1st 2014 and December 31st 2014
How many of the paediatric patients were aged 10 and under between January 1st 2015 and December 31st 2015
How many of the paediatric patients were aged 10 and under between January 1st 2016 and December 31st 2016
How many of the paediatric patients were aged 11-16 between January 1st 2014 and December 31st 2014
How many of the paediatric patients were aged 11 -16 between January 1st 2015 and December 31st 2015
How many of the paediatric patients were aged 11 -16 between January 1st 2016 and December 31st 2016

Download response Eating disorders in paediatric patients 2014-2016.

1. What are the main Electronic Patient Records systems you operate in Mental Health, Community Health or Child Health?
2. Can you provide a name for these systems?
3. How much are you currently spending on these systems annually for licensing and support fees?
4. What is the date of contract expiry for the systems?
5. How many users? (An estimation if unsure)
6. How are the systems hosted?
7. Who is responsible for your local implementation of the objectives set out by the NHS in the Five Year Forward View?

Download response Electronic Patient Records systems in Mental Health, Community Health or Child Health 270616

1) How many females have you treated in connection to/relating to/as a result of FGM/C (female genital mutilation or cutting) practices?
2) Please can you break your answer down by financial years:
– 2015/16
– 2014/15
– 2013/14
3) Can you also break down and categorise the numbers by “reason for treatment”? So for example, i. bleeding ii. infection
4) Can you break down and categorise the numbers by what the treatment was? So for example, i. amputation ii. cosmetic surgery
5) Can you break down and categorise the numbers by the females’ ages? Ideally in these age brackets: i. 0 – 9 ii. 10 – 18 iii. 19 – 27 (and continue by nine-year age brackets)

Download response FGM C 2013-2016

1. For 2016,
a) How many people were diagnosed as being on the Foetal Alcohol Spectrum. With a breakdown of ages and hospitals.

2. and 3. Same for 2015/2014

Download response Foetal Alcohol Syndrome 2014-2016. 070417

Please supply information for all of the questions below relevant to – foetuses that were miscarried, stillborn or aborted and children up to one year old from 1988 to the present day (Nov 2016).

1. Are you holding organs or tissue samples or bodies of foetuses that were miscarried, stillborn, aborted or of children up to one year old, pending disposal?

2. If yes to Q1, please report how many organs, tissue samples, body parts or bodies of foetuses that were miscarried, stillborn, aborted or of children up to one year old you have retained and still have?

3. In how many of these cases of foetuses that were miscarried, stillborn or aborted or of children up to one year old which have been retained and you still have was consent given by the nearest relatives to take, use and dispose of organs or tissue samples or body parts or bodies?

4. In how many of these cases of foetuses that were miscarried, stillborn or aborted or of children up to one year old which were retained but have since been disposed of was consent given by the nearest relatives to take, use and dispose of organs or tissue samples or body parts or bodies?

Download response Foetuses that were miscarried, stillborn or aborted and children up to one year old from 1988 to the present day (Nov 2016). 011216

1. Do you distribute any free promotional disposable nappies (such as Pampers) or reusable nappies to parents at any services, including (but not exhaustive of) antenatal, maternity, midwife, post-natal and family services?
If the answer is yes to 1, please answer questions 2-7.
2. Which disposable or reusable nappy brand do you allow to distribute their promotional nappies?
3. Which services are they distributed at and how many parents use these facilities annually?
4. How frequently a year have these disposable or reusable nappy brands been able to distribute their promotional material at these services?
5. What is the process for allowing disposable or reusable nappy brands to distribute at your services and who signs it off?
6. Is there any remuneration for the NHS from these disposable or reusable nappy brands for distributing their promotional material?

Download response Free promotional disposable nappies.260219

1. Total number of children currently on your waiting lists and for each of the past five years.
2. The average waiting time from referral to treatment by year for each of the past five years.
3. The total number of children currently on the waiting list who have waited more than a) six months b) one year c) 18 months
3. The five longest waits faced by people currently on the waiting list in days.
4. The number of children (under 18s) who have a surgical procedure cancelled or delayed at your trust, in each of the past five calendar years (2022, 2021, 2020, 2019, 2018).

General anaesthesia (GA) paediatric dental waiting times.140223.docx

I write under the Freedom of Information Act to request copies of all Clinical policies and procedures, guidelines and standards that were in use to govern the clinical decisions concerning the treatment of Haemolytic disease of the newborn (HDN) also known as Rhesus Disease/Maternal Antibodies made in the Neo-natal units within the Maidstone & Tunbridge Wells NHS Trust from 1998 to 2002.

These documents will include but not be limited to the management of :

Rhesus Disease
Haemolytic Disease of the newborn (HDN)
Neo natal jaundice in pre-term and term neonates
Hyperbilirubinemia in the newborn
Phototherapy
Exchange transfusions in neonates

And any other interventions/guidelines into how to treat Haemolytic Jaundice in newborns.

These documents pre-date NICE guidelines and the parameters of 1998 – 2002 are especially important.

Download response Haemolytic disease of the newborn (HDN) also known as Rhesus Disease-Maternal Antibodies. 300920

For each of the past five financial years (12/13 – 16/17) please tell me the following:

The total number of allegations of misconduct made by employees of your trust against another employee, broken down by:
• The job category of the complainant, for example doctor, nurse, porter, receptionist.
• The nature of the alleged misconduct. For example sexual harassment, sexual assault, physical assault, theft, bullying, racism.
• The outcome of the complaint. For example, unsubstantiated, written warning, dismissed, training requirement, police informed.

Download response Allegations of misconduct. 081117

1. Between 1 September 2018 and 1 September 2022, how many complaints of sexual misconduct were made by patients, visitors and Trust employees against staff members in your NHS Trust.
2. How many of the complaints were upheld?
3. What was the outcome of the upheld complaints? Outcomes can include but are not limited to verbal warning, written warning, suspension, or dismissal
If it does not push the request over the cost limit, please can you also include:
4. The nature of the allegation
5. The gender of the complainant
6. The gender of the staff member

Allegations of sexual misconduct.040123.docx

1- How many allegations of a) sexual assault and b) sexual harassment has your trust received against staff members in each of the past four years?
2- In how many of the cases were any of the alleged victims aged 18 or under at the time of the alleged offence?
3- In how many of the cases were any of the alleged victims current or former patients?
4- For each case, did it lead to i) internal disciplinary proceedings, ii) external disciplinary proceedings (i.e. through a regulator) and/or iii) a financial settlement.
5- For each case, please provide a broad description of the allegations involved, including the number of alleged victims / alleged perpetrators; their age (within a 10-year band); the date of the alleged offence and whether the alleged perpetrator occupied a managerial position.
6- For each case, please list the gender of the alleged perpetrator and the alleged victim. Alternatively, provide totals for the genders of the alleged perpetrators and alleged victims across all of your cases.
7- For each case which was dealt with by disciplinary proceedings, how many alleged offenders were i) fired; ii) suspended, iii) received written or verbal warnings.
8- Please provide the value of any financial settlement in each case.
9- Did any settlements (financial or otherwise) include clauses placing any restriction on the ability of the alleged victim to discuss the events involved or the institution? If so, how many?

Download response Allegations of sexual assault or sexual harassment. 081117

1. A list of every amputation operation at your hospital over the past ten years.
2. The amount of cases of the above that have resulted in claims of medical negligence.
3. The amount of cases of the above that have resulted in your informing your insurers of a possible claim for medical negligence.
4. The details of each incident.

Download response Amputation operations. 201119

1a.Approximately how many members of staff do you have?
1b.Approximately how many contractors have routine access to your information?

2a.Do you have an information security incident/event reporting policy/guidance/management document(s) that includes categorisation/classification of such incidents?
2b.Can you provide me with the information or document(s) referred to in 2a? (This can be an email attachment of the document(s), a link to the document(s) on your publicly facing web site or a ‘cut and paste’ of the relevant section of these document(s))

3a.Do you know how many data protection incidents your organisation has had since April 2011? (Incidents reported to the Information Commissioners Office (ICO) as a Data Protection Act (DPA) breach)
Answer: Yes, No, Only since (date):
3b.How many breaches occurred for each Financial Year the figures are available for?
Answer FY11-12: FY12-13: FY13-14: FY14-15:

4a.Do you know how many other information security incidents your organisation has had since April 2011? (A breach resulting in the loss of organisational information other than an incident reported to the ICO, eg compromise of sensitive contracts or encryption by malware. )
Answer: Yes, No, Only since (date):
4b.How many incidents occurred for each Financial Year the figures are available for?
Answer FY11-12: FY12-13: FY13-14: FY14-15:

5a.Do you know how many information security events/anomaly your organisation has had since April 2011? (Events where information loss did not occur but resources were assigned to investigate or recover, eg nuisance malware or locating misfiled documents.)
Answer: Yes, No, Only since (date):
5b.How many events occurred for each Financial Year the figures are available for?
Answer FY11-12: FY12-13: FY13-14: FY14-15:

6a.Do you know how many information security near misses your organisation has had since April 2011? (Problems reported to the information security teams that indicate a possible technical, administrative or procedural issue.)
Answer: Yes, No, Only since (date):
6b.How many near-misses occurred for each Financial Year the figures are available for?
Answer FY11-12: FY12-13: FY13-14: FY14-15:

Download response Breaches of the Data Protection Act 230516

1. How much money has been paid out in compensation for botched breast augmentation or botched breast enlargements? Please provide information for the last three years.
2. How many people have made successful compensation claims for botched breast augmentation or botched breast enlargements? Please provide information for the last three years.
3. How many unsuccessful claims for compensation for botched breast augmentation or botched breast enlargements has there been in the last three years?
By last three years I mean 2015, 2016 and 2017. Please provide information for each calendar year.

Download response Breast augmentation claims. 010319

Could you please tell me between 1st March 2020 and the date of this email (31st July 2020):
1) How many PALS enquiries and official complaints your Trust has received from patients concerned about
a) the impact of the coronavirus pandemic and your Trust’s response on their access to cancer treatment
b) and access to cancer testing – including tests to find out whether their cancer has spread, returned or occurred for the first time
NOTE: I suggest you search for these complaints by using the keywords ‘cancer treatment’, ‘chemotherapy’, ‘cancer testing’, ‘coronavirus’, ‘COVID-19’ and other relevant terms.
2) For the five most recent PALS enquiries/official complaints received, please provide me with
a) a summary of the complaint (e.g. a patient with stage 4 lung and breast cancer has contacted PALS to complain about their chemotherapy being indefinitely suspended)
b) the exact wording of the complaint, with redactions to remove potentially identifying information
c) what action the Trust took in response

Download response Cancer complaints. 170820

1. How many hospital negligence claims have been made against the Trust relating to deep vein thrombosis and pulmonary embolism (blood clots) in the last five financial years?
2. Of the legal claims referred to in question 1, how much money has been paid to those who have brought claims against the Trust?
3. Please break down the data to questions 1 and 2 by hospital.

Download response Claims relating to deep vein thrombosis (DVT) and pulmonary embolism (PE). 010319

1. In the past 5 years how many complaints have you had regarding communication with or supplying information to patients (written and oral)?
2. In the past 5 years how many complaints have you had regarding the inappropriate or incorrect taking of consent?
3. If the level of detail in questions 1 and 2 is unknown then please say how many complaints have you had in the past 5 years categorised as communication complaints?
4. In the past 5 years how many claims for compensation have you had involving the inappropriate or incorrect taking of consent?
5. If the level of detail in question 4 is unknown please say how many claims for compensation have you had categorised as communication claims?
6. How much did you pay the NHSLA for insurance last year?
7. Can I have a copy of your Consent to Examination or Treatment Policy?
8. If no Consent to Examination or Treatment Policy exists then can you supply me with your approved documented process for obtaining consent, as specified in the NHSLA Risk Management Standards 2013-14?
9. Can you tell me how information is provided to patients to support their decision making, including risks, benefits and alternatives where appropriate?
10. Can you tell me how the discussion and provision of information to patients is recorded?
11. Can you tell me the process for recording that consent has been given?
12. Can you tell me how your organisation monitors compliance with points 9 to 11?
13. Who has overall responsibility for your Consent to Examination or Treatment Policy? (There name would helpful)?

Download response Communication and consent. 031117

I would like information on the number and nature of compensation claims brought against your organisation by members of staff who have sustained an injury or contracted a disease while employed your organisation in the past five years.
I would like a year by year breakdown, preferably on an excel document via email, detailing:
Details of the injury (i.e. moving and handling injury, slips/trips/falls and so on)
Staff role if known (i.e. staff nurse, doctor)
Whether compensation was paid
The total amount of compensation paid
If information available, any action taking following the incident (i.e. additional training, non-slip flooring and so on)

Download response Compensation claims by staff. 070417

1. Between January 2018 and February 2022 how much in total did the Trust spend on compensation pay outs, including court costs
2. Could you also provide the number of claims by category and the total amount of compensation for this category since 2018? e.g. ‘inadequate nursing care’ or ‘maternity

Compensation pay outs and court costs.010422.docx

1) How many compliments did your trust receive in 2017?
2) Do you have a procedure for handling compliments?
3) Do you respond to the authors?
4) Do you pass the compliments onto to the complimentees?
5) Do management see copies of compliments?
6) Do you analyse the content of compliments?

Download response Complaints. 090719

I am seeking information about the number of complaints received by your hospital trust in the past five years for the following specialties: neurosurgery, orthopaedic surgery, cardiothoracic surgery, and vascular surgery.
Specifically, I would like to request the following information for each specialty:
1. The total number of complaints received for each specialty in each of the past five years;
2. The nature of the complaint;
3. The outcome of the complaint, including any actions taken by the hospital trust to address the issue;
I did have a quick question as to whether I could incorporate two further questions into my request. This would put any complaint data you able to provide into an appropriate context (e.g. to contextualise 10 complaints with the fact 1,000 operations were performed):
4. Number of operations performed in the past five calendar years for the following specialties: neurosurgery, orthopaedic surgery, cardiothoracic surgery, and vascular surgery;
5. Number of reportable / recordable patient safety incidents in the past five calendar years for the following specialties: neurosurgery, orthopaedic surgery, cardiothoracic surgery, and vascular surgery
a. Breakdown by incident category (if available);
Complaints.220323.docx

1. Does the Trust routinely publish the complaints data it reports to NHS Digital (KO41a) via any other public channel, i.e. on your website (please indicate YES or NO in the box below)? If YES, please provide details of where and how frequently you publish this data.
Further information on publication:
2. Does the Trust routinely publish, make public or evidence the outcomes and/or learning taken from complaints received (please indicate YES or NO in the box below)? If YES, please provide details of where and how frequently you publish this data.
Further information on publication:
3. Do you record complaints made by third parties who don’t have the expressed consent of the patient(s)? I.e. members of the public, people visiting other patients and/or external non-medical contractors who have concerns about the way patients are being treated or cared for.
4. If you record complaints made by third parties, please could you provide the numbers of complaints received by your NHS Trust for the following financial years?
5. Do you record complaints made by third parties in your official complaints figures as reported to NHS Digital (KO41a)?

Download response Complaints. 280119

How many noise-related complaints the organisation has received in the past three years? For each year, I would like to know:
The department/ward the noise-related complaint refers to
Who made the complaint (patient/relative/staff member etc.)
The nature of the complaint – i.e. if it is noise from staff, noise from another patient, equipment, building work etc.
I would also to know if your organisation has a noise policy or any noise-reduction measures in place – for example soft-closing doors, not transferring patients at night, ‘sleep kits’ for patients and so on.

Download response Complaints about noise for 2013 – 2016 270616

I would like to know how many complaints/issues have been lodged or raised in any way about this/these consultants.

Complaints against consultants.270422.docx

1) Please can you tell me the name of your Trust?
2) How many patient complaints has your Trust received, for any given reason?
Please break down into the following calendar years
2017
2018
2019
3) How many patient complaints has your Trust received, citing racism as one of the problems during the patient’s treatment?
Please break down into the following calendar years
2017
2018
2019
4) How many complaints relate to the treatment of women who have given birth in your Trust?
Please break down into the following calendar years
2017
2018
2019
5) How many of those from Q4 included racism in their complaint?
2017
2018
2019
6) How many members of staff have received some form of disciplinary action due to a complaint by a patient?
Please break down into the following calendar years and please list what action was taken.
2017
2018
2019
7) How many members of staff have received some form of disciplinary action, whereby racist behaviour towards the patient was included? Please break down into the following calendar years and please list what action was taken where possible.
2017
2018
2019
8) How many members of staff have made a complaint regarding racism from a patient?
Please break down into the following calendar years
2017
2018
2019

Download response Complaints and Racism. 040121

1. How many complaints were upheld by the Ombudsman?
2. How many complaints were partly upheld by the Ombudsman?
3. What was your complaints (3 working days) performance as a percentage?
4. What was your complaints (final response) performance target in days?
5. What was your performance as a percentage in response to this target? (e.g. 75% of complaints are answered within 25 working days or as agreed with the complainant)
6.How many days does it take on average for you to respond to a complaint?

Download response Complaints data for 2018-19. 151119

1. For each of the last three calendar years (2019, 2018, 2017), please provide a monthly list of the chief complaints for patients admitted to A&E, broken down by:
• The name of the chief complaint.
• The number of patients admitted to A&E for each chief complaint.
• The number of male patients admitted for each chief complaint.
• The number of female patients admitted for each chief complaint.
Please note that the Chief Complaint is the presenting symptom rather than the primary diagnosis.
2. For each of the last three calendar years (2019, 2018, 2017) please disclose the total number of patients that were admitted to A and E.
3. For each of the last three calendar years (2019, 2018, 2017) please disclose the total number of patients admitted to A and E that were not GP registered.

Download response Complaints for patients admitted to A&E.241219

1. In your trust, in each of the last 5 calendar years, how many formal patient/family complaints were made regarding communication?
2. How many of these complaints were regarding lack of updates to Next of kin or patient families?
3. In your trust in the last 5 years, what were the top 5 categories for complaints? For example, ‘communication’ or ‘clinical care’ may be examples

Complaints made regarding communication.201222.docx

Please detail the number and type of complaints made to your End of Life Care Strategy Group in the last four years. Please break the information down into complaints per month (where possible) and whether the complaint was to do with, for example poor communication, issues to do with consent or the care itself etc. Where recorded, please also detail the outcome of the complaint.

Download response Complaints made to the End of Life Care Strategy Group. 070219

1) Name of:
a) Your trust
b) The hospitals in your trust
2) Between April and October 2015, how many complaints/concerns were raised by Trust staff members regarding?
a) Staffing levels/staffing shortages
b) Shifts being filled by under-qualified staff/staff “acting up”/agency staff/locums
c) Staff overwork/unpaid overtime
d) Staff not being able to take breaks
3) What is the longest time (in days) one patient has remained in a bed at your NHS Trust due to delays in transfer of care (DTOC) from September 2014 to September 2015?
4) What was the age of the patient (from question 3) and the reason for delay?
5) What is the longest time (in days) one patient has remained in a bed at your NHS Trust due to delays in transfer of care (DTOC) from September 2013 to September 2015?
6) What was the age of the patient (from question 5) and the reason for delay?

Download response Complaints or concerns raised by staff members 270516

Q1.) For each of the past five years please state the number of complaints reported by members of staff (including locums, agency workers or casual staff) against other members of staff received of:
2016 2017 2018 2019 2021
a) Sexual Misconduct
b) Sexual Harassment
c) Sexual Assault
d) Rape Allegation
Q2.) By year for each of the complaints recorded above can you state the outcome following each allegation:
a) Complaint withdrawn
b) Insufficient evidence to make a finding of fact.
c) Perpetrator cautioned – or similar note made on their employment file
d) Disciplinary action
e) Sacked
Q3.) By year can you state in each category in the table how many of the complaints were referred to the police?
Q4.) By year, please state the number of settlement/compromise agreements which contain non-disclosure clauses your organisation made with current or former staff which involve or relate to sexual misconduct, sexual harassment, sexual assault, rape. For each of these, please state the number and financial value of the settlements.

Complaints reported by members of staff (including locums, agency workers or casual staff) against other members of staff. 030322.docx

1. How many people does your organisation employ?
2. What is the total annual expenditure budget of your organisation?
3. How many full-time employment staff does your organisation employ dedicated to counter fraud activities?
4. If you employ such staff, how many full-time employment staff are directly employed by your organisation?
5. If any of your counter fraud staff are supplied by another organisation, could you identify the name of the organisation(s) which supplies them?
6. Approximately how much did you spend on counter fraud activities in the last reporting year?
7. How many referrals for fraud investigation has your counter fraud team received in the last reporting year?
8. How many fraud cases has your counter fraud team successfully investigated? I.e. leading to sanction and/or recovery of monies in the last reporting year.

Download response Counter Fraud. 030619

1. Staff headcount at your organisation?
2. Annual budget of your organisation for the financial year 2019-2020?
3. What is your organisation provider type (as recorded on your SRT submission – i.e. Acute teaching, Ambulance)?
4. Who provides your organisations counter fraud provision? (In house – NHS consortium – Private provider)
5. How many days were recorded for proactive counter fraud work (Strategic governance, Inform and Involve & Prevent & Deter) carried out at your organisation during the financial year 2019-20?
6. How many days were recorded for carrying out reactive investigation work at your organisation during the financial year 2019-20 (hold to account)?
7. How many counter fraud referrals did your organisation receive during the financial year 2019-2020?
8. What was the recorded fraud loss identified by your organisation during the financial year 2019-2020?
9. What was the amount of fraud losses recovered by your organisation during the financial year 2019-2020?
10. How many criminal sanctions relating to fraud, bribery and corruption did your organisation apply during the financial year 2019-2020?
11. How many disciplinary sanctions relating to fraud, bribery and corruption did your organisation apply during the financial year 2019-2020?
12. What was the cost of counter fraud staffing or outsourced counter fraud provision to your organisation during 2019-2020 for – Strategic Governance, Inform and Involve and Prevent and Deter?
13. What was the cost of counter fraud staffing or outsourced counter fraud provision to your organisation during 2019-20 for – Hold to Account?

Download response Counter fraud provision. 230920

1. “Since 01 January 2017, please specify the number of individual cases where the Court has had to intervene in the treatment of a critically ill child, when there has been a difference of opinion between parents and doctors, over the course of treatment for that child?”

Download response Court intervention. 141119

1. Since 1.1.15 how many times have you taken court action to evict a patient from a hospital in your trust because you believe they are fit for discharge but they have failed to leave their hospital bed? For each occurrence please state how many days they had occupied a hospital day for while considered fit for discharge?
2. Of those patients discharged from your hospital in either 2014/15 or 2015/16 please state how many patients had been considered fit to discharge but remained in hospital in excess of one full calendar year before they were discharged? For each patient please state how many days they occupied a hospital bed while considered fit to discharge?
3. Using the most recent convenient date do you have any patients in your hospital who are considered fit to discharge but have been in hospital and been fit to discharge in excess of one full calendar year? For each patient please state how many days they have occupied a hospital bed while considered fit to discharge?

Download response Delayed discharge and court action. 070317

1. For each of the past five financial years, what was the total number of employees that left your trust through judicial mediation?
2. For each of the last five financial years how much was paid to departing employees through judicial mediation? Again, I am looking for annual breakdowns of the data.
The annual breakdown should include the following three elements;
A – The statutory amount the employee received (i.e. the sum to which they were legally entitled for redundancy).
B – The amount paid in special severance payments.
C – The overall total of statutory and special severance payments.
3. For each of the past five financial years, how many of the employees who left through judicial mediation signed a settlement agreement (formerly known as a compromise agreement)?
4. For each of the past five financial years, how many employees who left through judicial mediation agreed a confidentiality clause?
5. Taking the definition of confidentiality clauses used in Question 4, for each of the past five financial years, how many fell under the definition 1? 2? 3? Other?
6. For each of the past five financial years, how many staff who left via judicial mediation received an agreed reference?
7. For each of the past five financial years, how many of the judicial mediation cases were referred to the Department for Health/Treasury for sign off?

Download response Employees who have left the Trust as a result of judicial mediation 2011 – 2016

The number of patients who have been taken to the Royal Courts of Justice Court of Protection, to have a DNR placed upon their lives by your hospital. I would like to know if the patient had a Lasting Power of Attorney and the sex, age, ethnicity of the patients and the length of time each case took & outcomes of each case. From when the hospital opened to the present day.

Download response Enforced DNR. 300317

In the recent BBC health news, published on 23rd May 2023, suggesting that more than 35,000 incidents of sexual misconduct and sexual violence were recorded on NHS premises between 2017 to 2023.
I seek information regarding the ethnicity or national identity of the perpetrators and the victims in cases of sexual misconduct and violence in your Trust.

Ethnicity or national identity of the perpetrators and the victims in cases of sexual misconduct and violence.060723.docx

1. What is your spend with external law firms
2. Do you use eBilling technology to manage your law firms billing (e.g. systems such as Legal Tracker, Brightflag, Apperio, CT Tymetrix, Mitratech etc.)
3. Who is your head of legal / general counsel
4. Do you have a law firm panel / preferred supplier list / use a framework to buy your external law firm services

Download response External law firm services. 161121.docx

1. How many members of staff are directly employed at the Trust at present as of 24 August 2015?
2. What was your external legal advice expenditure from 01/04/2014 to 31/03/2015?
3. What is your budget for external legal advice for the current financial year?
4. Please provide the list of the solicitors instructed for external legal advice from 01/04/2014 to 31/03/2015.
5. Please provide the full structure of your legal services team (titles of the positions- no names are required).
6. Please provide your Trust’s policy which relates to the process of provision of internal legal advice to the members of staff within your Trust.
7. Please provide the name of the software or system which you use for the claims management.
8. Please provide the annual cost of your claims management system.
9. Please provide the name of the software or system which you use for the complaints management.
10. Please provide the annual cost of your claims management system.
11. How many active Coroner’s Inquest cases are you managing at your Trust as of 24 August 2015?
12. How many active clinical negligence claims against your Trust as of 24 August 2015 (claims reported to the NHSLA)?
13. How many active clinical negligence claims against your Trust as of 24 August 2015 (claims not reported to the NHSLA)?
14. How many active Employer’s Liability claims against your Trust as of 24 August 2015 (claims reported to the NHSLA)?
15. How many active Employer’s Liability claims against your Trust as of 24 August 2015 (claims not reported to the NHSLA)?
16. How many active Public Liability claims against your Trust as of 24 August 2015 (claims reported to the NHSLA)?
17. How many active Public Liability claims against your Trust as of 24 August 2015 (claims not reported to the NHSLA)?
18. Please attach a relevant policy and a flowchart which describe the process of how your legal services team communicates the lessons learned from the claims and coroner’s inquests to the relevant teams across the Trust, to ensure the effective risk management and prevention of similar incidents and to improve care provided.
19. Please provide two, most recent, monthly claims management/ legal services reports. If you do not have monthly reports please provide two most recent quarterly reports.

Download response External legal advice 280716

1. What does your organisation spend on legal fees e.g. external legal advice and what is the breakdown of fees and expenses.
2. What is the breakdown of spend e.g. what percentage of work is completed on an hourly rate basis, capped fee, fixed fee etc. We do not break it down in these terms.
3. Who in your organisation is responsible for managing external legal spend-
4. What controls do you have in place to manage external legal counsel spend?
5. Do you use any of the eBilling (also known as Enterprise Legal Management or Legal Spend Management) tools (e.g. Serengetti, Mitratech, CT Tymetrix, Datacert etc.) available in the market to manage your legal spend – if yes what are you currently paying for this system and does the vendor charge your firms to use the same
6. Do you use a matter management system and if yes how much do you pay for the system.
7. How do you decide if work is completed internally or by external counsel?
8. What performance management do you complete with your external legal counsel to ensure you are receiving value for money?
9. What is the breakdown of spend e.g. % of time billed by partner, by senior associate, junior associate, trainee and paralegals etc.
10. What is the breakdown of your legal spend by location e.g. how much work is performed in London, Manchester, Birmingham, Edinburgh, Glasgow, Cardiff, Belfast etc.
11. How do you measure what value added services law firms provide to you (e.g. free advice, free training, free secondees etc.)
12. Do you use external consultants to advice on how to manage your legal spend more effectively. If yes, who and what have you spent with them in the last 12 months

Download response External legal spend 180216

1) How many official complaints and PALS concerns your Trust received from patients alleging they had been discriminated against or badly treated by a member of staff because of their being overweight or obese
2) Can you select the first five such complaints from 2021 and provide me with the following details:
a. What type of staff member was the complaint levelled against? E.g. healthcare assistant, junior doctor, consultant, cleaner, kitchen staff
b. Please quote the words allegedly used by the hospital staff or summarise the offending action
c. Please tell me what, if any, action was taken by your trust in response to these five sample complaints from the beginning of 2021

Fat shaming 2021.270522.docx

Could you please tell me for the calendar year 2019:
1) How many complaints through the patient advice and liaison system (PALS) your Trust received from patients alleging they had been discriminated against or badly treated by a member of staff because of their being overweight or obese
Please do this by searching for complaints containing any of the words “weight”, “fat”, “obese”, “overweight” and “bariatric” and filtering these to find those that refer to fat-shaming comments made by a member of staff.
2) Can you select the first five such complaints from 2019 and provide me with the following details:
a. What type of staff member was the complaint levelled against? E.g. healthcare assistant, junior doctor, consultant, cleaner, kitchen staff
b. Please quote the words allegedly used by the hospital staff or summarise the offending action
c. Please tell me what, if any, action was taken by your trust in response to these five sample complaints from the beginning of 2018

Download response Fat shaming complaints. 020620

1) How many complaints through the patient advice and liaison system (PALS) your Trust received from patients alleging they had been discriminated against or badly treated by a member of staff because of their being overweight or obese
Please do this by searching for complaints containing any of the words “weight”, “fat”, “obese”, “overweight” and “bariatric” and filtering these to find those that refer to fat-shaming comments made by a member of staff.
2) Can you select the first five such complaints from 2020 and provide me with the following details:
a. What type of staff member was the complaint levelled against? E.g. healthcare assistant, junior doctor, consultant, cleaner, kitchen staff
b. Please quote the words allegedly used by the hospital staff or summarise the offending action
c. Please tell me what, if any, action was taken by your trust in response to these five sample complaints from the beginning of 2020

Download response Fat shaming complaints. 140521

Could you please tell me for each of the years 2016, 2017 and 2018

How many complaints through the patient advice and liaison system (PALS) your trust received from patients alleging they had been discriminated against or badly treated by a member of staff because of their being overweight or obese.

Please do this by searching for complaints containing any of the words “weight”, “fat”, “obese”, “overweight” and “bariatric” and filtering these to find those that refer to fat-shaming comments made by a member of staff.

Can you select the first five such complaints from 2018 and provide me with the following details:

1. What type of staff member was the complaint levelled against? E.g. healthcare assistant, junior doctor, consultant, cleaner, kitchen staff

2. Please quote the words allegedly used by the hospital staff or summarise the offending action

3. Please tell me what, if any, action was taken by your trust in response to these five sample complaints from the beginning of 2018

Download response Fat-shaming complaints. 210519

1. How many inpatients developed food poisoning (relating to E.coli, listeria, campylobacter, salmonella or other) during a stay at the hospitals in your trust between the end of May 2018 and the end of May 2019?
2. How many inpatients developed food poisoning (relating to E. coli, listeria, campylobacter, salmonella or other) during a stay at the hospitals in your trust between the end of May 2013 and the end of May 2014?
3. Are meals prepared on site or off the premises by an outside provider?
4. How many complaints did you receive about hospital food between the end of May 2019 and the end of May 2018?
5. How many complaints did you receive about hospital food between the end of May 2013 and the end of May 2014?

Download response Food poisoning. 020819

All questions are shown as received by the Trust.
1. The number of Formal Grievances lodged by employees at Maidstone and Tunbridge Wells NHS Trust since the 1st January 2015.
2. The number of occasions on which the Trust employed the use of a protected conversation in their handling of a Formal Grievance by an employee in the same time period.
3. The number of those protected conversations which went on to lose their legal protection as a result of improper behaviour on behalf of the Trust’s representative. Improper conduct includes but is not limited to:
• all forms of harassment, bullying and intimidation, including through the use of offensive words or aggressive behaviour;
• physical assault or the threat of physical assault and other criminal behaviour;
• all forms of victimisation;
• discrimination because of age, sex, race, disability, sexual orientation, religion or belief, transgender, pregnancy and maternity and marriage or civil partnership; and
• putting undue pressure on a party

Formal Grievances.080923.docx

1. The number of all the Grievance complaint cases dealt with by MTW Trust in the last five years?
2. The outcome of these cases:
a. Numbers and percentage of Grievance cases accepted
b. Numbers and percentage of Grievance cases upheld
c. Number of staff members suspended, demoted or sacked within a year of making a grievance complaint.
3. Numbers and percentage of cases made by BME members of staff.
4. Outcome of BME grievance complaints in numbers and percentage as successful or upheld
5. Number of BME staff members suspended, demoted or sacked within a year of making a grievance complaint.

Download response Grievance complaints in the last five years 270616

1. Please can you detail the number of grievances & bullying and harassment complaints that have been raised in the last 5 years.
1st April 2018 – 31st March 2019
1st April 2019 – 31st March 2020
1st April 2020 – 31st March 2021
1st April 2021 – 31st March 2022
1st April 2022 – 31st November 2022
2. How many of the above cases remain unresolved as of 31st November 2022.
3. What number of employees, who have raised a grievance or B&H complaint since 1st April 2018, remained at the Trust, in their same role, one year after their complaint was concluded?
4. What number of respondents* involved in grievance or B&H complaints since 1st April 2018, remained at the Trust, in their same role, one year after their complaint was concluded?
*respondent refers to the person who is the subject of the grievance or bullying and harassment complaint.

Grievances and bullying and harassment complaints.141222.docx

I understand the HSIB have written a “letter of concern” to MTW about maternity services (particularly about Crowborough Birthing Centre).

Under the FOI, could I see a copy of their correspondence please and the Trust’s response.

Download response Healthcare Safety Investigation Branch (HSIB). 220921.docx

Background Information:
How many clinical staff do you employ and how many are BAME? (inc locum/bank/agency)?
Questions:
1.How many BAME staff and how many non BAME staff have been working in ‘Covid wards’:
• In March/In April/In May so far.
2.How many redeployment requests were received from BAME and non BAME staff (inc locums/bank/agency)? And how many have been redeployed as a result?
• In March/In April/In May so far.
3.Since the NHS England guidance on Risk Assessments was issued during the Covid crisis, how many Risk Assessments have you carried out of your BAME staff?
4.How many BAME staff (inc locums/bank/agency) have been successfully redeployed since this Risk Assessments guidance was issued, as a direct result of it?
5.How many complaints or reports of discrimination by BAME and non BAME staff (inc locum/bank/agency) have been made regarding deployment since Covid hit i.e start of March?

Download response BAME staff. 131120

Q1. Please state (yes or no) whether your trust has carried out a risk-assessment of staff at potentially greater risk of COVID-19, including people from Black, Asian and Minority Ethnic backgrounds. [If answer to Q1 is yes, please answer questions 2-5]
Q2. Please state when this risk assessment was carried out.
Q3. Please provide a short summary of what the risk assessment entailed.
Q4. Please provide a copy of the findings of the risk assessment.
Q5. Please list and provide brief details of any measures that your trust has subsequently put in place to offer protection to staff who are at higher risk from COVID-19.

Download response BAME staff risk assessments. 100620

“1) Bed Capacity – last 5 years: Please provide average bed capacity for the previous five years as follows:
Total Bed Capacity (all wards).
Covid-19 Bed Capacity
2) Bed Capacity for 2021: Please provide bed capacity for the current year so far. For comparative purposes please use the following period each month: The first Wednesday of every month between the hours of 12noon and 4.00pm.
Total Bed Capacity (all wards)
Covid-19 Bed Capacity
3) Hospital Admissions – last 5 years: Please provide number of Admissions (all causes) for the previous five years as follows:
All Admissions
Admissions – where the patient has received 1 or more dose of an authorised Covid-19 Vaccination
Admissions – where the patient has NOT received any Covid-19 vaccination
4) Hospital Admissions for 2021: Please provide total number of admissions (for all causes) by month for the current year so far, split by Covid-19 vaccinated and unvaccinated.
All Admissions
Admissions – where the patient has received 1 or more dose of an authorised Covid-19 Vaccination
Admissions – where the patient has NOT received any Covid-19 vaccination
5) PCR Result of Hospital Admissions: Please provide breakdown of number of patients testing positive/negative with a Covid-19 PCR Test 2019 and 2020
Number of Patients testing positive with a Covid-19 PCR Test
Number of Patients testing negative with a Covid-19 PCR Test
6) PCR Result of Hospital Admissions for 2021: Please provide breakdown of number of patients testing positive/negative with a PCR test for the current year
At the time of Admission
No of Patients testing positive
No of patients testing Negative
7) Covid-19 Specific Admissions: Please provide total number of patients admitted where the primary reason for treatment was Covid-19 in 2019 and 2020.
Total number of Admissions where the primary treatment was for Covid-19
8) Covid-19 Admissions for 2021: Please provide number of Covid-19 admissions for 2021 where the primary reason for treatment was Covid-19
Total number of patients admitted where the primary reason for treatment was Covid-19”

Bed capacity and hospital admissions.110722.docx

Could I please ask for an honest breakdown of your covid admissions? A surgeon in your employment has shared the above information and I’d just like to know how many are completely unvaccinated and who have had one or more vaccinations.

Completely unvaccinated Covid-19 admissions and those who have had one or more vaccinations. 170322.docx

Due to recent concerns and government changes in advice related to working (regarding the Coronavirus), we are putting together our plan for our staff that are working from outreach locations.

We are getting in touch with all outreach locations our staff work from to ask for their plans/policies in light of the Coronavirus. Are we able to get your plan also?

Download response Coronavirus outreach working. 310320

1. The number of patients in your hospital(s) who tested positive for Covid-19, having tested negative at their time of admission
2. The number of these patients who subsequently died from Covid-19.

Download response Coronavirus transmission in hospital. 071020

1. Confirmation that all reported cases of SARS-COV2 in your Trust have been diagnosed and confirmed by PCR test;
2. If not with a PCR test, provide details of what method was employed to confirm the presence of SARS-COV2;
3. Details of the laboratories performing the PCR tests producing the confirmation of SARS-COV2 on behalf of your Trust;
4. Details of the Ct thesholds currently employed in the PCR tests performed by the labs at 3.;
5. Details of the Ct thresholds used to confirm all reported cases of SARS-COV2 in your Trust between 01/01/2020 and 18/12/2020;
6. Details of the manufacturers of the PCR tests used to confirm the presence of SARS-COV2 in your Trust;
7. In the document “Understanding cycle threshold (Ct) in SARS-CoV-2 RT-PCR” published on the UK government website, page 7 includes the statement “Some commercial RT-PCR techniques are closed ‘black box’ systems whereby the operator cannot observe the reaction in real-time and the result is interpreted by software into a qualitative non-interrogatable positive or negative result.”
a. Please confirm which manufacturers have been engaged that employ such a ‘black box’ method,
b. which labs have used such a manufacturer, and
c. which results confirming the presence of SARS-COV2 in the UK have been based on such techniques;
8. Where such results have been produced using the ‘black box’ method, please describe what further action was taken to confirm the results produced by the ‘black box’ method.

Download response Covid-19. 020321

1. The number of hospital patients who tested positive for Covid-19 after initially testing negative between November 30 2020 and 31 January 2021.
2. The number of these patients who subsequently died
3. If available, please could I have details of the date of admission, the reason for their initial hospital admission e.g. fractured bone, chest infection, the date of the positive test and the date of their death.

Download response Covid-19. 040221

1. How many people have dies from Covid-19 in the Maidstone & Tunbridge Wells NHS Trust hospitals from 1st January 2020 to 1 May 2021? This is only to include patients who have had Covid-19 tests and have not died with pre-existing conditions.
2. How many patients at Maidstone & Tunbridge Wells NHS Trust hospitals are currently there, currently confirmed with Covid-19?

Download response Covid-19. 110621

1. Please can you provide a breakdown of data of actual Covid-19 cases that the Maidstone and Tunbridge Wells Trust have dealt with since the start of the pandemic? This includes the following:
Actual cases
By age group
Survival rates by age group
Death rates by age group and if they have underlying conditions (comorbidities)

2. Can you also confirm what treatments you are using to treat real cases.

Download response Covid-19. 130121

1. Number of beds that are currently being used for COVID-19 patients across the health authority covering Tunbridge Wells and Maidstone
2. The information for the number of beds that were being used for the same winter period last year
3. The actual number of fatalities due to COVID-19 this year for this area.
4. The number of flu cases last year that resulted in death for the same period
5. The numbers of COVID-19 cases pre lockdown and post lockdown

Download response Covid-19. 150221

1. How many people have died from Covid 19, without any pre-existing medical conditions?
2. How many Covid 19 patients are you currently treating at hospitals in the Trust (Maidstone and Tunbridge Wells)?
3. How many of those patients are in intensive care units?
4. What is the total number of beds available in the Trust?

Download response Covid-19. 181220

Since 1 March 2020 up to the present day (17th December)
1. Please can you tell me how many patients with respiratory conditions were admitted to covid-19 wards at the trust.
a. Please include the date they were admitted.
b. Please can you also tell me how many of these patients were tested for covid-19
c. please also include the date of the first test,
d. the date of the result
e. whether the result was positive or negative.
If you are unable to answer these questions,
2. Please could you tell me how many patients with respiratory conditions were admitted to covid-19 wards at the trust?
3. How many of these patients tested positive for covid-19 before they were admitted to a covid-19 ward.

Download response Covid-19. 220421

How many people have been admitted to the Trust’s Hospitals with Covid 19 since the 1st August 2020 and how many have survived or died as a consequence please up to today’s date of the 18th August 2020.

Download response COVID-19. 220920

You asked:
Please can you supply me with the following monthly data for the trust, for March, April, May, June, July, August, September, October, November and December 2020?
1. How many people were unable to have treatments for illnesses and conditions due to the Covid-19/Coronavirus crisis?
2. How many of these cases were for life threatening illnesses and conditions?
3. How many people had further health complications because of missing these treatments?
4. How many people died because of missing these treatments?
5. How many mental health admissions were due to COVID 19/coronavirus issues?
6. How many Covid 19/Coronavirus patients were in intensive care units?
7. Total number of beds in the trust at the time?
8. How many of these beds were occupied?
If applicable, could you also provide the following:
9. Community Occupancy %
10. Adult Mental Health Beds Occupancy %
11. Older Adult Mental Health Occupancy %
12. How many of the patients died FROM Coronavirus/Covid-19
13. How many of the patients died WITH Coronavirus/Covid-19

Download response Covid-19. 260321

1) Between 1 March 2020 and 1 March 2021 (or the most recent date for which figures are available), how many Covid-19 infections in patients were hospital acquired?
i) of these, how many were probable infections (i.e. within 8-14 days of admission to hospital)?
ii) and how many were definite infections (15 days or more after admission to hospital)?
2) Of those who acquired Covid-19 while in hospital between 1 March 2020 and 1 March 2021 (or the most recent date for which figures are available), how many died?
3) What was the total number of Covid-19 deaths at your trust between 1 March 2020 and 1 March 2021 (or the most recent date for which figures are available)?
4) How many members of staff contracted Covid-19 between 1 March 2020 and 1 March 2021 (or the most recent date for which figures are available)?
5) How many members of staff were absent from work due to Covid-19 between 1 March 2020 and 1 March 2021 (or the most recent date for which figures are available)?
6) How many members of staff died due to Covid-19 between 1 March 2020 and 1 March 2021 (or the most recent date for which figures are available)?
7) What is the total number of Covid-19 infections a) among patients and b) among staff recorded at your trust between 1 March 2020 and 1 March 2021?

Download response Covid-19. 30.04.21

Please provide me with freedom of information on the evidence that COVID-19 has been isolated (a pure sample containing no other genetic material other than COVID-19 i.e. just COVID-19).

Download response Covid-19. 300421

1) How many covid-19 outbreaks have there been in care homes in your region between March 1st and June 16th 2020?
2) How many care homes did you provide oxygen to as a result of covid-19 outbreaks between?
a) March 1st to April 15th
b) April 15th to June 16th
3) How many hospital patients were discharged to care homes between?
a) March 1st to April 15th
b) April 15th to June 16th
4) How many hospital patients discharged to care homes were tested for covid-19? Please give totals for:
a) March 1st to April 15th
b) April 15th to June 16th
5) How many of the test results in Q4 were:
a) positive
b) negative
c) inconclusive/ void
6) How many of the hospital patients discharged to care homes who tested positive for covid-19 were asymptomatic?
7) How many covid-19 related ambulance call-out requests did you receive from care homes between?
a) March 1st to April 15th
b) April 15th to June 16th
8) How many of the call-out requests referred to in Q6 did you send an ambulance to between?
a) March 1st to April 15th
b) April 15th to June 16th
9) How many care home residents did you admit to hospital between March 1st to June 16th. Please give totals for:
a) Those with suspected or confirmed covid-19
b)Non-covid-19 related patients

Download response Covid-19 and patients resident in care homes. 240620

1. The number of pregnant women your trust has treated for Covid-19 between 1st March 2020 and 31st January 2021?
2. The number of pregnant women your trust has treated in ICU for Covid-19 between 1st March 2020 and 31st January 2021?
3. The number of women who had recently given birth that required treatment for Covid-19 by your trust between 1st March 2020 and 31st January 2021?
4. The number of women that had recently given birth and required treatment for Covid-19 in ICU at your trust between 1st March 2020 and 31st January 2021?
5. The number of maternal deaths in your trust where Covid-19 or a Covid-19 related illness was recorded as the cause of death between 1st March 2020 and 31st January 2021?
6. The total number of maternal deaths (from all causes) in your trust for the period 1st March 2020 to 31st January 2021?
7. The total number of maternal deaths (from all causes) in your trust for the period 1st March 2019 to 31st January 2020?
8. The number of pregnant workers in your trust (employees, agency workers, self-employed or locum) that are currently in patient-facing roles?

Download response Covid-19 and pregnancy. 310321

I would like to know how many people died of covid-19 in this trust with no pre-existing health conditions from march 2020 until present and how many suicide deaths you have had vs the same time frame can I also have this in age breakdown please.

Download response Covid-19 and suicide deaths. 160621

Of the Covid-19 antibody tests conducted to date among staff at your trust, please provide information on:

• The proportion of staff that are antibody positive
• The proportion of BAME staff who are antibody positive

Download response Covid-19 antibody testing. 150720

1. The number of actual deaths within the trust (for both hospitals) due to Covid-19 for the period February 2020 to September 2020 (inclusive).
2. All Deaths from October 2020 to present.

Download response Covid-19 deaths. 101220

I would like to know how many deaths the hospital has recorded of Covid 19 in the months between February 1st and December 1st.

Download response Covid-19 deaths. 1012202

The actual number of Covid-19 deaths for the period- February 2020 to November 2020 within the Maidstone and Tunbridge Wells Trust In addition the number of Covid-19 deaths with underlining medical conditions.

Download response Covid-19 deaths. 1012203

How many people have died in your hospitals from Covid 19 alone? As in they died only due to Covid 19. I can see the figures that you publish online, but these are deaths within 28 days of a positive Covid test, so they could have died from other causes. I just want to know the exact figure from 1st February 2020 until the 20th December of people that have died due to Covid-19 and not anything else please.

Download response Covid-19 deaths. 130121

I would like to enquire as to the amount of Covid 19 deaths with no pre-existing health conditions.

Download response Covid-19 deaths. 151220

I am writing to ask how many deaths you have had of covid-19 or coronavirus since March 2020.

Download response Covid-19 deaths. 151220

All questions pertain to the following dates: 01/12/2019 to 30/11/2021. I would like to know the following:
1.a) How many people have died in your hospitals within 28 days of testing positive for COVID-19?
1.b) Of those people, how many had underlying health conditions / co-morbidities and how many did not? Please provide absolute numbers and percentages.
1.c) Please also state the top 5 underlying health conditions / co-morbidities of those people.
1.d) Please state how many of those people were vaccinated and how many were not. Please provide absolute numbers and percentages. For vaccinated people, please break down the response in the following way: i) received one dose, ii) received two or more doses.
2.a) How many people have died in your hospitals purely and only due to COVID-19?
2.b) Of those people, how many had underlying health conditions / co-morbidities and how many did not? Please provide absolute numbers and percentages.
2.c) Please also state the top 5 underlying health conditions / co-morbidities of those people.
2.d) Please state how many of those people were vaccinated and how many were not. Please provide absolute numbers and percentages. For vaccinated people, please break down the response in the following way: i) received one dose, ii) received two or more doses.

Please keep the numbers/figures/percentages/etc. provided in response to questions 2.a-d separate from the numbers/figures/percentages/etc. provided in response to questions 1.a-d. If that is not possible, please clearly indicate which numbers are combined.

Covid-19 deaths.200522.docx

I am requesting that within the dates of 01/03/2020 – 01/11/2021 can you supply the total number of deaths from COVID-19 alone, not within 28 days of a positive test, from all the hospitals in your trust.

Download response Covid-19 deaths. 221221.docx

I am writing to ask how many patients admitted to the Trusts hospitals to date have died of COVID-19 (SARS COV2) I am excluding patients who died from something else and at the time tested positive for covid-19.
I am excluding cases where covid-19 is mentioned on the death certificate but the patient did not test positive.

Download response Covid-19 deaths. 241220

• How many people have died in your hospital only due to Covid 19 alone? As in they died only due to Covid 19.
I can see the figures that you publish online, but these are deaths within 28 days of a positive covid test, so they could have died from other causes. I just want to know the exact figure from 1st February 2020 until 30th November 2020 of people that have died due to covid 19 and NOT anything else please.

Download response Covid-19 deaths. 311220

Under the freedom of information act, please could you send me the exact numbers of people who have died of Covid 19 or Corona virus from February 2020 to December 31st 2020.

I would like the numbers you provide to only include people who have died without any other underlined illnesses.

Download response Covid-19 deaths. 311220 2

1. How many patients have been reported to have died from “Covid -19” as the main / primary cause of death with no major underlying health issues between March 2020 – December 2020?
2. How many patients have been reported to have died from “Covid -19” as the main / primary cause of death with no major underlying health issues between January 2021 – June 2021?
3. How many patients have been reported to have died having suffered severe adverse effects from the covid-19 “vaccinations? From January 2021 – June 2021?
4. How many patients have reported and been hospitalised following adverse effects from the Covid-19 “vaccinations? From January 2021 – June 2021?

Download response Covid-19 deaths and adverse vaccination effects. 020721

1. Please could you give me the number of deaths whereby covid is the sole cause of death listed. There were no pre-existing conditions or comorbidities noted on the death certificate covering the period March 2020 until present day. Please also provide the average age of death.

2. I would also like the number of cycles you run your PCR tests on normally as well as the number of cycles you run when you are aware the patient has been vaccinated.

If there is a difference between cycles used on patients compared to vaccinated patients please explain why.

Download response Covid-19 deaths and PCR testing. 020721

Please could you send me the figures for all hospitals covered under the Maidstone and Tunbridge Wells trust.
1. How many pregnant ladies have died of covid with no pre-existing medical conditions in 2020 and 2021.
2. How many new born babies with no medical conditions have died of covid in 2020 and 2021.
3. How many still births you have had as a result of a pregnant mother having covid in 2020 and 2021.
4. The total number of still births for the last 5 years per year.

Download response Covid-19 deaths and still births. 041021.docx

1. I would like to know how many people died of cover 19 in this trust with no pre-existing health conditions from March 2020 until present.
2. How many suicide deaths you have had vs the same time frame can I also have this in age breakdown please.

Download response Covid-19 deaths and suicides. 160621

1. I would like to know how many people have died in your hospitals from COVID-19 alone. As in they died only due to COVID-19. I can see the figures that you publish online, but these are deaths within 28 days of a positive COVID test, so they could have died from other causes. I just want to know the exact figure from 1st February 2020 until 28th March 2021 of people that have died due to COVID-19 and not anything else.
2. The percentage & number of people with underlying health conditions in the overall total.
3. The percentage & number of those without underlying health conditions.
4. If someone had died outside of the 28 days of testing positive would COVID-19 still be their cause of death i.e. Covid-19 (pneumonia) or would it just be pneumonia?
5. Lastly, the vaccination is authorised for emergency use only and is still in live clinical trials until 2023, do you make patients aware of this before they are given their vaccine?

Download response Covid-19 deaths and vaccinations. 060421

We would like to know between the dates of Jan 1st 2020 and March 1st 2021 the number of healthcare workers employees within your trust have died due to COVID-19.

Download response Covid-19 deaths of staff members. 170321

1) Between 01/02/2020 to 01/07/2020, how many patients were discharged from hospitals run by your Trust into care homes? Please provide a weekly breakdown.
2) Of those patients who were discharged into care homes in the specified period, how many were tested for COVID-19 prior to leaving hospital? Please provide a weekly breakdown.
3) Finally, please tell me how many tested positive but were nonetheless discharged into care homes. Please provide a weekly breakdown.

Download response COVID-19 discharges into care homes. 120820

Could you please reply to this email attaching a copy of your hospital’s full local guidelines on the following topics?
1. Current local guidelines for the treatment and management of Covid 19.
2. Current local infection control guidelines regarding testing and quarantining/isolation of Covid positive patients

Covid 19 Local guidelines. 140422.docx

1) Is your hospital still running the PCR tests for SARS-Cov-2 at 40-45ct cycles?
2) Is the NHS still classifying any death as a Covid death for anyone who has tested positive with a PCR test within the past 28 days, as previously stated in the March 2020 update on the NHS website about dealing with excess deaths?
3) Is the NHS aware that the PCR is a non-diagnostic test and becomes 100% unreliable after 27ct cycles?
4) How does the NHS testing system determine which variant a patient has and is this via the PCR tests?
I am aware of the online statistics site where a lot of information can be found, however i would like some more detailed information regarding specifics so my following questions are;
5.a) How many people have died in your hospital from Covid alone since February 1st 2020 to December12th 2021 without any other underlying conditions or possible causes of death?
b) How many of these patients were prescribed Midazolam?
6) What are the annual numbers of prescriptions of Midazolam for the past 10 years within your hospital?
7) What are the annual numbers of DNR’s issued in the past 10 years at your hospital?
8) Have the following viruses/strains, to your knowledge, been isolated or purified;
-SARS-Cov-2?
-Kent variant B117?
-Delta variant?
-Omicron variant?
9.a) How many patients have been admitted to your hospital for Covid and were vaccinated against it since December 5th 2020?
b) How many died while in your care?
10.a) How many patients have been admitted to your hospital for Covid and were unvaccinated against it since December 5th 2020?
b) How many of them died while in your care?
11) What are the annual numbers of patients diagnosed with myocarditis for the past 10 years within your hospital?
12) What are the annual numbers of blood clot related deaths for the past 10 years within your hospital?
13) What are the annual numbers of miscarriages for the past 10 years within your hospital?
14) What percentage of your beds are allocated for Covid patients?

Covid-19 PCRs, treatments and deaths.130622.docx

1) How many of your clinical staff have tested positive for COVID-19 at your Trust?
2 How many of those staff who tested positive, worked in clinical areas designed to cater for positive / likely positive Covid Cases?
3 How many of these positive staff, work directly in areas not designated to cater for non COVID-19 patients?

Download response COVID-19 positive staff. 101220

1 – The number of people who have entered MTW NHS Trust ICU’s with Covid-19 and been released back to wards alive and on the road to recovery.
2 – The number of patients who have recovered from Covid-19 and released from MTW NHS Trust hospitals.
3 – The numbers of people who have had a second infection from covid-19 and returned to a MTW NHS Trust hospital.

Download response COVID-19 recoveries. 150520

1 – The number of people who have entered MTW NHS Trust ICU’s with Covid-19 and been released back to wards alive and on the road to recovery.
2 – The number of patients who have recovered from Covid-19 and released from MTW NHS Trust hospitals.
3 – The numbers of people who have had a second infection from covid-19 and returned to a MTW NHS Trust hospital.

Download response COVID-19 recoveries. 150520

1) Please provide the number of patients admitted to any hospitals within your trust between 1st January 2021 and 21st December 2021, where the reason for hospitalisation is solely COVID-19 or any complication of this and not due to any other underlying issues. Please exclude from this number any patients who have had any complications or adverse reactions following the COVID-19 vaccine.
2) Please provide a breakdown of how many of those patients, during the period between 1st January 2021 and 21st December 2021, have been admitted after receiving one dose of the COVID vaccination, 2 doses, 3 doses and how many have not been vaccinated at all.
In order that there is no room for misunderstanding here about vaccination status, please use the following definitions in your reply:
• Unvaccinated means the patient has had no COVID-19 jab/vaccine/injection
• 1st Dose solely means a patient has been injected once against COVID-19, regardless of how many days have passed since the intervention or how many subsequent doses are available. (i.e., a single dose when a second one is available does not render them unvaccinated for the purpose of this FOI request)

• 2nd Dose solely means a patient has been injected twice against COVID-19, regardless of how many days have passed since the interventions or how many subsequent doses are available. (i.e., a double dose when a third one is available does not render them unvaccinated for the purpose of this FOI request)
3) Please provide the number of patients who have died at any hospital in your trust between 1st January 2021 and 21st December 2021 that are solely as a result of COVID-19 or any complications thereof and not due to other underlying health issues. Please also exclude any patients who have died as a complication of the COVID-19 vaccine.
4) Please provide the number of patients, for the same period mentioned above, who have died as a result of reactions or complications from the COVID-19 vaccine.
5) Please provide the number of patients who have died at any hospital in your trust from complications or adverse reactions arising from the COVID-19 vaccine.
6) Please note that for all the above questions, any reference to a patient with COVID-19 is a patient that has been confirmed as someone who has tested positive to a PCR test or Lateral Flow Test.
7) When there is confirmation of a positive test, please include whether it was through PCR or LFT and the number of cycles of amplification used when processing the results.

Download response Covid-19 related admissions, deaths and vaccinations. 070122.docx

1. Has your organisation completed risk assessments on all Black Asian and Minority Ethnic (BAME) staff?
2. What precautions, if any, have you put in place to protect BAME staff once they’ve been risk assessed?”

Download response COVID-19 staff risk assessment. 020620

1. Please can you tell me how many coronavirus tests the trust has used on patients between 1st March 2020 and today’s date (4th June 2020).
2. Please can you tell me both the number of patients that have been tested, and the number of tests carried out (i.e. if a patient has been tested more than once).
3. In each case, please can you tell me how long it took for the trust to receive the patients’ test result. If you do not have data for every patient please can you provide me with the average length of time it has taken to get test results for all patients.

Download response COVID-19 testing. 300720

Can you advise when it comes to Covid, are your hospitals actually treating cases and if you are not why not?

Download response Covid-19 treatments. 301220

1. Please can you provide me with all admissions in Maidstone hospital in the past 5 Years 2016-2020 with the current year so far?
2. Of those who died of any cause this year, how many had received the Covid -19 vaccine and how many were unvaccinated?
3. Out of those admitted in 2021 how many of them had got the vaccine?

Download response Covid-19 vaccinated and unvaccinated deaths. 270821.docx

1) What percentage of Trust all staff have had a) one dose b) two doses c) three doses of the Covid-19 vaccine
2) What percentage of each the following staff members have had two or more doses- Medical and dental, nursing and midwifery, healthcare scientists, pharmacists, admin and clerical, estates and ancillary, allied health professionals, students, additional professional scientific and technical, additional clinical services.

Covid-19 vaccination status of Trust staff. 220222.docx

Please can you tell me how many of your staff have declined to have a coronavirus vaccine. If possible, please give the reason why the vaccine was declined.

Download response Covid-19 vaccinations. 030321

Would it be possible to be provided with the following information please in relation to the hospital vaccination hubs being run by your trust?
1. Between 8 December and 8 January, how many doses of the Pfizer Covid vaccine were administered at each of your hospital vaccination hubs?
2. Between 8 December and 8 January, how many doses of the Pfizer Covid vaccine were destroyed/discarded/thrown away at each of your hospital vaccination hubs? Do you have a daily breakdown of these figures? If so, can I be sent these please?
3. In those instances where doses were destroyed/discarded/thrown away, what reasons were given for staff not being able to administer them to patients?

Download response Covid-19 vaccinations. 130121

1. How many NHS staff currently working at your trust remain unvaccinated with a Covid19 vaccine? Including bank/agency workers.
2. What percentage of your overall staff does this equate to?
3. Since the start of the pandemic (01/03/20), with your data from staff absence due to Covid19, contact tracing and Healthcare acquired infection (HCAI), what percentage of HCAI is directly attributable to Covid19 infection in an NHS frontline worker?
4. Since the vaccination programme has started (Approx. Dec 2020), what is the breakdown of this being from
a. a covid 19 vaccinated NHS worker
b. unvaccinated NHS worker?
5. If not directly attributable, what is the rate of your patients in non Covid19 wards/area getting a HCAI and becoming infected with Covid19 within a set time frame (~10days) of an NHS worker in that ward/area testing positive for Covid 19?
6. What is the breakdown of this being
a. a Covid19 vaccinated NHS worker
b. non-vaccinated NHS worker?

Download response Covid-19, vaccinations and Healthcare acquired infection (HCAI). 081221.docx

1. Please tell me what percentage of front-line staff at your trust have received their first dose of the Covid vaccine?
2. If possible, please tell me what percentage of a) doctors b) nurses and midwives c) other front-line staff have received their first dose of the Covid vaccine?
3. Please also tell me the total numbers of front-line staff who have received their first dose of the Covid vaccine and the total numbers of front-line staff who have not received their first dose of the Covid vaccine
4. If possible, please tell me the total numbers of staff who have received the first dose of the vaccine and who have not yet been vaccinated broken down by a) doctors b) nurses and midwives c) other front-line staff.
5. Please tell me what percentage of front-line staff at your trust have received their second dose of the Covid vaccine?
6. Again, if possible, please break this down by a) doctors b) nurses and midwives c) other front-line staff
7. Please also tell me the total numbers of front-line staff who have received their second dose of the Covid vaccine and the total numbers of front-line staff who have not received their second dose of the Covid vaccine
8. Please provide the total numbers for staff who have received their second dose and not yet received their second dose broken down by a) doctors b) nurses and midwives c) other front-line staff

Download response Covid-19 vaccine uptake. 200521

What steps you and your organisation will be taking to fulfil your ethical and legal obligations to ensure patient and staff submission to Covid vaccination is given with free, voluntary, and fully informed consent.

Covid Booster Informed Consent.131022.docx

All questions are shown exactly as received by the Trust.
i would like all latest data on covid cycle testing for vaccinated and unvaccinated people i am aware there will be 2 separate test cycles of amplification thank you.
Your response is in correct.i asked what are the current test cycle to date for omnicrom variant you have a base number for cycle amplification that you start with .you dont get a cycle numbed AFTER the test ,you have a start point and that is the data i am asking for. The starting amplification cycle number for un vaccinated people and the cycle start number for vaccinated.thank you..this will be fact checked by my associates thank you.

Covid cycle testing for vaccinated and unvaccinated people.221122.docx

I would like to know how many Covid-related capital bids have been approved centrally since March 17 and was hoping you could answer a few questions.

To avoid confusion, covid-19 related capital refers to bids submitted in respect of the covid-19 capital expenditure scheme https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/04/COVID-19-capital-reimbursement-process-27-04-20.pdf. All other types of capital bids should not be included.

In addition, can you please tell me?

• The total value of your Covid-related capital bids
• The total in funding you’ve received for Covid-related capital bids.
• How many bids you have made and how many are awaiting central approval.

Download response Covid-related capital bids. 091220

1. Is my DATA/DNA etc. kept on file, stored and shared in any way?
2. On the swab/tube (or before being placed into the tube) have the following: “Hydrogel”. or “Quantum Dot” used and or applied?
3. Do you have a “Magnetic Testing System” which “alters” your “DNA” via these “Covid Swab Tests”?
4. Are these `one hour Covid Swab Tests` (or for all tests?) stored and shared with my DNA and other information, third party or otherwise?

Download response Covid Swab Tests. 101220

1. Please confirm how many of the 1367 patients admitted from 1 January to 21 December 2021 were admitted where the sole reason for hospitalisation was COVID-19 or any complication of this, who were then confirmed by positive PCR test within 8 days. Please exclude from this figure any patients who were admitted due to other reasons who tested positive within 8 days, as well as any patients who may have been admitted due to adverse reactions following the COVID-19 vaccine.

2. According to your breakdown below, the grand total of patients who have received at least one COVID-19 vaccine was 651. Since you claim 1367 patients were admitted during the stated period who tested positive within 8 days, this would render 716 patients who were unvaccinated.
2a. The 10th column on your table stated 267 patients had no vaccine. Can you please confirm this is the case and also explain why these 267 patients have a category of “no vaccine” on their own and why the other 716 patients (total admissions – grand total provided by you) have not been included in this category?
2b. Can you confirm that the 716 patients, that is, the total admissions of patients who tested positive within 8 days (1367) minus the grand total of patients on your table (651) had not received any COVID-19 injection or booster? Just to clear and avoid misunderstandings, I am asking you to use the word unvaccinated to mean somebody who has not had any vaccine injected in their body at any time and conversely, vaccinated means someone who has had a vaccine irrespective of how long it has been since they had received it or the number of vaccines they have received.

3. Your answer to my third question was “Total number of patients admitted within 8 days of a positive swab from 1 January to 21 December 2021 who died – 149”.
Similarly, to question 1, this may include patients who had died due to complications of other issues such as cancer, a road traffic accident or a heart attack who had tested positive within 8 days of admission.
3a. Please confirm how many of the 149 patients you stated died solely due to COVID-19 or any complication thereof and exclude from this number any patient who died due to other medical conditions, including complications from taking a COVID-19 vaccine.

4. Your reply to my last question was “Confirmation of Sars CoV2 is by PCR testing. Cut off for positive is 28 CT”.
4a. Can you please confirm that all 1367 patients who were admitted to hospital between 1st January 2021 and 21st December 2021 had tested positive by returning a positive PCR test result at 28 CT?
4b. Has the CT cut off benchmark varied within the period in question? If so, please provide a breakdown of any periods where the cut off benchmark has been altered.

Download response Covid, vaccination and deaths 280122.docx